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Abstract
Several well-characterized fungal proteins act as prions, proteins capable of
multiple conformations, each with different activities, at least one of which is self-
propagating. We report a protein-based heritable element that confers resistance to
glucosamine, [GAR+]. Genetically it resembles other yeast prions: it appears
spontaneously at a rate higher than mutations and is transmissible by non-Mendelian,
cytoplasmic inheritance. However, [GAR+] is in other ways profoundly different from
known prions. [GAR+] propagation involves Pmal, the plasma membrane protein pump,
and [GAR+] formation is induced by Stdl, a member of the Snf3/Rgt2 glucose signaling
pathway. Also, [GAR+] does not appear to involve the formation of an amyloid template
and the prion state represents only a fraction of the Pmal protein in the cell,· consistent
with the prion form constituting a complex between Pmal and Stdl, a much lower
abundance protein. [GAR+] propagation is subject to a strong species barrier, as
substitution of PMAl from other Saccharomyces species blocks propagation to s..
cerevisiae PMAl. Direct competition between [gar-] and [GAR+] cells indicate that cells
carrying [GAR+] have an advantage under certain environmental conditions. [GAR+]
appears spontaneously in a yeast isolated from a variety of sources and can be induced by
co-culturing yeast and a number ofStaphylococcus species. Overall, [GAR+] expands the
conceptual framework for self-propagating protein-based elements of inheritance to
include non-amyloid, potentially multicomponent systems such as transmembrane
proteins and signal transducers.
Summary 
 
 
Several well-characterized fungal proteins are capable of acting as prions: 
proteins capable of multiple self-propagating conformations, each with different 
activities.  The different prion conformers in cells with identical genotypes exhibit 
multiple different phenotypes.  The most thoroughly characterized phenotypes are [PSI+], 
the prion form of the translation termination factor Sup35, and [URE3], the prion form of 
the nitrogen catabolite repressor Ure2.  Both are well studied in S. cerevisiae but are 
conserved in diverse fungi, including K. lactis and C. albicans.  The Sup35 and Ure2 
proteins enter into an aggregated, amyloid-like conformation in the [PRION+] state.  
Whether many proteins can form prions and whether all prions involve an amyloid-like 
state are points of considerable debate. 
Here I present evidence that the previously unexplained non-Mendelian element, 
[GAR+], is a novel type of prion that does not aggregate or form an amyloid.  [GAR+] 
(glucosamine resistant) was isolated in a screen for resistance to the non-metabolizable 
glucose analog D-(+)-glucosamine.  It showed non-Mendelian inheritance patterns and 
could not be explained by contemporary knowledge (Ball et al., 1976; Kunz and Ball, 
1977).  I found that the genetic attributes of [GAR+] overlap with those of fungal prions: 
it appears spontaneously at a high frequency (~5 in 104 cells), and segregates in a non-
Mendelian 4 [GAR+] to 0 [gar-] pattern following meiosis.  [GAR+] can be inherited by 
cytoplasmic transfer without nuclear exchange (cytoduction).  Also, [GAR+] can be 
converted to [gar-] by altering levels of molecular chaperones (i.e. “cured”). 
I found that [GAR+] results from the association of Pma1, the plasma membrane 
proton pump, and Std1, a member of the Snf3/Rgt2 glucose signaling pathway.  Transient 
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overexpression of STD1 strongly induces [GAR+] but STD1 was not required for [GAR+] 
propagation.  Instead, PMA1, and possibly STD1, are involved in [GAR+] propagation.  
[GAR+] thus presents a marked distinction from known prions in having separable 
induction and propagation elements.  [GAR+] further differs from other yeast prions in 
that it does not cause aggregation of the prion determining protein.  Instead, Pma1 is still 
located at the plasma membrane in [GAR+] but associates with Std1 rather than its 
ortholog, Mth1, which Pma1 associates with in the [gar-] state.  Mutations in 
phosphorylation sites in Pma1 alter the frequency of [GAR+] within a population and 
show defects in signaling down the Snf3/Rgt2 pathway, suggesting that Pma1 is involved 
in glucose signaling. 
Finally, I address the question of whether [GAR+] has any role in wild yeasts.  I 
found that the average rate of appearance of [GAR+] is 20-fold higher in strains isolated 
from fruit than in clinical isolates.  Using quantitative trait locus (QTL) analysis, I found 
that the rate of [GAR+] is influenced by regions on chromosome VIII and chromosome 
XIV.  [GAR+] has an increased growth rate compared to [gar-] when grown in a mixture 
of glucose and other carbon sources, suggesting that it might have a competitive 
advantage under particular conditions as well.  Thus, I conclude that [GAR+] is a protein-
based heritable element that can be induced in non-lab yeast and might confer a 
competitive advantage on its host. 
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Chapter One: 
 
Introduction 
 
Inheritance of biological information across generations is essential for life.  The 
primary example is the temporal heritability of nucleic acids, which carry the information 
necessary for the production of a new organism.  Information can also be passed 
spatially, such as signaling between types of tissue in a multicellular organism and in the 
quorum sensing phenomenon in bacteria and fungi.  However, this type of information is 
not generally heritable. 
Cross-generational inheritance can be either Mendelian or non-Mendelian.  
Mendelian inheritance involves the chromosomal-based inheritance patterns described by 
Mendel’s theories of segregation.  It is the predominant mechanism for information 
transfer between generations and is essential for biological replication.  “Mendelian” was 
historically used to describe only inheritance patterns that follow the simple phenotypic 
segregation predictions of Mendel’s monoallelic traits but was eventually expanded, 
through the work of Bateson and Punnett, to include multigenic, chromosomal traits.  
Chromosomal traits are largely encoded by the sequence of nucleic acid basepairs. 
Epigenetic inheritance is caused by chemical changes to the nucleic acids that do 
not modify the sequence, such as DNA methylation, that changes the way information is 
used but not the basic information recorded.  This can occur on a cellular/organismal 
level or a generational level.  Cellular differentiation, which prevents cells from returning 
to a pluripotent state, is the result of epigenetic modification that inactivates factors 
involved in pluripotency (Reik et al., 2001).  On a generational level, parental imprinting 
can alter the expression of particular regions of chromosomes depending on whether the 
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chromosome originated in sperm or egg (Nafee et al., 2008).  Imprinting can also affect 
the penetrance of alleles.  For example, a particular allele in sheep gives rise to its 
associated phenotype only when the allele is paternally inherited (Cockett et al., 1996). 
Non-Mendelian inheritance refers to traits whose segregation patterns do not 
follow those of chromosomes.  The most salient examples are extranuclear and 
infectious.  Following the reemergence of Mendelism in the late 19th century, a number 
of investigations tested inheritance patterns of easily observable plant phenotypes; some 
of these led to the accidental observation of extranuclear traits.  Carl Correns and Erwin 
Baur, who simultaneously studied leaf color variegation in different plants, showed that 
Mirabilis jalapa and Pelargonium zonale leaf color violates Mendel’s laws; this was the 
first cytoplasmically inherited trait described.  The Mirabilis leaf color variegation trait 
was eventually identified as a chloroplast mutation by Ruth Sager (Goldschmidt, 1950).  
In addition to organelle-based traits, virus- and plasmid-based inheritance was eventually 
categorized as extranuclear (infectious) and non-Mendelian.  This allowed the term “non-
Mendelian” to cover an extremely wide variety of mechanisms of inheritance. 
 
Scrapie, Prions, and the “slow virus” 
The work on the “transforming principle,” first Frederick Griffith (1928) and then Avery, 
McCarty, and MacLeod (1944) established that DNA and not protein is the heritable 
macromolecule.  Therefore, explanations for a group of slow-acting central nervous 
system diseases, now known to be caused by protein, initially centered around the “slow 
virus” hypothesis (Sigurdsson, 1954).  These included scrapie, a disease of sheep and 
goat; kuru, which infected the Fore tribe in New Guinea; and human prion diseases such 
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as Creutzfeldt-Jacob (CJD, which can be either familial or sporadic).  Connections 
between scrapie and CJD  and kuru and scrapie were suggested based on infectivity and 
the pathology of the diseases (Hadlow, 1959; Klatzo et al., 1959). 
 Early studies of scrapie showed that it was caused by a biological factor that was 
capable of reproducing itself.  An infectious agent found in brain homogenate could still 
cause disease following seven serial-dilution passages through sheep, which the authors 
calculated must have diluted the original by agent 10-18 (Stamp et al., 1959).  However, 
the infectious agent was still active after eight hours at 100°C, treatment with 
acetylethyleneimide, treatment with formalin (Stamp et al., 1959), or exposure to UV 
radiation (Alper et al., 1967), all of which had been shown to inactivate viruses.  
Proposed explanations included self-replicating polysaccharides (Field, 1966), a “true” 
virus combined with a heat-resistant agent (Stamp et al., 1959), a completely novel 
macromolecule (Alper et al., 1967), or a protein (Pattison and Jones, 1967). 
Another unusual aspect of diseases such as scrapie and CJD is that patients did 
not mount an immune response, as would be expected in a viral infection (Prusiner, 
1998).  This lack of immune response was one reason why investigators hypothesized 
that these diseases might be caused by a non-viral agent.  However, the conceptual 
framework for an infectious element that did not involve nucleic acid did not exist in the 
1950s. 
 Initial resistance to the idea that scrapie might be caused by a protein-based agent 
was based on two factors: DNA was known to be the hereditary material and a 
mechanism for self-replicated proteins was not known.  There was, as described by J.W. 
Griffith, “fear that the existence of a protein agent would cause the whole theoretical 
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structure of molecular biology to come tumbling down.”  Griffith then proposed several 
mechanisms by which a protein could cause a heritable phenotype.  One of these 
depended on contemporary ignorance concerning the function of the adaptive immune 
system.  The other two, though, are quite impressive.  One involved the scrapie-causing 
protein acting as an inducer for the gene that encodes it.  The other is a kinetic model in 
which the scrapie agent is a multi-subunit oligomer for which dimer formation is highly 
energetically unfavorable but addition of further subunits is very energetically favorable 
(Griffith, 1967). 
 Contemporary proponents of the Central Dogma, including Francis Crick, argued 
that Griffith’s models violated the Central Dogma (Crick, 1970).  However, the 
contemporary discovery of reverse transcriptase established precedent for expanding the 
Central Dogma, albeit only for nucleic acids.  The protein agent model received a further 
boost when work from Stanley Prusiner’s lab demonstrated partial purification of the 
infectious scrapie agent.  The agent was termed “prion” for “proteinaceous infectious 
particle,” and no detectable nucleic acids were found in the purification (Prusiner et al., 
1981).  A nearly homogenous purification (Bolton et al., 1982) identified one particular 
protein, which was named PrP, for prion protein. 
The discovery that PrP was a normal protein in the mammalian brain provided a 
stunning change in the prion concept (Prusiner, 1998).  It was no longer necessary to 
postulate that an exogenous protein had replicative capability.  Rather, the infectious 
agent merely had to change the conformation of a protein that was already present in or to 
replicate infectivity.  Indeed, PrP protein present in normal brain is rich in α-helices and 
the form found in infectious material is β-sheet rich (Harris and True, 2006). 
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PrP, is a small (~27kDa) GPI-linked plasma membrane protein.  Initial evidence 
in favor of PrP being the scrapie agent was mostly correlative.  The PrP proteins of 
patients with familial forms of prion disease carry mutations that are genetically linked to 
the disease (Hsiao et al., 1989; Gabizon et al., 1993).  Mice in which the PrP gene has 
been knocked out do not acquire scrapie when infected with scrapie brain homogenate 
(Weissmann et al., 1994) and mice overexpressing PrP show higher rates of spontaneous 
scrapie disease (Westaway et al., 1994).  The transmissible disease-causing scrapie form 
of PrP is termed “PrPSc,” named after scrapie disease; the non-infectious form of PrP is 
termed “PrPC,” for the normal “cellular” form. 
A few scientists still object to the protein-only theory of scrapie.  One argument is 
that trace amounts of nucleic acids could remain in PrP purifications (Manuelidis et al., 
1995).  Some propose that PrP could be a receptor for a virus that causes scrapie, which 
would explain why homozygous PrP null mice are resistant to scrapie (Chesebro and 
Caughey, 1993).  The best way to resolve this debate would be to induce scrapie 
infectivity following injection of a purified, recombinant, scrapie conformer of PrP into 
wildtype animals.  Researchers have come close, but the acid test has yet to be fully 
realized.  Recombinant PrP in a β-sheet rich conformation was injected into mice and 
caused disease.  However, this has only been seen with very large innocula and in mice 
overexpressing PrP at levels just below those which cause spontaneous disease (Legname 
et al., 2004).  Thus it has been argued that this injection only hastens the natural disease 
process.  Among the most convincing pieces of evidence in favor of the protein-only 
hypothesis is that PrPSc can convert large amounts of PrPC to PrPSc in vitro when PrPC is 
in extreme excess.  The newly converted PrPSc was serially diluted and the conversion of 
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PrPC to PrPSc continued, even after the starting material was so dilute that it could no 
longer be detected (>103-fold dilution) (Saborio et al., 2001).  Indeed, in vitro conversion 
of PrPC to PrPSc can be detected even after the starting PrPSc material has been diluted up 
to 10-55.  Furthermore, in vitro converted PrPSc material has been shown to be infectious 
in a mouse model after 10-20 dilution of the starting material (Castilla et al., 2005).  This 
provides powerful evidence that protein conformational conversion alone is sufficient for 
prion disease. 
 
Non-Mendelian inheritance and fungal prions 
 Protein-based elements with genetic properties that are normally reserved for 
nucleic acids (“prions”) are also found in fungi, where they are both infectious and 
heritable.  In contrast, mammalian prions are only infectious. (Uptain and Lindquist, 
2002; Chien et al., 2004; Wickner et al., 2004; Shorter and Lindquist, 2005).  The first 
genetic elements later realized to be prions found in S. cerevisiae were [URE3] 
(Lacroute, 1971) (caused by the protein Ure2 (Wickner, 1994)) and [PSI+] (Cox, 1965) 
(caused by the protein Sup35 (Chernoff et al., 1993; Ter-Avanesyan et al., 1993; Doel et 
al., 1994; Ter-Avanesyan et al., 1994; Patino et al., 1996)).  Another prion, [Het-s], was 
genetically characterized in the filamentous fungus in Podospora anserina (Rizet, 1952) 
and is now known to be caused by the protein Het-s (Coustou et al., 1997).  Later prions 
identified include [RNQ+] (also called [PIN+]) (Derkatch et al., 2000; Sondheimer and 
Lindquist, 2000; Derkatch et al., 2001) and [SWI+] (Du et al., 2008) in S. cerevisiae and 
[Cin] in S. pombe (Collin et al., 2004). 
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Fungal prions also exhibit diverse phenotypes.  [URE3] is involved in the uptake 
of nitrogen sources (Lacroute, 1971) and [PSI+] showed increased read-through at stop 
codons (Cox, 1965).  [Het-s] causes heterokaryon incompatibility, in which hyphae from 
genetically diverse P. anserina mycelia die after cell-cell fusion (Rizet, 1952).  However, 
all the fungal prions had distinct and similar genetic attributes. 
Early work on fungal prions described their non-Mendelian patterns of 
inheritance.  Naturally this led to comparisons with known mechanisms of infectious or 
non-Mendelian inheritance, such as fungal viruses (mycoviruses) and organellelar traits.  
These prions, however, showed their own distinct inheritance patterns (figure 1.1) that 
did not match the genetic characteristics of any of the other mechanisms of non-
Mendelian inheritance (table 1.1).  Eventually Reed Wickner postulated that that [URE3], 
and by extension [PSI+], were analogous to mammalian prions in that they were caused 
by a protein-based heritable element (Wickner, 1994).  Still, because of study of fungal 
prions began with non-Mendelian inheritance and progressed to protein-based heritable 
elements (prions), the former will be discussed first. 
 
Non-Mendelian Inheritance in S. cerevisiae 
 Prions are one of many mechanisms of non-Mendelian inheritance in S. 
cerevisiae.  These include mitochondrial traits, dsRNA viruses, ssRNA viruses, plasmids, 
retroviral transposons, and retro-transposing mitochondrial introns.  Most of these modes 
of inheritance are infectious, meaning that cytoplasmic transfer is sufficient for 
inheritance.  The genetic characteristics of these non-Mendelian mechanisms overlap to 
some extent with those of yeast prions.  Distinguishing attributes include de novo 
 19
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Figure 1.1: Genetic attributes of yeast prions based on self-propagating amyloid templates 
a) Yeast prions appear and disappear spontaneously (“metastable”).  Molecules of protein 
occasionally assemble into self-templating aggregated conformations.  These can then be 
passed from mother to daughter during mitosis.  The [PRION+] element is stably 
inherited because the daughter cell’s protein is efficiently templated by aggregates 
inherited from its mother.  b) Aggregates are occasionally not passed to daughters, 
resulting in heritable loss of the prion.  c) Prions are dominant and inherited in a non-
Mendelian manner.  When an aggregate-carrying [PRION+] cell is mated to a [prion-] 
cell, the resultant diploid contains heritable [PRION+] aggregates that can seed [prion-] 
protein into the [PRION+] conformation.  The [PRION+] element is therefore dominant.  
[PRION+] aggregates are passed to daughter cells during meiosis, resulting in non-
Mendelian 4 [PRION+] : 0 [prion-] segregation.  d) Prions are passed to mating partners 
by cytoplasmic mixing.  When a mating is performed between a [PRION+] and a [prion-] 
cell, one of which carries a kar1 mutation, cells fuse and the cytoplasm mixes but nuclei 
do not fuse and nuclear material is not exchanged.  Instead the binucleate cell produces a 
monokaryotic bud, which contains mixed cytoplasm but only one parental nucleus 
(“cytoductant”) (Conde and Fink, 1976).  The [PRION+] element is transmitted in these 
“cytoduced” cells that contain cytoplasm from the [PRION+] parent but a nucleus from 
the [prion-] parent.  Prion elements can therefore be inherited independently of the 
nucleus.  e) Changes in levels of chaperones, which are proteins involved in the folding 
and unfolding of other proteins, can prevent [PRION+] aggregate inheritance.  When 
chaperones levels increase, such as in response to heat or chemical stress, protein 
aggregates are no longer efficiently passed down to daughter cells.  This converts cells 
from [PRION+] to [prion-].  Chaperones can block aggregate inheritance by changing 
prion folds or other mechanisms.  Chaperones can also promote prion function by 
shearing aggregates.  In this case loss of shearing results in loss of the prion. 
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 acquisition rates, whether these traits show chaperone-dependent reversible curing, and 
whether the phenotype of interest can be induced by protein-only transformation (table 
1.1). 
Chaperones are proteins that assist in the folding of other proteins.  Perturbations 
in chaperone levels can “cure” prions by preventing the inheritance of [PRION+] protein 
aggregates by daughter cells.  This curing and reappearance of a phenotype is specific to 
fungal prions and is an important feature in distinguishing prions from viruses (Shorter 
and Lindquist, 2005) and other forms of infectious inheritance. 
The [PRION+] form of a protein is induced by transient overexpression of the 
prion-determining protein.  This attribute was fundamental to Wickner’s original 
argument that [URE3] represented an altered state of the Ure2 protein (Wickner, 1994).  
The particularly surprising aspect of this prion attribute is that a temporary change in 
protein levels is sufficient to induce a permanent change in the cell’s phenotype (Uptain 
and Lindquist, 2002; Wickner et al., 2004).  This ability is not observed in any other 
mechanism of non-Mendelian inheritance.  Furthermore, it has been successfully 
exploited many times to aid in the identification of new prions  (Derkatch et al., 2001) 
and prion-determining proteins (Chernoff et al., 1993; Ter-Avanesyan et al., 1993). 
 A defining attribute of prions is protein-only transformation.  As prions are 
heritable proteins, the ultimate proof of protein-based inheritance is inducing a prion  
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Table 1.1: Non-Mendelian inherit  ance in yeast
  
spontaneous, 
frequent 
appearance dominant
non-
Mendelian 
inheritance 
infectious 
(cytoplasmic) 
inheritance 
chaperone-
dependent 
curing 
reversible 
chaperone-
dependent 
curing 
Prion    + + + + + +
organelle trait + sometimes + + - - 
mycovirus       - + + + -* -
plasmid       - + + + - -
transposon       + sometimes - - - -
retro-transposing 
intron + sometimes -    - - -
 *correct folding of the KIL+ toxin requires ER lumen chaperones  
 
 
 
 
phenotype by transformation of prion conformers produced in vitro; this was 
accomplished in 2002 for [Het-s] and in 2004 for [PSI+] (Maddelein et al., 2002; King 
and Diaz-Avalos, 2004; Tanaka et al., 2004).  As the Het-s and Sup35 protein had been 
purified from E. coli and the prion-inducing fibers created in vitro, these data firmly 
establish that protein fibers are sufficient to induce a prion.  This method has since been 
used to indisputably demonstrate protein-only inheritance of [URE2] (Brachmann et al., 
2005), and [RNQ+] (Patel and Liebman, 2007).  Protein-only transformation is always 
sufficient to demonstrate that a phenotype is based on a prion.  The transformation 
procedure necessitates that the infectious protein conformation can be produced in vitro.  
However, this technique only works if the prion-determining protein can be purified from 
E. coli and if it can be converted into the stable prion conformation in vitro.  Because it is 
a relatively new technique and was not used historically to distinguish prions from other 
mechanisms of infectious inheritance and because it is virtually impossible to perform if 
the prion conformation of the protein cannot be stably induced in vitro, protein 
transformation is not discussed in detail in the following section. 
 Yeast prions and organellar traits have a number of genetic attributes in common.  
Yeast has long been used as a model organism to study organelle inheritance, which was 
the first mechanism of extranuclear non-Mendelian inheritance discovered (Goldschmidt, 
1950). The first mitochondrial mutation, petite (ρ0), was isolated in S. cerevisiae 
(Ephrussi et al., 1949).  However, the first mitochondrial mutations to be identified as 
such were isolated in Neurospora (Mitchell and Mitchell, 1952).  Organelle inheritance 
violates Mendel’s laws of segregation and independent assortment because organelles are 
passed on to all progeny, either bi- or uni-parentally, following meiosis. 
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Mitochondrial inheritance 
Yeast mitochondria are inherited cytoplasmically in a polarized, actin-dependent 
manner that is linked to cell cycle control (Boldogh et al., 2001).  Unlike mammalian 
mitochondrial inheritance, yeast mitochondria show biparental inheritance.  Indeed, the 
diploid colony (i.e. several generations downstream of the mating event) formed by 
mating two haploids is highly heterogeneous: markers from both parental cells are 
present in the colony and both or just one are present in individual cells.  Within 20 
generations each diploid cell will contain only a single mitochondrial marker (Dujon et 
al., 1974).  There is some stochasticity in the process, as either marker could be present in 
the end cell tested, but the yeast cells eventually become mitochondrially “pure.” 
Mitochondrial traits superficially resemble yeast prions in that they show 4:0 
segregation and infectious inheritance.  Furthermore, the heterogeneity typical of 
mitochondrial crosses superficially resembles chaperone-dependent curing of prions in 
that the phenotype of interest is lost over the course of generations.  However, “curing” 
of mitochondrial traits is not reversible, as the chaperone-mediated curing of yeast prions 
is, nor does it depend predominantly on chaperones, the protein folding machinery of the 
cell.  Also, once a mitochondrial trait has reached purity, it is no longer be curable.  The 
distinguishing characteristics between yeast prions and mitochondrial traits is thus 
reversible curing. 
 
Mycoviruses 
 It is also important to compare mycoviruses to fungal prions because the 
inheritance patterns of the two are quite similar and can be somewhat difficult to 
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distinguish.  S. cerevisiae contains both dsRNA and ssRNA viruses.  dsRNA viruses in 
yeast belong to two major families, L-A and L-BC, or a subfamily, M.  L-A and L-BC 
each contain two ORFs, one for a coat protein (Gag) and one for an RNA polymerase 
(Pol).  L-A and L-BC are sufficiently widespread that a majority of wild yeast isolates 
contain a member of one or both families (Wickner, 1996a).  These viruses are spread 
horizontally by cell-cell fusion (primarily by mating but sometimes by heterokaryon 
formation) and vertically by mitosis and meiosis; they show 4:0 meiotic segregation.  
Yeast viruses do not have a known mechanism of extracellular spread (i.e. cell lysis), 
presumably due to the difficulty of crossing the yeast cell wall.  They are therefore 
occasionally referred to as “virus-like particles” (VLPs) for historical reasons (Schmitt 
and Breinig, 2006). 
 L-A family of viruses are frequently found in conjunction with a member of the 
smaller M family of dsRNA viruses, which together cause a “killer” phenotype.  Yeast 
that are KIL+ secrete a peptide toxic to kil- yeast.  The M family has three known 
members, M1, M2, and M28.  Each contains a single open reading frame encoding a 
preprotoxin (pptox; K1, K2, and K28, respectively).  M viruses confer both the ability to 
produce the killer toxin and immunity to it.  As M viruses contain neither gag nor pol 
genes, they require the presence of L-A viruses to replicate (Schmitt and Breinig, 2006).  
The presence of particular chromosomal alleles is also necessary for the maintenance of 
dsRNA virus (Wickner, 1980).  Therefore, the phenotype exhibited by these viruses, 
KIL+, requires at least two viruses and one chromosomal genetic element for exhibition.  
The complexity of the KIL+ phenotype has resulted in occasional speculation that it 
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might on some level involve a heritable protein element (Uptain and Lindquist, 2002).  
For this reason KIL+ is discussed in depth here. 
 The “killer” phenotype requires the synthesis and secretion of one of the three 
toxic peptides coded by the M viruses.  These peptides consist of five regions and an 
HDEL-retention sequence (Schmitt and Breinig, 2006).  These regions, N-terminius to C-
terminus, are the secretion signal (“pre”), a middle region (“pro”), α, γ, and β.  Through 
interaction with cytosolic and luminal chaperones and protein modification enzymes, the 
toxin precursor protein is processed in the ER and golgi, then secreted into the culture 
medium (Martinac et al., 1990). 
 Because the processing of killer toxin involves chaperones, KIL+ shows 
inheritance patterns similar to yeast prions.  However, since killer toxin is secreted, it can 
be assayed for in the yeast growth medium.  One can therefore distinguish between yeast 
prions and KIL+ by testing whether phenotypes of interest can be conveyed 
independently of cells. 
 S. cerevisiae also contains ssRNA viruses (genus: narnavirus (Van Regenmortel 
et al., 2000)) that are spread by cytoplasmic exchange (mating) and show 4:0 non-
Mendelian segregation.  20S (Kadowaki and Halvorson, 1971), 23S  ssRNAs, and 
replicative intermediates W and T have so far been characterized (Wickner, 1996b).  20S 
and 23S ssRNA code only for an RNA polymerase and lack capsid proteins.  Without 
capsid proteins, 20S ssRNA (and presumably 23S ssRNA) is protected from degregation 
by interaction with its RNA pol proteins (Fujimura and Esteban, 2007).  20S and 23S are 
highly contagious and found in most yeast laboratory strains (Wickner, 1996b) but their 
phenotypic consequences have not been well characterized.  Neither 20S nor 23S 
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narnaviruses have been shown to be curable (Solorzano et al., 2000).  Therefore, although 
ssRNA viruses show non-Mendelian segregation, they would not resemble prions 
because they would not be susceptible to chaperones, would not be induced by transient 
overexpression of causal genes, and could not be transmitted by transformation with 
protein. 
 Overall, the genetic characteristics of fungal viruses very closely resemble those 
of fungal prions.  Segregation is 4:0 following meiosis and phenotypes are inherited 
independently of the nucleus, as shown by cytoduction.  Some phenotypes caused by 
viruses, such as KIL+, are sensitive to chaperones.  However, KIL+ and viruses in general 
do not reappear in yeast cells from which they have been “cured” due to chaperone 
effects (reversible curing). 
 
Plasmids 
 Inheritance of plasmids and other “selfish” genetic elements is by definition 
extrachromosomal and shows non-Mendelian segregation (Beggs, 1978).  Nonetheless, 
plasmids are not technically infectious, as they do not show efficient cytoplasmic 
inheritance (cytoduction).  2µ plasmids are found in the majority of yeast strains but they 
are intra-nuclear.  Mutations that alter chromosome segregation affect plasmid 
partitioning and plasmids missegregate in tandem with chromosomes (Velmurugan et al., 
2000).  More recent work showed that the cohesin complex, which is involved in sister 
chromatid segregation and is necessary for timely and proper segregation of 
chromosomes, is also found on 2µ plasmids (Mehta et al., 2002).  A 2µ plasmid-
 28
dependent phenotype, albeit showing non-Mendelian segregation, would be “cured” by 
mutants that affect chromosome segregation and not by chaperones. 
 
Mechanisms of spontaneous phenotypic acquisition: Ty elements and infectious introns 
 Another mechanism for the spontaneous acquisition of new phenotypes is Ty 
transposition.  The Saccharomyces cerevisiae nuclear genome contains five families of 
retrotransposable elements (Ty1-5) that are capable of causing phenotypic change 
(Lesage and Todeschini, 2005).  Ty elements consist of two long terminal repeats (LTR) 
flanking two open reading frames that code for enzymes needed for replication.  Ty 
elements are fairly common in the yeast genome (3.1% of S288C sequence is predicted to 
consist of Ty elements; (Kim et al., 1998)). 
 There are three possible ways that Ty factor integration can induce change: 
altered expression from an adjacent gene; novel regulation of an adjacent gene, or 
genomic rearrangement due to recombination between Ty elements.  When Ty1 is 
inserted in a 5’ upstream region in the same orientation as the downstream gene it results 
in decreased expression from the adjacent gene because the Ty1 element replaced the 
regulatory elements of the gene.  Ty1 has also been shown to result in novel regulation 
when inserted 5’ and within 175bp of an ATG in the opposite orientation of a gene 
(Lesage and Todeschini, 2005) because it contains binding sites for a number of 
transposons (Gray and Fassler, 1993; Baur et al., 1997; Madhani and Fink, 1997). 
 Another mechanism of non-Mendelian inheritance in S. cerevisiae is that of self-
splicing “infectious” introns.  They are found predominantly in the mitochondria but can 
also be nuclear.  Transposition can be either site-specific (group I) (Lambowitz and 
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Belfort, 1993) or random (group II) (Mueller et al., 1993).  Intron insertion can change 
the phenotype of a cell by either altering expression from a gene of by genomic 
rearrangements via recombination between intron copies (Mueller et al., 1993). 
 Overall, retrotransposable elements and infectious introns do not greatly resemble 
yeast prions genetically.  They phenomena are similar to prions, however, in that they 
allow for spontaneous acquisition of new phenotypes.  These novel phenotypes tend to 
appear at rates similar to genetic mutation but sometimes appear at higher rates (Taguchi 
et al., 1984).  However, once the Ty- or intron-induced changes are inserted into the 
genome, the resultant phenotypes show Mendelian segregation.  Therefore, they easily be 
differentiated from fungal prions by analysis of segregation patterns. 
 
Fungal prions 
 Prion-dependent phenotypes in fungi were identified in a manner similar to 
mammalian prions: researchers found phenotypes that could not be explained by 
contemporary knowledge of molecular biology.  The earliest of these was [Het-s], a 
cytoplasmic element in P. anserina involved in mating-type incompatibility (Rizet, 
1952).  Two later-identified, albeit better-studied, phenomena in Saccharomyces 
cerevisiae, [URE3] (involved in uptake of nitrogen sources) (Lacroute, 1971) and [PSI+] 
(which showed stop codon read-through) (Cox, 1965) were described as being 
extrachromosomal, inherited by infectious cytoplasmic exchange (cytoduction), non-
viral, non-mitochondrial, and not due to a known plasmid (Tuite et al., 1982).  All of 
these early prions were defined by their genetic characteristics (see figure 1.1), which are 
unique to prions (Wickner, 1994). 
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 In 1994, Reed Wickner suggested that [URE3], and by extension [PSI+], represent 
an S. cerevisiae phenomenon similar to mammalian prions: that a phenotype was caused 
by an alternative conformation of a protein (Wickner, 1994).  There was, however, one 
key difference: fungal prions are heritable and infectious, whereas mammalian prions are 
only infectious.  The heritability of the fungal prion phenotype allowed for the 
elucidation of a distinct set of genetic characteristics, outlined by Wickner, that formed 
the basis for identifying additional fungal prions (figure 1.1) (Derkatch et al., 2000; 
Sondheimer and Lindquist, 2000; Derkatch et al., 2001; Collin et al., 2004; Du et al., 
2008). 
[URE3] showed non-Mendelian segregation and cytoplasmic inheritance 
(Lacroute, 1971), attributes shared by mycoviruses, the non-Mendelian elements that 
most closely resemble prions (table 1.1).  However, what surprised Wickner was that the 
gene URE2 was required for [URE3] maintenance but that a ure2 knockout mutant, 
∆ure2, exhibited the same phenotype as [URE3] (Aigle and Lacroute, 1975; Wickner, 
1994).  This was shocking; Wickner pointed out that one could not expect a heritable 
element to have the same phenotype as a loss-of-function mutation in a gene that is 
required for the maintenance of that heritable element. 
With mycoviruses, the knockout phenotypes of genes required for production of 
L-A and/or M viruses (e.g. TOP1, MAK3, MAK10) are different from the phenotype 
caused by the element they control, the viruses themselves.  The knockout phenotypes of 
∆top1, ∆mak3, and ∆mak10 include sensitivity to DNA-damaging agents, elongated 
telomeres, and a growth defect on non-fermentable carbon sources, respectively.  The 
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viral phenotype is the ability to kill yeast cells that do not carry L-A and M viruses 
(“killer” phenotype) (Wickner, 1996a). 
 Wickner’s second observation that [URE3] is inconsistent with a mycovirus was 
that transient overexpression of the URE2 gene product increases the rate of appearance 
of the [URE3] prion.  Fungal viruses have no known mechanism of extracellular spread, 
so in contrast to mammalian prions, the argument cannot be made that Ure2 represents a 
receptor for the [URE3] virus.  However, if [URE3] was an altered, prion, form of Ure2, 
an increase in the amount of Ure2 protein by overexpression of the gene product would 
increase the probability of the protein entering the [URE3] form (Wickner, 1994).  It was 
also intriguing that the overexpression phenotype of URE2 was the same as [URE3] and, 
as mentioned previously, ∆ure2 (Aigle and Lacroute, 1975).  None of these would be 
expected for virus-based heritable elements (Wickner, 1996a, b). 
The final puzzling attribute of [URE3] was that it showed reversible curing.  
Treatment with guanidinium hydrochloride (guanidine or GdHCl) (Wickner, 1994), 
converts [URE3] to [ure3] with almost 100% efficiency.  Wickner was readily able to 
reisolate [URE3] derivatives from cured cells.  The reappearance of [URE3] following 
curing implies that the [URE3] “replicon” is not removed during curing.  When 
mycoviruses are cured, however, the virus phenotype cannot spontaneously reappear in 
the cured strain.  The combination of curing data with data linking the URE2 gene 
product with propagation and induction of [URE3] suggest that [URE3] is an alternative 
state of the Ure2 protein (Cox, 1994b; Wickner, 1994). 
 Wickner’s original yeast prion paper is very interesting and important for what it 
did argue but it is also worth noting what it did not argue.  Primarily, Wickner suggested 
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that [URE3] might be the result of a conformational changes but he was not adamant 
about a precise mechanism.  The definition and the argument were entirely genetic and 
allow for a wide range of physical models.  Possibilities include a purely conformational 
difference between [prion-] and [PRION+] macromolecules, self-propagating covalent 
modification such as glycosylation or phosphorylation causing an “altered” state that 
creates a new phenotype but also causes the proteins to perpetuate the modification, auto-
activating enzymes, or self-maintaining signaling cascades.  Contemporary reviews 
focused on conformational change or auto-activating enzymes as mechanisms (Cox, 
1994a; Wickner et al., 1995).  Notably, the mammalian prion field also did not initially 
make any claim about conformation, modification, structure, etc., and focused solely on 
whether the heritable agent of the infectious scrapie/CJD/kuru pathogen is proteinaceous.  
In any case, proteins in multiple kingdoms of life can perform functions traditionally 
thought to be reserved to nucleic acids (figure 1.1). 
 
[PSI+] and conformational change 
 [PSI+] was identified in 1965 as an permanent, non-Mendelian enhancer of the 
SUQ5 stop-codon suppressor (Cox, 1965).  [PSI+] was originally thought to be caused by 
a plasmid or some unknown nucleic acid determinant, although that was controversial 
(Cox et al., 1988).  The plasmid theory was based on mutagenesis studies showed that 
[PSI+] could be converted to [psi-] by exposure to UV and that this conversion to [psi-] 
could by reduced by induction of DNA repair enzymes. (Later it was shown that Hsp104, 
the protein conformation remodeling factor that cures [PSI+], is induced by many 
stresses, including UV (Sanchez et al., 1992)).  The kinetics were similar to those of 
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mitochondrial mutations, implying a nucleic acid determinant (Tuite and Cox, 1980).  
Claims were made that transformation of DNA from a [PSI+] strain was capable of 
converting [psi-] and that this activity co-purified with a 3µ circle (Dai et al., 1986), but 
this was not reproduced.  (Indeed, since that time it has been shown that aging yeast cells 
characteristically generate episomes of ribosomal DNA and this was likely the origin of 
the circles (Sinclair and Guarente, 1997)). 
 Work relating [PSI+] to a change in protein folding started because the protein 
chaperone Hsp104 was shown to cure [PSI+] to [psi-] (Chernoff et al., 1995).  
Chaperones, which are necessary for the proper folding of proteins, had not been shown 
to act on nucleic acids, thus implying that [PSI+] might be caused by a heritable protein 
fold.  Wickner had presciently suggested in his seminal [URE3] paper that [PSI+] might 
be propagated by a similar protein-based mechanism (1994). 
[PSI+] had been linked to the SUP35 gene prior to Wickner’s publication.  
Specifically, overexpression of either full-length or the N-terminus of SUP35 increased 
the percentage of read-through of stop codons (Ter-Avanesyan et al., 1993) and induced 
[PSI+] (Chernoff et al., 1993).  In fact, the N-terminal region of SUP35 is required for 
[PSI+] maintenance (Ter-Avanesyan et al., 1994).  A dominant point mutant that 
prevented [PSI+] propagation was mapped to the N-terminal region of SUP35 (Doel et 
al., 1994). 
Direct support for the proteinaceous nature came when it was discovered that the 
Sup35 protein in the cell forms large, insoluble aggregates in the [PSI+] form but remains 
soluble in [psi-] (Patino et al., 1996; Paushkin et al., 1996).  Like PrPSc, Sup35 from 
[PSI+] cells is partially resistant to proteinase K digestion.  Finally, changes to the state of 
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Sup35 correlated with the switch between [psi-] and [PSI+].  Sup35 was fused to GFP and 
its localization observed; in [psi-], Sup35-GFP showed diffuse, cytosolic localization.  In 
[PSI+], Sup35-GFP rapidly formed aggregates (Patino et al., 1996).  Curing of [PSI+] to 
[psi-] correlated with the return of Sup35 to a soluble state (Chernoff et al., 1993; Patino 
et al., 1996).  Combined, these data suggested that [PSI+], and by extension [URE3], 
represented an altered aggregated form of the Sup35 (and Ure2) proteins that had an 
infectious character: the ability to recruit newly-made protein to the same aggregated 
conformation. 
 
[Het-s] 
 [Het-s] was the first fungal prion to be described (Rizet, 1952) but one of the 
more recent to be identified as a prion.  This is because the [Het-s] phenotype, which 
causes heterokaryon incompatibility in the [PRION+] form, is among the more 
complicated prion-based phenotypes.  For starters, Podospora anserina carries multiple 
het-s alleles, one of which is capable of forming a prion and one of which is not.  This 
results in three possible “genetic” states: HET-S (protein coded by allele that cannot form 
prion), [Het-s] (prion form of protein), and [Het-s*] (non-prion state of prion-forming 
allele).  Second, the prion state, [Het-s], only results in a phenotype when its organism 
forms heterokaryons with a Podospora strain containing the het-S allele, which cannot 
form a prion.  When a [Het-s] Podospora hypha fuses with a het-S hypha to form a 
heterokaryon, apoptosis is triggered and the heterokaryon dies. 
 [Het-s] fulfils the genetic criteria of prions: reversible curing, induction of the 
[Het-s] phenotype with overexpression of the het-s gene, and a het-s knockout strain (het-
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s0) cannot propagate the [Het-s] prion phenotype (Coustou et al., 1997).  However, het-s0 
does not phenocopy [Het-s].  Het-s protein isolated from a [Het-s] colony is resistant to 
protease-K digestion, whereas Het-s protein from [Het-s*] colony is not protease-K 
resistant.  The Het-s protein itself therefore shows a conformational change, very strongly 
suggesting a prion-based mechanism of inheritance rather than a plasmid (Coustou et al., 
1997).  PrPSc shows a similar protease resistance when compared to PrPC (Bolton et al., 
1984).  With the advent of protein transformation, [Het-s] was shown to be induced by 
the transformation of Het-s protein fibers; [Het-s] is therefore a prion. 
 
Mechanism of prion inheritance 
 All yeast prions identified to date operate by a similar mechanism but involve 
unrelated proteins and result in different phenotypes.  In [PSI+] and [URE3], the prion 
determining protein (Sup35, a translation termination factor, and Ure2, a nitrogen 
catabolite repressor, respectively) is soluble in the [prion-] state and either cytosolic or 
nuclear, respectively.  When in the [PRION+] form, the majority of the Sup35 and Ure2 
protein aggregates in the cytoplasm.  This titrates away soluble protein, resulting in a 
[PRION+] phenotype that phenocopies either a partial ([PSI+]) or complete loss-of-
function ([URE3]) phenotype of the determining protein.  [PSI+] thus results in increased 
readthrough at stop codons and [URE3] causes a defect in nitrogen regulation that results 
in uptake of poor nitrogen sources (ureidosuccinate) in the presence of good nitrogen 
sources (ammonia) (Shorter and Lindquist, 2005).  The phenotypic consequences of 
[PSI+] and [URE3] are thus very different. 
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 [Het-s] has a different mechanism of action.  Specifically, while the het-s protein 
is aggregated in the [Het-s] form and soluble in the non-prion, [Het-s*] form (Coustou-
Linares et al., 2001), the [Het-s] phenotype does not phenocopy a loss-of-function of the 
het-s genetic locus.  Loss of het-s has no known phenotype (Coustou et al., 1997).  [Het-
s] resembles PrP in this property, as the PrPC protein has no known phenotype other than 
an inability to propagate prion disease for many years (Steele et al., 2007).  These data 
imply that the [PRION+] form represents a gain-of-function phenotype.  Still, the het-s 
protein aggregates in [Het-s], and thus all the early fungal prions involved some state of 
heritable aggregation. 
 
Similarities between mammalian and fungal prions: “species barrier,” “strains,” and 
amyloids 
 Fungal and mammalian prions have three major overlapping attributes: the 
species barrier phenomenon; the ability to exist in distinct, self-propagating prion strains; 
and a difference in protein structure associated with the [PRION+] state.  Prion strains 
and the species barrier were particularly puzzling for mammalian prion researchers.  
Viruses also involve “strains” with varying phenotypes and a species barrier to 
infectivity.  The finding that fungal prions also exhibit a species barrier and can 
propagate as distinct prion strains strengthens the connection between seemingly 
disparate phenomenon. 
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 Prions and amyloids 
 Perhaps the most important conserved characteristic between PrP and the known 
fungal prions is the ability of these proteins to assume very different structures in 
[PRION+] and [prion-] forms.  The [PRION+] form of all known fungal prion proteins is 
amyloid.  Amyloid is an extremely stable, β-sheet rich protein fold that is also found in 
several late-onset neurodegenerative diseases, including Parkinson’s, Alzheimer’s, and 
Huntington’s diseases (Chiti and Dobson, 2006).  Amyloids do not denature in 1% SDS; 
cause fluorescence or birefringence of the dyes thioflavin T or Congo Red, respectively; 
and are often self-templating in vitro.  It is thought that most proteins can form amyloid 
under some condition, based on the observation that a number of non-aggregating 
proteins unrelated to amyloid diseases spontaneously form amyloid in vitro (Guijarro et 
al., 1998; Litvinovich et al., 1998; Serio et al., 2000).  These were later shown to be a 
generic property of many polypeptides under semi-denaturing conditions (Chiti et al., 
1999).  However, fungal prion-determining proteins are among the few genetically 
tractable amyloids and have been extensively studied for that reason. 
Amyloid and pre-amyloid structures (fibrils, oligomers, etc.) can be heritable and 
infectious because the ends of amyloid fibrils self-template.  This recruits protein of the 
non-prion form into the amyloid deposits (Shorter, 2008).  The rate of fragmentation of 
the amyloid fibers is thought to contribute to whether an amyloid-forming protein is 
heritable (Tanaka et al., 2006).  Fragmentation forms oligomeric seeds; if seeds do not 
form at a sufficient rate to be passed on to daughter cells, the amyloid state is not 
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inherited.  Why oligomers are toxic in mammalian cells but heritable in fungi is poorly 
understood but a major point of investigation (Douglas et al., 2008). 
 
Prion Strains 
 The potential structural diversity of prion-forming proteins results in another 
unusual characteristic of prions: the strain phenomenon.  Different infectious lines, still 
presumably caused by PrPSc, resulted in different incubation times and caused 
spongiform pathology in different regions of the brain.  Incubation times and infected 
brain regions were, however, stable within a line (Aguzzi et al., 2007).  These differences 
can be propagated through serial rodent infections, so the difference in phenotype is 
stable and transmissible (Dickinson and Fraser, 1977).  These data were initially 
interpreted as strong evidence against the protein-only hypothesis because “strains” are 
characteristic of viruses.  Strains were hypothesized to result from mutations within a 
virus, whereas a mechanism by which a protein could accomplish such stable infectious 
specificity was difficult to imagine.  However, it was shown that PrPSc from different 
prion strains showed different digestion patterns by proteinase K (Bessen and Marsh, 
1994).  The strain-associated differences of PrPSc transmit to and convert PrPsen into the 
different PrPres strains in vitro (Bessen et al., 1995). 
 Fungal prions also exhibit “strains” that correlate with [PRION+] protein 
structure.  Fungal prion strains tend to be either “strong” or “weak” version of the 
[PRION+]-associated phenotype (e.g. strong [PSI+] shows more read-through of stop 
codons than weak [PSI+]).  These strains are stably propagated and in a non-Mendelian 
manner  (Derkatch et al., 1996).  The amount of aggregated protein differs between 
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strains, which presumably is what causes differences in strength of the prion phenotype 
(Bradley et al., 2002).  Variances between yeast prion strains appear to be entirely 
structural, as formation of infectious Sup35 fibers at different temperatures is sufficient to 
result in different strains without any difference in sequence or change other than 
temperature of the assembly reaction (Tanaka et al., 2004).  Furthermore, the regions of 
the Sup35 protein forming the “core” of the prion-causing fiber differ between [PSI+] 
strains (Krishnan and Lindquist, 2005), as do the amino acid contacts formed during the 
polymerization (Tessier and Lindquist, 2007).  These data combine to show that, 
analogously to PrP, the proteins that cause fungal prions are capable of entering into 
several different possible prion-causing structures and that structural differences of the 
infectious form of the prion result in strain differences. 
 Overall, the prion strain phenomenon is thought to result from the inherent 
flexibility of the protein causal agent (Morales et al., 2007).  Because the causal protein is 
inherently unstructured, it is capable of entering into a number of related folds.  Some of 
these are self-propagating, which creates prions.  Slight differences in the self-
propagating prion fold results in different prion strains.  This structural flexibility of 
proteins capable of forming prions implies that a large number of different strains are 
possible.  In mammals the self-propagating strains lead to different diseases, many with 
different clinical symptoms.  Understanding the structure of PrPSc and how it differs 
between species and strains is therefore an important epidemiologic question. 
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The species barrier prevents cross-species infectivity 
The “species barrier” refers to the inefficiency of transmission of infectious prion 
material from one species to another.  Inter-species infection occurs at much lower 
frequencies and requires longer incubation times than the infection within a species 
(Moore et al., 2005).  The species barrier can be “crossed” by transmitting the disease to 
a different species than the originating one, but only at low frequency and with long 
incubation times (Zlotnik and Rennie, 1965).  When the species barrier is crossed the 
strain in question then propagates in the new species with increased efficiency that 
eventually stabilizes (Kimberlin and Walker, 1977). 
This species barrier was shown to be attributable to the prion protein itself.  
Transgenic mice carrying copies of the hamster PrP gene acquire prion disease more 
efficiently when infected with prion inoculum from hamsters and disease was then 
transmitted efficiently to hamsters (Scott et al., 1989) but not to mice (Prusiner et al., 
1990).  The neuropathology resembled the originating species rather than the infected 
species (Scott et al., 1989; Prusiner et al., 1990). 
 Differences in the primary sequence of PrP from different species are thought to 
contribute to structure differences within the PrP protein that cause the species barrier 
phenomenon (Morales et al., 2007).  For example, the amino acid residues implicated in 
the mouse/hamster prion species barrier are 138 (Priola and Chesebro, 1995) and 154 
(Priola et al., 2001).  Replacement of one residue with the other prevents the conversion 
of PrPC to PrPSc in a cell-based assay by PrPSc from the origin species (e.g. hamster PrPSc 
cannot convert hamster PrPc that carries the mouse amino acid at position 138 or 154) 
(Priola et al., 1994). 
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Residue 129 in human PrP contributes to susceptibility to the infectious prion 
diseases vCJD and kuru.  Residue 129 is either methionine (M) or valine (V) in all 
populations tested, with approximately 51% of the UK population being M/M 
homozygous (Collinge et al., 1991).  Kuru patients show an over-representation of M/M 
homozygotes (Lee et al., 2001) and all but one of the 130+ vCJD cases are M/M 
homozygotes (Peden et al., 2004).  Sporatic (Palmer et al., 1991) and iatrogenic (Brandel 
et al., 2003) CJD patient populations are enriched for homozygotes at 129 (either M/M or 
V/V).  M/V heterozygotes appear to be protected from kuru (Lee et al., 2001; Mead et al., 
2003).  There has also been selection for heterozygosity at the PrP allele (Mead et al., 
2003), possibly because variation within an individual’s native PrP allele is thought to 
prevent PrP protein polymerization and thus PrPSc formation (Palmer et al., 1991).  A 
very controversial interpretation of this data is that the selection for heterozygosity of PrP 
is indicative of widespread cannibalism in early human populations (Mead et al., 2003). 
 Fungal prions also exhibit a species barrier both in vivo and in vitro (Santoso et 
al., 2000).  The SUP35 genes from fungi such as Candida albicans and Pichia 
methanolica have been engineered into S. cerevisiae and can act as prions in that yeast.  
However, the foreign Sup35 protein does not coaggregate with S. cerevisiae Sup35 
protein or induce S. cerevisiae Sup35 to form [PSI+] (Chernoff et al., 2000; Santoso et al., 
2000).  Similar results were obtained with SUP35 alleles from sensu stricto 
Saccharomyces species, which can mate with S. cerevisiae but do not produce viable 
offspring.  These proteins show between 77% and 94% amino acid identity with the 
prion-causing region of S. cerevisiae Sup35.  However, they still cannot induce S. 
cerevisiae Sup35 into the [PSI+] form, despite coaggregation of the different Sup35 
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proteins within the same cell (Chen et al., 2007).  These data suggest that alterations to 
the primary sequence alone are not sufficient to explain the species barrier and that 
environment, and thus presumably structure, plays some part. 
Sup35 protein from Candida albicans that was converted in vitro into self-
polymerizing fibers cannot induce fiber formation of Sup35 from S. cerevisiae, nor vice 
versa (Chien and Weissman, 2001).  This fiber formation is an attribute of most prion-
causing proteins and has been used extensively to study mechanisms of self-propagation, 
the species barrier phenomenon, and protein infectivity.  A chimeric species that contains 
the N-terminal S. cerevisiae PrDs and C-terminal C. albicans PrD shows seeding of 
soluble S. cerevisiae Sup35 protein under some conditions but C. albicans Sup35 under 
others.  The specific residues involved in the nucleation of polymerization have been 
mapped, differ between C. albicans and S. cerevisiae, and found to contribute to the 
species barrier (Tessier and Lindquist, 2007). 
 
Are all prions amyloid? 
 Some fungal prion proteins, including Sup35 and Ure2, form amyloids in the 
prion-associated forms.  Although amyloids can be prions and prions can be amyloid, an 
amyloid or amyloid-like fold is not required in order to be a prion.  Mammalian prions 
were defined by a protein-based heritable element; the analogous fungal phenomenon 
was defined by genetic attributes.  Any protein-based mechanism that fits the genetic 
criteria could therefore theoretically fit under the definition of “prion.” 
Along these lines, Roberts et al. recently proposed that a self-activating vacuolar 
protease, [β], can be a prion (2003).  This claim has been criticized because [β] is only 
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auto-activating under artificial conditions.  However, it represents an important proof-of-
principle experiment because it is this first example in fungi of a non-amyloid self-
templating protein element. 
The active form of protease B (PrB), is formed when the protease B precursor 
protein (proPrB) is cleaved, first by protease A (PrA, coded by the PEP4 gene) then by 
mature protease B (PrB or [β]).  PrB is capable of self-cleavage in the absence of PrA, 
which results in the [β] (self-processed) form of PrB.  This self-processed form can be 
called a prion because it is auto-activating.  [β] can be cytoduced to [β-o] ([prion-]) cells, 
and [β] can be cured by extended growth under conditions that repress proPrB 
transcription (Roberts and Wickner, 2003).  However, PrB is only self-activating under 
artificial conditions of a ∆pep4 background.  Another aspect of [β] is that its self-
activation requires a covalent modification rather than a change in protein conformation.  
The overall case in favor of [β] is thus a very nuanced argument, as the PrB/[β] 
phenotype is present in wildtype yeast but PrB is only the non-Mendelian element [β] in 
a ∆pep4 mutant background.  However, [β] does demonstrate that non-amyloid prions 
could exist. 
Another putative prion in Podospora anserina, C (crippled growth), is proposed 
to result from a self-activating MAP kinase cascade (Kicka and Silar, 2004; Kicka et al., 
2006).  The MAP kinase changes location (cytosolic to nuclear) in concert with the 
appearance of the C phenotype and the C phenotype requires MAP kinase kinase and 
MAP kinase.  Overexpression of the MAP kinase also increases the appearance of C.  
The authors have shown that C is infectious but they know little about its mechanism of 
inheritance (Kicka et al., 2006). 
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 Overall, both mammalian and some fungal prions enter into an amyloid form but 
amyloids are not necessary and sufficient for prions.  Any type of self-propagating 
protein structure, theoretically including signaling cascades and self-activating enzymes, 
or even an RNA molecule with a self-templated change in folding, could fulfill the 
genetic criteria for being fungal prions.  Because [PSI+] and [URE3] are so well studied, 
they historically provided a yardstick by which to measure putative prions.  This criterion 
biases the discovery of new prions in favor of those such as [RNQ+], which is a self-
templating amyloid that is mechanistically similar to [PSI+] and [URE3]. 
 
Prions and chaperones 
Reversible curing is one of the key distinguishing features of prion-based 
phenotypes.  Curability both establishes that the heritable element is not the result of a 
genetic alteration, which would only rarely be “cured” without mutagenesis under 
nonselective conditions, and demonstrates that the heritable element is not a virus, as 
viruses would not reappear de novo after curing.  It was eventually determined that 
methods for curing prions acted through chaperones (Jones and Tuite, 2005; Shorter and 
Lindquist, 2005).  The study of prion/chaperone interactions has provided rich insight 
into prion formation, phenotypic consequences, and even mechanisms of inheritance. 
 Molecular chaperones are proteins that assist in the proper folding, translocation, 
subunit assembly, and unfolding of the majority of proteins in a cell.  As protein folding 
in a cell takes place under crowded conditions, a small amount of “misfolding” is not 
unusual (Luby-Phelps, 1994).  Several chaperones act constitutively to prevent 
aggregation or unfold misfolded states.  Stress conditions increase the basal misfolding 
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rate.  Many chaperones are induced by cellular stress such as heat shock and thus are also 
termed “heat shock proteins” (Hsps).  This induction is necessary for survival of stressful 
conditions.  Pretreatment under moderate stress conditions (e.g. 37°C for S. cerevisiae, a 
mild heat shock) increases chaperone levels and increases survival under more severe 
stress (e.g. 50°C) (Sanchez and Lindquist, 1990). 
 Chaperones are divided into families by function and molecular weight: Hsp40s 
(DnaJ in prokaryotes), Hsp70s (DnaK in prokaryotes), Hsp100s, small Hsps (sHsps), 
Hsp90s, and Hsp60s/chaperonins (GroE in prokaryotes).  Hsp40s, Hsp70s, and Hsp100s 
are the subclasses predominantly shown to date to be involved in prion formation and 
inheritance.  Hsp90s have only recently been implicated in prion inheritance, and even 
then by an unknown and possibly indirect mechanism (Fan et al., 2007).  Chaperonins 
have not been shown to be involved in prion formation and propagation and so will not 
be discussed. 
 Various eukaryotic chaperones have de novo folding activity and together have 
the abilities to unfold and prevent aggregation.  The predominant chaperones of the 
eukaryotic cytosol are Hsp40s and Hsp70s.  These two combined have “holding” activity 
to prevent aggregation (Hsp40) and ATP-dependent release mechanism that allows 
folding (Hsp70).  Interaction between Hsp70 and substrate-bound Hsp40 transfers the 
unfolded substrate to Hsp70 and stimulates hydrolysis of ATP by Hsp70, which increases 
the affinity of Hsp70 for the substrate.  Nucleotide exchange factor (NEF) binds to 
Hsp70, releasing ADP (Liberek et al., 1991).  Hsp70 and Hsp40 can prevent protein 
aggregation by binding to and “holding” unfolded peptides, which keep them from 
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aggregating.  Hsp70 acts with Hsp90 to complete folding of certain substrates following 
Hsp40 and NEF disassociation (Walter and Buchner, 2002). 
 The chaperone critical to prion inheritance is Hsp104, a member of the 
Hsp100/ClpB family (Shorter, 2008).  Hsp104 was first identified as a protein that 
confers tolerance to extreme stresses (Sanchez et al., 1992; Lindquist and Kim, 1996).  It 
increases survival by as much as 10,000 fold and does so by disaggregating aggregated 
proteins.  This ability of Hsp104 to resolve aggregated protein requires the Hsp70 Ssa1 
and the Hsp40 Ydj1 in vitro.  In the case of prion amyloids, Hsp104 activity also 
increases prion protein seeds by fragmenting them, which are necessary for heritability 
(Shorter and Lindquist, 2004).  Without Hsp104, seeds are not created and a prion is not 
passed on to the daughter cell.  Too much Hsp104 fragments [PSI+] seeds, destroying 
them and curing the prion.  Hsp104 therefore cures prions by either deletion or 
overexpression (Jones and Tuite, 2005; Shorter, 2008). 
The finding that aggregated proteins could be renatured was shocking to the 
chaperone community because aggregated proteins were thought to be dead (reviewed in 
Bösl 2006).  Prior to this work, the most likely mechanisms for thermotolerance had been 
thought to be either prevention of aggregation (Hsp70-like) (Sanchez et al., 1993) or 
proteolysis of aggregated proteins (ClpB-like).  Hsp104 acts particularly efficiently on 
amyloid forms of proteins (Shorter and Lindquist, 2006), including Sup35 in the [PSI+] 
form, Ure2 in the [URE3] form, and some proteins associated with neurodegenerative 
diseases (Shorter and Lindquist, 2004; Vacher et al., 2005; Lo Bianco et al., 2008). 
 Small heat shock proteins (sHsps) are, like Hsp104, involved in rescuing proteins 
from aggregation.  S. cerevisiae contains two sHsps, Hsp26 (Petko and Lindquist, 1986) 
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and Hsp42 (Haslbeck et al., 2004), and analogous proteins are found in bacteria.  sHsps 
bind unfolded proteins (Cashikar et al., 2005; Haslbeck et al., 2005).  sHsps are function 
in protein disaggregation by rendering refolding by Hsp104 more efficient (Cashikar et 
al., 2005).  sHsps, however, apparently are not involved in prion propagation and 
inheritance. 
 The disaggregating activity of Hsp104 is critical to the formation of the prion 
seeds that are passed from mother to daughter cell during mitosis or meiosis (Cox et al., 
2003).  Deletion of HSP104 cures all S. cerevisiae prions and decreases the fidelity of 
[Het-s] propagation.  The interplay between Sup35/[PSI+] and Hsp104 is particularly 
tight, since [PSI+] is “cured” to [psi-] by either overexpression or deletion of Hsp104.  
Hsp104 aids prion propagation by promoting formation of critical prion oligomers.  It 
does this by creating [PSI+] “seeds” via interaction with prion protein fibers and 
fragmenting seeds into heritable oligomers (propagons) (Shorter and Lindquist, 2004). 
These propagons are passed from mother to daughter in a cytoskeleton-dependent fashion 
(Ganusova et al., 2006).  A daughter cell that does not inherit a sufficient number of 
propagons becomes [prion-].  Inhibiting the activity of Hsp104 decreases the number of 
propagons and thus cures [PSI+] (Ness et al., 2002; Kryndushkin et al., 2003).  Instead, 
the prion-determining protein forms extremely large cytoplasmic aggregates that are not 
passed on to the daughter.  Overexpression of Hsp104 fragments amyloid fibers formed 
by Sup35, possibly fragmenting them into oligomers (or monomers) smaller than the 
minimum propagon size.  This would cure because few, if any, seeds would be in 
existence to be passed down to the daughter cell (Cox et al., 2003). 
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 Hsp70s and Hsp40s are also involved in prion formation and propagation, change 
in their expression has less drastic effects than change in Hsp104.  Overexpression or 
deletion of various Hsp70s cures [URE3] and [PSI+] (Ness et al., 2002; Shorter and 
Lindquist, 2004; Kryndushkin and Wickner, 2007).  As Hsp40s and Hsp70s act in concert 
with Hsp104 in in vitro disaggregation assays (Glover and Lindquist, 1998), this is 
expected.  However, different Hsp70 isoforms have different affects on the same prion.  
Overexpression of the SSA family of cytosolic Hsp70s increases conversion to [PSI+] but 
overexpression of the SSB family of cytosolic Hsp70s prevents [PSI+] formation (Allen et 
al., 2005).  [URE3] also responds to different Hsp70s: overexpression of SSA family 
member SSA1 cures [URE3] (Schwimmer and Masison, 2002). 
 The dependence of all the early fungal prions on aggregation and chaperones that 
act on aggregated proteins raises the questions of whether all aggregating, amyloid-
forming proteins are prions and whether all prions must aggregate and/or form amyloid.  
Modeling of disease-causing proteins from humans in yeast show that such proteins 
aggregate and are toxic (Lindquist et al., 2001; Meriin et al., 2002; Outeiro and Lindquist, 
2003) but there is no evidence that these aggregates are heritable.  Yeast can therefore 
distinguish between heritable and non-heritable aggregates.  There is growing evidence 
that the heritability of [PSI+]-like aggregates depends on association with the 
cytoskeleton(Ganusova et al., 2006) and might be linked to an aggresome-like structure 
in yeast (Tyedmers and Lindquist, unpublished). 
 Amyloid-based prions oligomerize, aggregate, and then interact with chaperones 
to form prion seeds.  Would prions that do not aggregate show a similar dependence on 
chaperones?  Since all proteins must fold to function, there would presumably be a basic 
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dependence on protein folding.  Prions that involved an alteration in protein conformation 
would probably depend on chaperones, since changing the efficiency of protein folding 
could cause switching between [prion-] and [PRION+].  Whether self-activating, self-
propagating enzymes would require chaperones is more difficult to predict. 
 
Identification of additional fungal prions 
 [PSI+], [URE3], and [Het-s] are phenotypically different but mechanistically 
similar.  How common, then, are fungal prions and what sorts of phenotypes might they 
cause?  Two primary methods were used to identify further prions: finding prions with 
similar sequences or finding phenotypes that act like prions genetically. 
 Prion-determining regions (PrDs) of the Sup35 and Ure2 prion-determining 
proteins have several identifying characteristics: extreme amino acid bias and modularity.  
Sup35 and Ure2 PrDs are strongly enriched in Q/N residues (Harrison and Gerstein, 
2003). This bias is conserved among hemiascomyces (Ure2) and even out to 
basidiomyces and euascomyces, which are estimated to have diverged from the 
hemiascomyces ~1 billion years ago (Harrison et al., 2007).  PrDs are also modular and 
transferable.  When the PrD of SUP35 (termed “NM” for N-terminus and Middle region) 
is fused to the sequence of glucacortacoid receptor (GR) it is sufficient to confer prion 
properties to GR.  NM-GR can switch between [prion-] and [PRION+] forms and is cured 
by chaperones (Li and Lindquist, 2000).  Sup35 PrD contains six imperfect oligopeptide 
repeats that are involved in [PSI+] induction (Liu and Lindquist, 1999) and maintenance 
(Osherovich et al., 2004).  Repeats are also found in the mammalian prion protein but not 
the Ure2 PrD (Tuite, 1994). 
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 Several groups attempted to identify additional prions by sequence (Michelitsch 
and Weissman, 2000; Sondheimer and Lindquist, 2000; Harrison and Gerstein, 2003).  
The RNQ1 gene was found by searching for regions similar to the Sup35 PrD that 
showed approximately constant expression (less than two-fold change) between 
logarithmic and stationary phases (Sondheimer and Lindquist, 2000).  Expression levels 
of candidate genes were considered because [PSI+] and [URE3] are maintained over 
many generations, which would require constant protein levels.  However, neither ∆rnq1 
nor [RNQ+] had a discernible phenotype, so experiments had to be performed on Rnq1-
GFP and other such non-native fusion proteins.  [RNQ+] exhibits all the genetic attributes 
of a prion, including chaperone-dependent curing, cytoplasmic inheritance, and non-
Mendelian inheritance (Sondheimer and Lindquist, 2000). 
 A second protein capable of forming a prion, [NU+], was also discovered by 
searches for Q/N-rich genes (Michelitsch and Weissman, 2000; Osherovich and 
Weissman, 2001).  This search identified the NEW1 and PAN1 genes as prion-forming 
candidates (Osherovich and Weissman, 2001).  New1 showed all the genetic 
characteristics of prions but Pan1 did not.  Although Pan1 aggregates, these aggregates 
are not heritable (Michelitsch and Weissman, 2000).  The distinguishing feature between 
New1 and Pan1 are imperfect repeats in the putative PrD of New1, which resemble those 
in the Sup35 PrD (Michelitsch and Weissman, 2000).  These repeats were later shown to 
be involved in [NU+] maintenance and prion stability (Osherovich 2004).  Like [RNQ+], 
[NU+] did not have a phenotype when first discovered and thus had to be studied as a 
fusion protein (Osherovich and Weissman, 2001). 
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Recent work on the S. cerevisiae chromatin remodeling factor Swi1 suggests that 
Swi1 is capable of acting as a prion, [SWI+] (Du et al., 2008).  Swi1 was identified by 
searching for glutamine and asparagine rich proteins.  A number of members of the 
Swi/Snf complex, including Snf5, also show N- and Q-rich regions but do not act as 
prions.  However, [SWI+] is dominant and shows infectious, cytoplasmic inheritance.  
[SWI+] acts independently of Snf5, as Swi1 but not Snf5 aggregates in [SWI+]. 
 Although searches for Q/N-rich proteins have identified interesting prions, they 
have several limitations.  Neither PrP nor Het-s are Q/N-rich so Q/N predominance is not 
deterministic of prion-forming ability.  Proteins identified in sequence-based searches are 
biased to aggregate but aggregation is not sufficient for heritability.  Some SUP35 
mutants aggregate but do not propagate [PSI+] (Osherovich et al., 2004) and polyQ 
aggregates in yeast but is not heritable (Meriin et al., 2002).  Furthermore, a protein does 
not have to aggregate or form an amyloid to be a prion (Wickner et al., 2007).  While all 
known fungal prions aggregate, there were only three known fungal prions at the time of 
these studies.  Various genetic mechanisms, such as feedback loops or self-activating 
enzymes, might result in the genetic attributes of fungal prions.  Thus searching for 
prions by sequence, while informative, limits the type of prions that one finds. 
 Attempts to identify additional prions based on phenotypes do not bias the 
outcome, as sequence-based attempts do, but require an appropriate starting phenotype.  
One such candidate, [PIN+] (PSI-inducible), was based on the observation that the 
induction of [PSI+] by overexpression of SUP35 requires a non-Mendelian, Hsp104-
dependent element (Derkatch et al., 1997).  [PIN+] arises frequently from previously 
cured ([pin-]) yeast and is necessary for [PSI+] induction but not maintenance.  
 52
Researchers thus had an intriguing phenotype but no causal agent for [PIN+], a frustrating 
state that lasted until 2001.  A genomic screen for chromosomal regions that induced 
[PIN+] when overexpressed identified 11 candidates, including the prion-causing genes 
URE2, RNQ1, and NEW1 (Derkatch et al., 2001).  The authors then demonstrated that 
[URE3], [RNQ+], and [NU+] could act as [PIN+].  This established a phenotype for 
[RNQ+] and [NU+], showed that prions can interact with each other, and proposed eight 
other putative prions and a phenotype to test them under.  Identifying new prions by 
phenotype can thus be rewarding but is limited by candidate phenotypes. 
 The S. pombe phenotype [Cin] allows cells to survive in the absence of the 
essential chaperone calnexin (Collin et al., 2004).  To perform mutation analysis of 
calnexin, the authors transformed cells deleted for the genomic copy of the essential  
calnexin gene with plasmids carrying wildtype and mutant calnexin genes.  These were 
scored for wildtype or mutant plasmids after six days of growth.  The authors observed 
that cells carrying a mutant form of calnexin from which the highly conserved domain 
(hcd) had been removed showed loss of both wildtype and mutant plasmids.  Assuming 
that the calnexin gene had simply recombined into the genome, they performed 
Southerns, Westerns, and Northerns but could not detect any evidence of calnexin.  This 
state was named [Cin] (calnexin independent). [Cin] is dominant in a mating experiment 
and shows non-Mendelian inheritance by random spore analysis.  The authors 
transformed [Cin] cell extracts into [cin-] S. pombe to induce [Cin].  These extracts were 
not sensitive to DNase, RNase, or UV treatment but could not induce [Cin] when treated 
with UV.  [Cin] is thus probably caused by a proteinaceous factor.  However, this factor 
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has yet to be identified.  The difficulty of identifying factors from such studies is the 
primary difficulty when investigating prions based on phenotype. 
 
Phenotypic consequences and biologic importance of fungal prions 
 An ongoing controversy in the field of prion biology is the relevance of prions to 
the biology of their fungal hosts.  Prion-determining regions in Sup35 and Ure2 are 
conserved to euascomycota (~1 billion years) and hemiascomyces (same order as S. 
cerevisiae; ~700 million years (Hedges et al., 2004)), respectively (Harrison et al., 2007).  
The PrDs of Rnq1 and New1 are less well conserved.  Whether the prion domains are 
conserved for prion-determining properties or other reasons is a point of controversy 
(Wickner et al., 2007).  Sup35 from C. albicans and K. lactis have been tested for prion-
forming ability.  Both can form [PSI+] in S. cerevisiae (Nakayashiki et al., 2005; Tanaka 
et al., 2005) but only K. lactis Sup35 has been tested in its native organism, where it can 
also form a prion (Nakayashiki et al., 2001). 
 One proposal in favor of the relevance of fungal prions is that the read-through of 
stop codons caused by [PSI+] results in new phenotypes.  [PSI+] results in growth 
differences compared to [psi-] under a variety of conditions that vary with genetic 
background (True and Lindquist, 2000).  Over 50 different culture conditions were tested 
in seven genetic backgrounds; [PSI+] and [psi-] showed growth differences approximately 
50% of the time.  In 25% of those cases [PSI+] had an overall growth advantage 
compared to [psi-].  Whether a condition was advantageous differed with genetic 
background and what might be an advantageous condition for [PSI+] in one genetic 
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background was not necessarily advantageous in another.  For example, [psi-] grew better 
than [PSI+] at pH 6.0 in one genetic background (D1142) but worse in another (5V-H19). 
[PSI+]-dependent traits are genetically complex and have not yet been mapped to 
causal loci.  [PSI+]-dependent traits are also polyallelic, as outcrossed phenotypes never 
segregated 2:2 (True et al., 2004).  Phenotypes also were easily fixed, as outcross 
progeny sometimes maintained the [PSI+]-dependent phenotype following curing (True 
2004).  This latter point is especially interesting because it provides a mechanism for 
fixation if a [PSI+]-dependent phenotype is advantageous.  That way the host cell does 
not need to maintain detrimental read-through for long.  These studies suggest that [PSI+] 
might allow for the gain and loss of read-through dependent traits that vary with genetic 
background and thus acts as an agent of phenotypic plasticity. 
 The counterargument to the idea that [PSI+] can provide an advantage under 
specific growth conditions is that [PSI+] appears to be disadvantageous because it has 
never been found in a wild S. cerevisiae strain (Nakayashiki et al., 2005).  This theory 
criticizes many authors for studying [PSI+] only in laboratory strains.  Nakayashiki et al. 
(2005) also argue that True and Lindquist (2000) show that a deletion of the SUP35 PrD, 
∆nm, results in a phenotypic change compared to either [PSI+] or [psi-] in some genetic 
backgrounds and environmental conditions (True and Lindquist, 2000).  ∆nm is 
obligatorily [psi-] (Ter-Avanesyan et al., 1994), so the claim that ∆nm showed a 
phenotype that differed from [psi-] raises the possibility that the PrD of Sup35 could have 
a function other than prion maintenance. 
Nakayashiki et al. (2005) extended the argument against the possible utility of 
yeast prions by testing for [PSI+], [URE3], and [RNQ+] in a variety of “wild” yeast that 
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had never been cultivated in the laboratory.  The logic behind these experiments is that, 
as prions are transferred horizontally like viruses and can arise spontaneously in ~1 in 105 
to 107 cells, they should be widespread unless selected against.  The authors found neither 
[PSI+] nor [URE3] in any of the 70 yeast strains tested but did detect [RNQ+] in 
approximately 16% (11 out of 70 samples).  For comparison, they also tested for 2µ 
plasmids, RNA viruses, and ssRNA replicons.  2µ plasmids, which are mildly detrimental 
to the yeast host cell (Futcher 1983; Mead 1986), were found in 54% of the yeast strains 
tested.  The two RNA viruses and two ssRNA replicons tested varied in frequency from 
1-20% (Nakayashiki et al., 2005).  As 2µ plasmids were more common than [RNQ+], the 
authors concluded that [RNQ+] is more detrimental to the host than the plasmid and that 
[PSI+] and [URE3], which were not found at all, are more toxic than [RNQ+].  Finally, 
Nakayashiki et al. (2005) suggested that a growth advantage for [PSI+] is perhaps less 
relevant than a survival advantage, since no one knows the conditions experienced by 
yeast in the wild.  True and Lindquist had also originally proposed that [PSI+] is usually 
detrimental but very rarely advantageous (2000) and the data from Nakayashiki and 
colleagues (2005) are consistent with this hypothesis. 
Overall, while S. cerevisiae prions other than [RNQ+] have not been found in wild 
yeast, it is difficult to discount prions function when prion-determining regions are so 
well conserved (Harrison et al., 2007).  Even wild and industrial yeasts that are not 
natively [PSI+] carry SUP35 alleles capable of forming [PSI+] (Chernoff et al., 2000), as 
do C. albicans clinical isolates (Handwerger and Lindquist, unpublished).  Recent work 
shows that the rate of [PSI+] appearance increases under a variety of strong stress 
conditions (up to 90% lethality) regardless of whether [PSI+] is advantageous under that 
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condition (Tyedmers et al., unpublished).  [PSI+] induction could therefore be a general 
response to stress which is only occasional advantageous, and thus would not be expected 
to be observed in wild yeasts. 
[Het-s], the prion from the filamentous fungus Podospora anserina, is involved in 
vegetative heterokaryon incompatability and meiotic drive.  The ability of [Het-s] to 
induce apoptosis in the mycelia of P. anserina carrying the non-prion forming het-S allele 
is well documented (Rizet, 1952).  The prion-forming het-s allele is present in a majority 
of P. anserina isolates (60% of 102 strains) (Dalstra et al., 2003); a majority of these 
carry the prion form, [Het-s], (51%) instead of the non-prion form, [Het-s*].  The [Het-s] 
prion is therefore thought to provide some benefit to its host, possibly because [Het-s]-
induced apoptosis would prevent the horizontal spread of fungal viruses to unexposed 
populations (Wickner et al., 2007).  This heterokaryon incompatibility takes place during 
the vegetative cycle of the organism.  [Het-s] was recently shown to be involved in spore 
killing and acts as a meiotic drive element to favor its own inheritance (Dalstra et al., 
2003). 
Several non-infectious (and thus non-prion) amyloids have been shown to have a 
beneficial phenotype that requires the amyloid fold.  Secreted proteins from several 
different bacterial species form amyloids, including E. coli (Chapman et al., 2002) and 
Streptomyces coelicolor (Claessen et al., 2003).  These amyloids are involved in biofilm 
formation or formation of hydrophobic surfaces, respectively.  Neurospora crassa has a 
similar amyloid-like hydrophobin (Mackay et al., 2001) and an amyloid-like protein in 
the silkworm eggshell protects from environmental damage (Iconomidou 2000).  
Intracellular amyloids can also perform novel functions; a prion-like amyloid-forming 
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protein (Si et al., 2003b) in the neurons of the sea slug Aplysia californica is involved in 
mRNA binding and the maintenance of synapses (Si et al., 2003a).  “Functional” 
amyloids are also found in the melanophore organelle Homo sapiens melanocyte and 
retinal pigment epithelial cells, where the protein Pmel17 forms amyloid fibrils following 
protease cleavage (Berson et al., 2003; Fowler et al., 2006).  These amyloids provide a 
scaffold for the formation of melanin pigment (Fowler et al., 2006). 
Overall, amyloids have been shown to provide unique functions to the cells that 
carry them and prions could well do the same (Chiti and Dobson, 2006).  Furthermore, 
prions potentially provide a new level of cellular regulation, with a single protein giving 
rise to multiple phenotypes.  As prions appear at a rate similar to or higher than genetic 
mutation (True and Lindquist, 2000), prion-dependent traits potentially provide a 
phenotypic flexibility not possible through standard genetic changes.  Thus identification 
of new prions and characterization of their functions could provide important information 
on how microorganisms survive and adjust to changing conditions. 
 
[GAR+]: a non-Mendelian phenotype conferring resistance to D-(+)-glucosamine 
 The ultimate goal of my thesis work was to identify new prions in Saccharomyces 
cerevisiae and determine the phenotypic consequences of the [PRION+] form on the host 
organism.  I have attempted to address the two basic questions of interest to the field: 
whether prions are common mechanisms of regulation and whether prions could be 
beneficial for their hosts.  I took a phenotype-based approach to identifying additional 
prions, which did not bias these studies towards identifying prions that necessarily 
resemble the well-characterized prions in sequence and/or mechanism. 
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 Given the tenuous nature of identifying potential prions computationally, 
searching for phenotypes with similar genetic attributes to known prions could be a more 
promising approach.  One could start by investigating dominant phenotypes that 
segregate in a non-Mendelian pattern or permanent phenotypic changes induced by 
transient overexpression of an ORF.  One of the most promising of these a the non-
Mendelian phenotype that confers resistance to D-(+)-glucosamine ([GAR+]), which was 
characterized as independent of mitochondria, cytoplasmically inherited, and described as 
possibly “allelic to [PSI+] and [URE3]” (Kunz and Ball, 1977). 
 D-(+)-glucosamine (glucosamine) is a non-metabolizable glucose mimetic 
(Woodward and Hudson, 1953) that is sufficient to maintain glucose repression in 
Saccharomyces (Hockney and Freeman, 1980).  When glucose is present, S. cerevisiae 
and other yeasts activate genes involved in glucose metabolism and growth and repress 
genes involved in the processing of secondary carbon sources.  Therefore, when both 
glucose and secondary carbon sources are present, many fungi will utilize the available 
glucose before processing the secondary carbon sources such as glycerol or galactose 
(Santangelo, 2006).  Glucosamine, like glucose, blocks growth on alternative carbon 
sources such as galactose and glycerol, probably by activating glucose signaling and/or 
repression pathways (Hockney and Freeman, 1980; Nevado and Heredia, 1996).  
Resistance to glucosamine therefore implies a lack of repression of non-glucose carbon 
pathways and thus confers the ability to process alternative carbon sources in the 
presence of glucose.  This ability might occassionally confer a growth advantage in the 
wild, since under some conditions it could be advantageous to switch rapidly between 
glucose and alternative carbon source utilization (Verstrepen et al., 2004; Santangelo, 
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2006).  Glucosamine can serve as a competitive inhibitor of hexokinase (McGoldrick and 
Wheals, 1989) and is a precursor to N-glucosamine, a component of yeast cell walls 
(Bulik et al., 2003).   
 
 The goal of this work was to identify new prions, specifically by focusing on the 
non-Mendelian phenotype [GAR+].  [GAR+] was selected because it showed cytoplasmic, 
non-Mendelian inheritance and was not mitochondrial (Ball et al., 1976; Kunz and Ball, 
1977).  Furthermore, [GAR+] conveys an interesting phenotype, glucosamine resistance, 
that one could imagine might have some importance for yeast under non-lab conditions.  
When I began my graduate studies only five fungal prions had been identified.  All 
aggregated in the [PRION+] form, involve an infectious amyloid species, and all but 
[Het-s] are rich in glutamines and asparagines.  While every graduate student has some 
hopes for an unusual project, I did not expect [GAR+] to be quite as surprising as it turned 
out to be.  While [GAR+] shows non-Mendelian, cytoplasmically infectious inheritance, 
the causal agents do not form an amyloid, do not aggregate, are not N/Q-rich, act 
independently of Hsp104, and overall represent a novel type of prion.  [GAR+] shows a 
growth advantage over [gar-] in particular environmental conditions and its frequency 
varies with the ecological niche of its host.  Overall, [GAR+] is a novel type of prion that 
shows environmental sensitivity. 
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Chapter Two: 
 
[GAR+], a non-amyloid protein-based inheritance system involved 
in glucose signaling 
 
Introduction 
The stable inheritance of biological information and phenotype across generations 
is a fundamental property of living systems.  Prions, self-perpetuating protein 
conformations that cause multiple phenotypes, represent an unusual mechanism of 
information transfer that occurs via protein instead of nucleic acid (Wickner, 1994).  
Prion proteins can assume multiple conformations and each conformation alters protein 
functionality, resulting in different phenotypes (Wickner et al., 2004; Shorter and 
Lindquist, 2005).  Because these conformational switches are self-templating, prion 
proteins acquire characteristics normally restricted to nucleic acids.  The first prion 
protein identified, the mammalian protein PrP, can behave as a transmissible pathogen 
and causes a neurodegenerative disease in its prion form (PrPSc) (Prusiner, 1998).  The 
prion proteins described in fungi, which are unrelated to PrP and to each other, act as 
non-Mendelian elements of inheritance by switching to the self-perpetuating, 
cytoplasmically transmissible prion conformation (Wickner, 1994). 
Four prions have been identified to date in fungi: [PSI+], [URE3], [Het-s], and 
[RNQ+].  [PSI+] (Cox, 1965) is caused by a change in conformation of the translation 
termination factor Sup35 (Stansfield et al., 1995; Patino et al., 1996; Paushkin et al., 
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1996) that results in increased read-through at stop codons.  [URE3] (Lacroute, 1971) is 
an altered form (Wickner, 1994) of the nitrogen catabolite repressor Ure2 that alters 
transcription (Courchesne and Magasanik, 1988).  [RNQ+] controls the ability of a cell to 
induce the [PSI+] prion, and its causal protein, Rnq1, has no known function other than 
the ability to form a prion and, thereby, influence the rate of appearance of other prions 
(Derkatch et al., 2000; Sondheimer and Lindquist, 2000; Derkatch et al., 2001).  [Het-s], 
found in the filamentous fungus Podospora anserina, causes heterokaryon 
incompatibility and cell death with certain mating partners (Rizet, 1952; Coustou et al., 
1997).  This is thought to serve as a mating isolation system to prevent the spread of 
viruses (Wickner et al., 2007).  All four proteins form a highly insoluble, self-templating 
conformation in the [PRION+] form (Chien et al., 2004). 
The four fungal prions share distinct and unusual genetic characteristics despite 
their disparate functions (Wickner 1994).  They characteristically appear spontaneously 
at a frequency higher than the frequency of genetic mutation.  All show dominant 
inheritance, non-Mendelian 4 [PRION+] to 0 [prion-] (or sometimes 3:1) segregation 
following meiosis, and are transmissible by cytoduction (cytoplasmic transfer).  Further, 
their inheritance is linked to the activities of chaperones, proteins that mediate 
conformational changes in other proteins (Uptain and Lindquist, 2002).  The yeast prions 
also share a distinctive feature of mammalian prions, a species barrier for transmission.  
Due to differences in amino acid sequence, proteins from one species exhibit defects in 
converting the homologous protein from another species to the [PRION+] form, even 
though the homologous protein is itself capable of forming a prion (Aguzzi et al., 2007). 
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Moreover, all four prions share a common mechanism for conformational change 
and propagating that change.  The infectious conformation is a self-templating amyloid 
fiber.  A striking feature of these prions is that transient overexpression of the prion 
protein is sufficient to cause a permanent change in phenotype.  It does so by nucleating 
formation of the amyloid fiber template (Patino et al., 1996; King et al., 1997; 
Sondheimer and Lindquist, 2000; Speransky et al., 2001; Kimura et al., 2003; 
Bagriantsev and Liebman, 2004).  In vitro these amyloids template soluble protein into 
the amyloid state (Glover et al., 1997; Paushkin et al., 1997; Taylor et al., 1999).  These 
amyloids are the sole determinant needed for prion formation because amyloid fibers are 
sufficient to convert [prion-] cells to [PRION+] cells (Maddelein et al., 2002; Tanaka et 
al., 2004; Brachmann et al., 2005; Patel and Liebman, 2007).  The self-templating 
conformation and the [PRION+] phenotype that results from the change in conformation 
are thus stably inherited by daughter cells following mitosis or meiosis (Uptain and 
Lindquist, 2002).  Another striking feature of prions is that transient changes in 
chaperone levels are sufficient to permanently eliminate (or “cure”) cells of the prions by 
altering conformational states of the protein and their transmission to daughter cells. 
The simple and robust character of self-templating amyloids provides a 
compelling framework for protein-based inheritance.  Amyloid structure is therefore 
commonly held to be a critical feature of all naturally occurring systems for protein-based 
inheritance (Chien et al., 2004).  However, Prusiner had initially defined “prion” as “a 
small proteinaceous infectious particle…resistant to inactivation by most procedures that 
modify nucleic acids” but made no restriction as to mechanism (Prusiner, 1982).  
Wickner extended this to proteins other than PrP by outlining genetic criteria for prions in 
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fungi (Wickner, 1994).  These include reversible curing, overexpression of the prion 
protein increasing the frequency of [PRION+] formation, and a phenotypic link between 
the prion-dependent phenotype and a mutation in the causal protein.  But he too did not 
restrict possible mechanisms (Wickner et al., 1999).  Indeed, both Wickner and Cox 
proposed multiple possible modes by which proteins could create heritable phenotypes, 
including self-modifying enzymes or altered conformations that convert the normal 
conformation (Cohen et al., 1994; Cox, 1994; Wickner, 1994). 
Taking an unbiased approach to identifying new prions, we searched the literature 
for phenotypes in S. cerevisiae that had prion-like characteristics of inheritance.  An 
unusual heritable phenotype was described many years ago in a screen for mutants 
resistant to the non-metabolizable glucose mimetic D-(+)-glucosamine (Ball et al., 1976).  
The basis of the screen was the extreme preference of yeast cells for glucose as a carbon 
source.  If glucose is present they will repress the cellular machinery necessary to process 
other carbon sources such as glycerol (Santangelo, 2006).  Glucosamine also mediates 
this repression but it cannot be used to produce energy.  Yeast cells, therefore, cannot 
grow on glycerol in the presence of glucosamine (Hockney and Freeman, 1980; Nevado 
and Heredia, 1996).  Some cells spontaneously acquire the ability to use glycerol in the 
presence of glucosamine, presumably due to defects in glucose signaling and/or the 
response pathways that mediate glucose repression.  Ball and colleagues demonstrated 
that in some cases cells that can grown on glycerol in the presence of glucosamine show 
non-Mendelian inheritance of the phenotype.  Further, the phenotype is not the result of a 
mitochondrial mutation or a plasmid (Kunz and Ball, 1977).  Puzzled, the authors 
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described the factor responsible for this non-Mendelian element of inheritance as 
possibly similar to [PSI+]. 
We show here that this factor, [GAR+], exhibits all of the genetic characteristics 
of a yeast prion but is physically of a very different type.  [GAR+] involves at least two 
factors: the glucose signaling protein Std1 and Pma1, stably associated in an oligomeric 
complex (Schmidt et al., 1999).  Pma1 is a P-type H+-ATPase and is the predominant 
protein at the plasma membrane.  It is a large (100kDa) essential protein with ten 
transmembrane domains.  Its cytoplasmic N- and C-termini are predicted to be 
unstructured or α-helical (Morsomme et al., 2000) and are thought to be important for 
regulation of both its oligomerization and ATPase function (Morsomme et al., 2000; 
Kuhlbrandt et al., 2002).  Pma1 is the major controller of plasma membrane potential and 
cytoplasmic pH (Morsomme et al., 2000) and undergoes a glucose-dependent 
conformation shift (Lecchi et al., 2005) that increases its ATPase activity 10-fold 
(Serrano, 1983). 
Our data indicate that Pma1 acts with Std1 to form [GAR+] by a novel mechanism 
that does not appear to involve protein aggregation or the formation of amyloid.  Instead, 
Pma1 associates with Std1 in [GAR+] cells and Mth1, the homolog of Std1, in [gar-] 
cells; these changes alter signaling through the Rgt2/Snf3 glucose signaling pathway.  
[GAR+] appears spontaneously at a high frequency in many strain backgrounds and 
shows chaperone-dependent non-Mendelian inheritance.  It also exhibits a strong species 
barrier within sibling species.  Replacing the S. cerevisiae Pma1 protein with that of the 
sibling species is sufficient to prevent the propagation of [GAR+].  Because [GAR+] 
involves proteins that are membrane-associated, not cytoplasmic or amyloid-forming, our 
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work suggests that self-perpetuating protein-based elements of inheritance can operate 
outside of the scope of an amyloid template and may be a much broader phenomenon in 
nature than previously surmised. 
 
 
Results 
[GAR+] shows non-Mendelian, infectious inheritance 
 We obtained glucosamine-resistant cells of the type described by Ball and 
colleagues (Ball et al., 1976; Kunz and Ball, 1977) by selecting for cells that could grow 
with 2% glycerol as a carbon source in the presence of 0.05% glucosamine.  Glucosamine 
resistant colonies appeared at a rate of approximately 5 in 104 cells in the W303 genetic 
background (figure S2.01).  Because some loss-of-function mutations can give rise to 
recessive glucosamine resistance (Ball et al., 1976; see table S2.1 table) and the novel 
phenotypes described by Ball and colleagues were dominant, we first crossed 
glucosamine-resistant colonies to wildtype.  All glucosamine-resistant colonies showed 
semi-dominant resistance (figure 2.1a).  Specifically, a cross of glucosamine-resistant to 
glucosamine-sensitive cells invariably yielded a mixed population of diploids, some of 
which showed “strong” (large) glucosamine-resistant colonies and others “weak” 
resistance (small colonies).  Weak glucosamine-resistant colonies invariably converted to 
strong over approximately 25 generations.  “Strong” and “weak” strains are characteristic 
of mammalian and fungal prions. 
In yeast, chromosomally inherited traits show 2:2 segregation following meiosis, tetrad 
dissection, and spore analysis.  All of our dominant glucosamine-resistant variants 
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exhibited non-Mendelian inheritance, segregating 4 resistant spores to 0 sensitive spores 
in each tetrad after meiosis (figure 2.1b).  Both strong resistant colonies and weak 
resistant colonies exhibited 4:0 segregation.  The spores produced by weak diploids 
generally had strong [GAR+] phenotypes (the meiotic products of fig2.1b are from the 
diploids of fig2.1a).  (Interestingly, when cells with a weak [GAR+] phenotype did 
produce weak [GAR+] spores after meiosis, this phenotype was observed in all four 
meiotic progeny (figure 2.1b, bottom)).  We named this genetic element [GAR+] for 
glucosamine resistant, with capitol letters indicating dominance and brackets its non-
Mendelian character. 
To determine whether [GAR+] is “infectious,” we used a mutant defective in 
nuclear fusion (kar1-1).  During mating kar1 cells fuse (with cytoplasmic mixing) but 
nuclei do not (Conde and Fink, 1976).  Selecting for a nucleus and cytoplasm of interest 
after mating effects cytoplasmic exchange without the transfer of nuclear material.  We 
mated a Ura+ His- [GAR+] strain to a kar1-1 Ura- His+ [gar-] strain, then selected for the 
nucleus originally associated with [gar-] (Ura- His+) and against the nucleus originally 
associated with [GAR+] (Ura+ His-).  All ten of the resultant strains tested positive for 
[GAR+] (figure 2.1c), demonstrating the “infectious” character of [GAR+] inheritance. 
 
[GAR+] appears at high frequency in a variety of genetic backgrounds 
We next examined the frequency of [GAR+] appearance in different genetic 
backgrounds.  In the BY background, [GAR+] appeared at a rate of ~9 in 105 cells.  The 
rate was ~1 in 104 cells in 74D, ~5 in 104 cells in W303, and ~7 in 104 cells in Sigma.  In 
the SK1 background, [GAR+] appeared at the astonishingly high rate of ~4 in 103 cells  
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Figure 2.1: [GAR+] shares the genetic characteristics of yeast prions 
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Figure 2.1: [GAR+] shares the genetic characteristics of yeast prions 
a) Mating of [gar-] MATa to [GAR+] MATα in the W303 background.  Resultant 
diploids show semi-dominant [GAR+] with a mixed population of large colonies 
(“strong”) and small colonies (“weak”).  All spot tests shown are five-fold dilutions.  b) 
Tetrad spores from the “strong” [GAR+] (top) and “weak” [GAR+] (middle, bottom) 
diploids in part A show non-Mendelian segregation of [GAR+].  “Weak” commonly 
reverts to “strong” during meiosis (middle) but occasionally stays “weak” (bottom).  c). 
Cytoduction shows cytoplasmic inheritance of [GAR+].  The [GAR+] donor is 10B Ura+ 
His- ρ+ kar1-1 and the acceptor is W303 Ura- His+ ρ0 KAR1.  d). [GAR+] frequency in 
various lab strains.  Data are shown as mean +/- standard deviation (n=6).  e). Tetrad 
spores from a [GAR+] diploid with the genotype hsp104::LEU2/HSP104.  ∆hsp104 
spores are still [GAR+].  f). Tetrad spores from a [GAR+] diploid with the genotype 
ssa1::HIS3/SSA1 ssa2::LEU2/SSA2.  ∆ssa1∆ssa2 spores are no longer [GAR+]. 
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Figure 2.1, continued. 
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(figure 2.1d).  Unlike Ball and colleagues, we did not observe a single incidence of 
Mendelian segregation of the glucosamine-resistant phenotype.  This is presumably 
because, in contrast to that study, we did not start with mutagenized cells. 
 
[GAR+] is curable by transient changes in chaperone protein levels 
 To test the influence of the major chaperone proteins on the inheritance of 
[GAR+], we crossed [GAR+] cells to cells carrying mutations in hsp104 or the Hsp70 
proteins ssa1 and ssa2 (Werner-Washburne et al., 1987).  Hsp104 is required for the 
propagation of [PSI+], [URE3], and [RNQ+], but was not required for [GAR+] 
inheritance, as ∆hsp104 spores were still [GAR+] (figure 2.1e).  However, when 
∆ssa1∆ssa2 cells were crossed to [GAR+] cells, all the meiotic products that were 
∆ssa1∆ssa2 lost the glucosamine-resistant phenotype (figure 2.1f). 
The ability of transient changes in chaperone expression to establish a heritable 
change in phenotype, by curing cells of the self-perpetuating protein conformation, is a 
hallmark of prion-based inheritance.  We tested whether the loss of the [GAR+] 
phenotype was due to an actual curing of the [GAR+] genetic element or whether it was 
retained in ∆ssa1∆ssa2 cells in a cryptic state by crossing them back to wildtype [gar-] 
(figure S2.02a).  Restoration of SSA1 and SSA2 function did not cause reappearance of 
the [GAR+] phenotype.  A transient change in chaperone protein levels was sufficient to 
cure cells of [GAR+].  The [GAR+] phenotype readily reappeared upon selection for 
glucosamine-resistance (figure S2.02b).  Thus, this curing was reversible, another 
hallmark of prion biology (Wickner, 1994).  [GAR+] therefore exhibits the distinguishing 
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characteristics of yeast prions that would indicate it is due to the propagation of an altered 
protein conformation.  
 
[GAR+] is regulated by the Rgt2/Snf3 glucose signaling pathway 
 We performed microarray analysis of [gar-] and [GAR+] to identify transcriptional 
consequences of the [GAR+] phenotype.  The results were surprising: only one gene showed 
a detectable difference between [gar-] cells and [GAR+] cells, and that gene was very strongly 
affected.  Hexose Transporter 3 (HXT3) was approximately 36-fold down-regulated in 
[GAR+] cells compared to [gar-] cells (figure S2.03).  No other transcript exhibited more than 
a two-fold change.  To investigate further, we examined the levels of an Hxt3-GFP fusion 
protein under the control of the endogenous HXT3 promoter.  Hxt3-GFP was readily visible 
at the plasma membrane in [gar-] cells prior to diauxic shift but no signal was detected in 
[GAR+] cells (figure 2.2a).  This result led us to hypothesize that a negative regulator of 
HXT3 expression is the causal agent of [GAR+]. 
 Work by many labs has established the pathways that regulate HXT3 expression 
(Santangelo, 2006).  HXT3 is predominantly silenced by the Snf3/Rgt2 pathway.  Hence, 
to investigate factors underlying the [GAR+] phenotype we first focused on this pathway 
(Kim et al., 2003).  When glucose is present, transmembrane glucose sensors Snf3 and 
Rgt2 transmit a signal to Yck1 and Yck2, which consequently phosphorylate Mth1 and 
Std1, marking them for degradation (figure 2.2b).  When glucose is not present, Mth1 and 
Std1 accumulate and are free to interact with Rgt1.  The Rgt1/Std1/Mth1 complex then 
binds to and represses the upstream region of HXT3.  Std1 and Mth1 are both necessary 
for the binding of Rgt1 to DNA (Lakshmanan et al., 2003). 
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To discover the protein responsible for the [GAR+] state, we took advantage of 
the fact that transient overexpression of the prion protein dramatically increases the 
appearance of the prion, because increased protein concentrations increase the likelihood 
of conformational change (Patino et al., 1996).  We tested each member of the Snf3/Rgt2 
regulatory pathway for induction of the [GAR+] phenotype when overexpressed from a 
plasmid with a strong constitutive promoter, GPD (table 2.I).  The STD1 plasmid caused 
in extraordinary increase in [GAR+] frequency in every strain tested.  In W303, for 
example, this increase in [GAR+] frequency was ~900 fold over that obtained with the 
empty vector; more than one in ten cells in these cultures converted to [GAR+].  No other 
gene in this pathway induced [GAR+].  Overexpression of the STD1 paralog MTH1 
blocked the spontaneous appearance of [GAR+], reaffirming the importance of this 
pathway. 
We also screened the S. cerevisiae haploid deletion library for mutants that are 
incapable of inducing [GAR+] (table S2.2), show a high rate of appearance of [GAR+] 
(table S3), or glucosamine-resistance (table S2.1).  Four of the eight members of the 
Snf3/Rgt2 pathway were found in this screen (p = 8x10-6; Fisher’s exact test).  We also 
did not find many members of other glucose signaling pathways in this screen, 
reaffirming our decision to focus on the Rgt2/Snf3 pathway.  We also screened a library 
of ~5000 ORFs to identify genes that induce [GAR+] following overexpression. and did 
not find any of the genes identified in the deletion library screen (see chapter three, figure 
S3.1). 
Because overexpression of STD1 strongly induced [GAR+], STD1 was identified 
by three different experiments as involved in [GAR+] (microarray, overexpression screen,  
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Figure 2.2: The Snf3/Rgt2 glucose signaling pathway affects [GAR+] 
a) Hxt3-GFP signal in [gar-] and [GAR+] cells by fluorescence microscopy.  Further 
microarray data are deposited at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi 
?token=btyhxgeiaauwyji&acc=GSE12479.  b) The Snf3/Rgt2 glucose signaling pathway 
(adapted from (Moriya and Johnston, 2004).  c) [GAR+] frequency of knockouts in the 
Snf3/Rgt2 glucose signaling pathway.  ∆snf3 is completely resistant to glucosamine and 
therefore [GAR+] frequency could not be measured.  This pathway is enriched for genes 
that alter [GAR+] frequency when knocked out relative to the library of nonessential 
genes (p = 8 x 10-6, Fisher’s exact test).  d) Top: tetrad spores from a [GAR+] diploid with 
the genotype std1::kanMX/STD1.  Bottom: spores from top crossed to a [gar-] strain with 
a wildtype STD1 allele.  e) Std1, Mth1, and Rgt1 are required [GAR+]-dependent 
decrease in Hxt3-GFP levels. 
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 gene 
[GAR+] frequency relative to 
vector 
vector 1 
SNF3                            0.7+0.3 
RGT2                            1.5+0.5 
YCK1                            1.9+0.6 
YCK2                            1.7+0.5 
STD1                        877+100 
MTH1                            0.03+0.02 
RGT1                            1.3+0.4 
HXT3                            1.2+0.3 
 
Table 2.1: [GAR+] induction following transient overexpression of Snf3/Rgt2 pathway 
members 
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knockout library screen) we hypothesized that Std1 was the [GAR+] prion protein.  To 
test this hypothesis, we asked whether STD1 is required for the maintenance of [GAR+] 
by performing a propagation assay.  This involves measuring whether [GAR+] could be 
transferred (“propagated”) through a strain that does not express STD1, a ∆std1 knockout 
mutant.  If STD1 were required for [GAR+] propagation we would observe a ratio 2 
[gar-]: 2 [GAR+] following mating of spores to [gar-] (see figure S2.02a for a diagram of 
this cross) instead of the 4 [GAR+] to 0 [gar-] segregation we normally observed.  A 
[GAR+] diploid heterozygous for an STD1 deletion was sporulated and dissected.  
Surprisingly, all the ∆std1 progent were glucosamine-resistant.  To determine whether 
∆std1 simply masked the phenotype of [GAR+] or actually carried the heritable [GAR+] 
element, we back-mated them to wildtype [gar-] cells.  Surprisingly, [GAR+] was present 
in all of the diploids.  [GAR+] inheritance therefore does not require STD1 (figure 2.2c).  
This makes [GAR+] unique among yeast prions in appearing to have separable inducing 
and propagating agents. 
We examined all other members of the Rgt2/Snf3 pathway for their ability to 
propagate [GAR+].  None of the other members behaved as would be expected for the 
[GAR+] casual agent.  Knockouts were all capable of propagating [GAR+] (figure S2.04).  
The rgt1 knockout itself did not exhibit glucosamine resistance.  However, RGT1 is not 
the [GAR+] heritable element because [GAR+] was retained in the ∆rgt1 cells in a 
“cryptic” form: the [GAR+] phenotype reappeared when ∆rgt1 cells were crossed back to 
[gar-] RGT1 cells. 
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Pma1 associates with Std1 and is a component of [GAR+] 
Since STD1 acts as an inducing agent for [GAR+], we hypothesized that it would 
physically interact with the unknown propagating agent.  We therefore 
immunoprecipitated HA-tagged Std1p from [gar-] and [GAR+] cells.  A high molecular 
weight band was found in [GAR+] protein lysates but not in [gar-] lysates (figure 2.3a).  
Mass spectrometry analysis identified the protein as Pma1.  To ensure that this 
association was specific to Std1, we also preformed the IP in ∆std1 cells.  Our band of 
interest was not detected in this lane. 
 Pma1, an essential P-type ATPase with ten transmembrane domains, contains 
cytoplasmic N- and C-termini.  The N-terminal domain of Pma1 is predicted to be 
unstructured (a characteristic of yeast prion proteins) while the C-terminal regions is 
predicted to be α-helical (Morsomme et al., 2000).  To test whether Pma1 affects 
[GAR+], we asked if the frequency at which cells were converted to [GAR+] increased 
following transient PMA1 overexpression.  Pma1 is the most abundant plasma membrane 
protein in yeast (Morsomme et al., 2000) and overexpression is not well tolerated (Eraso 
et al., 1987).  We were, however, able to obtain a three-fold transient increase in Pma1 
protein levels and a corresponding increase in [GAR+] frequency (figure 2.3b). 
When an N-terminally truncated (∆40) mutant of PMA1 was transiently overexpressed, 
no increase in [GAR+] appearance was observed despite increases in Pma1 protein levels 
(figure 2.3b).  When a C-terminally truncated PMA1 was overexpressed it did not 
accumulate as strongly as the wildtype protein but still caused a 2.2 fold increase in 
conversion to [GAR+].  These data indicate that the N-terminus of Pma1 contributes to 
the formation of [GAR+].  To ensure that this was due to overexpression of the PMA1 
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Figure 2.3: Pma1 is involved in [GAR+] propagation 
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Figure 2.3: Pma1 is involved in [GAR+] propagation 
a) Immunoprecipitation of Std1-6HA from ∆std1, [gar-], and [GAR+] strains.  One band 
was found in [GAR+] but not [gar-] or ∆std1.  This was analyzed by mass spectrometry 
and found to be Pma1.  Coverage was >25% of the protein. b) [GAR+] induction by 
transient overexpression of PMA1 in a wildtype background.  Data is shown as the mean 
of [GAR+] frequency +/- standard deviation (n=6).  Western is total protein probed with 
αPma1 antibody and quantified using Scion Image.  c) Propagation of [GAR+] is 
impaired in PMA1∆40N ∆std1 double mutants.  Top: tetrad spores from a [GAR+] diploid 
with the genotype GAL-PMA1∆40N/PMA1 std1::kanMX/STD1.  Bottom: spores from top 
crossed to a [gar-] strain with wildtype PMA1 and STD1 alleles.  PMA1∆40N ∆std1 
spores cannot propagate [GAR+] to wildtype [gar-] yeast.  d) Native gel of Pma1, Std1, 
and Mth1 in [gar-] and [GAR+].  Either Std1 (left) or Mth1 (right) was tagged with six 
tandem HA tags and samples were processed as described from [gar-] and [GAR+] strains 
of each background.  Total, supernatant (sup.), digitonin soluble (det. sol.), and digitonin 
insoluble (insol.) fractions were run on SDS gels and probed for Pma1 and Std1 or Mth1 
(lower right).  Blots of the total fraction were stained with Ponceau Red to confirm equal 
amounts of starting material (top right).   
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protein, we introduced a stop codon at position 23 or 59 on the N-terminal region.  
Neither plasmid increased [GAR+] frequency relative to vector alone (figure S2.05). 
 We could not test the effect of Pma1 deletions on [GAR+] propagation because 
PMA1 is essential.  Indeed, even deletions of the N-terminal domain is lethal (Portillo et 
al., 1989).  Mutations of up to 40aa from the N-terminus are tolerated but only when 
expressed from a very strong promoter such as GAL1 (Liu et al., 2006).  [GAR+] was 
propagated through PMA1∆40N cells (figure S2.06).  Strikingly, however, it was not 
propagated through a PMA1∆40N ∆std1 double mutant (figure 2.3c), suggesting that 
Std1 and the N-terminus of Pma1 are together involved in [GAR+] propagation but that 
each can maintain [GAR+] in the absence of the other. 
 Pma1 functions as an oligomeric complex at the plasma membrane (Kuhlbrandt et 
al., 2002).  Because transient overexpression of STD1 induces [GAR+] and MTH1 
inhibits it we asked if there were heritable changes in association of these proteins with 
Pma1 in [gar-] and [GAR+] cells.  In both [gar-] and [GAR+], Pma1 formed unresolved 
high molecular weight (HMW) oligomers and two lower molecular weight (LMW) 
oligomers when visualized by Blue Native gel analysis (figure 2.3d).  Std1 was more 
strongly associated with the LMW oligomers in [GAR+] than in [gar-].  Mth1, the 
homolog of Std1, showed the reverse: stronger association with LMW oligomers in [gar-] 
than in [GAR+].  Pma1 showed a minor but statistically significant change in protease 
sensitivity between [gar-] and [GAR+]: total Pma1 was digested slightly more rapidly by 
trypsin when vesicles are isolated from [GAR+] cells than from [gar-] (figure S2.07).  
Small differences in protease sensitivity could be consistent with the small amounts of 
Pma1 associated with Std1 in [GAR+]. 
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 Pma1 does not change SDS solubility between [gar-] and [GAR+] 
 Other yeast prions exhibit changes in localization and solubility when they enter 
into the prion state (Uptain and Lindquist, 2002).  Neither Pma1 nor Std1 formed an 
SDS-resistant species in [GAR+] (figure S2.08).  The lack of an SDS-resistant Pma1 
species and targeting to the same cellular location in [gar-] and [GAR+] show that Pma1 
does not form amyloid in [GAR+]. 
 
Pma1 is a determinant of [GAR+] 
 In order to strengthen the connection between Pma1 and [GAR+], we investigated 
whether mutations in genes involved in Pma1 oligomerization and trafficking to the 
plasma membrane alter [GAR+] frequency.  We hypothesized that genes involved in 
Pma1 trafficking and oligomerization, as shown by previous studies and Blue Native gels 
would exhibit a change in [GAR+] frequency when knocked out (fatty acid synthase 
SUR4 (Lee et al., 2002) and COPII coat protein LST1 (Roberg et al., 1999)).  Mutants 
that do not affect Pma1 oligomerization (sphingolipid synthesis genes LCB3, LCB4, 
DPL1) (Lee et al., 2002) or affect trafficking of mutant Pma1 but not wildtype (ATG19) 
(Mazon et al., 2007) should have the same [GAR+] frequency.  This was indeed the case: 
mutants that showed changed Pma1 oligomer patterns by Blue Native gel (figure 2.3d) 
also showed decreased [GAR+] frequency (figure 2.3e).  Overall, these data demonstrate 
that alterations in Pma1 oligomers are correlated with alterations in [GAR+] frequency.   
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Figure 2.4: Alterations to Pma1 affect [GAR+] 
 94
 Figure 2.4: Alterations to Pma1 affect [GAR+] 
a) Native gel blotted for Pma1 from knockout mutants of genes previously shown to 
affect (∆sur4, ∆lst1) (Eisenkolb et al. 2002) (Roberg et al. 1999) or not affect (∆lcb3, 
∆lcb4, ∆dpl1) (Gaigg et al. 2005) attributes of wildtype Pma1 (left).  SDS gels of total, 
supernatant (sup.), digitonin soluble (det. sol.), and digitonin insoluble (insol.) fractions 
were probed with αPma1 antibody following blotting (right).  The “total” blot was also 
stained with Ponceau Red to confirm equal amounts of starting material (bottom right).  
b) Measurement of [GAR+] frequency in mutants from part a.  c) Mutants in 
phosphorylation sites at the C-terminus of Pma1 affect [GAR+] frequency.  Starting strain 
is haploid, [gar-], genotype pma1::kanMX with p316-PMA1.  p314-PMA1 carrying 
wildtype PMA1 or mutants of interest were transformed in and then p316-PMA1 plasmid 
selected against by growth on 5-FOA.  Graph represents the mean +/- standard deviation 
(n=6).  P-values are the binomial distribution of the mean.  d) Pma1 mutants that increase 
[GAR+] frequency show decreased levels of Hxt3-GFP.  Graph represents the mean +/- 
standard deviation (n>6) and p-values were determined using the chi-squared test.  Strain 
background is a hybrid of W303 and S288C. 
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Furthermore ∆lst1 and ∆sur4 reduced the frequency of [GAR+] appearance they were not 
required for its propagation (figure S2.09). 
 Pma1 activity is regulated by both glucose and other environmental conditions.  
The addition of glucose to carbon-free medium increases the ATPase activity of the 
enzyme (Serrano, 1983) and results in a conformational shift (Miranda et al., 2002).  
Glucose-dependent phosphorylation contributes to this phenomenon (Lecchi et al., 2005).  
Residues in the C-terminal cytoplasmic tail of the protein, S899 (Eraso et al., 2006), 
S911, and T912 (Lecchi et al., 2007) are phosphorylated in response to carbon source 
conditions and are thought to contribute to the conformational shift in Pma1.  There is 
also evidence that the N-terminal region of Pma1 is phosphorylated but particular sites 
have not been identified (Lecchi et al., 2007).  This is unfortunate, as our previous data 
implicate the N-terminal region in [GAR+] induction (figure 2.3b).  However, we 
hypothesized that if Pma1 causes [GAR+], changing the activity and conformation of 
Pma1 would affect [GAR+] frequency, even if the mutations made were not located in the 
putative prion-determining domain. 
Pma1 has been shown to be responsive to glucose (Serrano, 1983) but has not 
been linked to a particular signaling pathway.  Our observation that Pma1 associates with 
Std1, a member of the Rgt2/Snf3 glucose signaling pathway, implies a connection.  To 
test this, we mutated the well-characterized regulatory sites S899, S911, and T912 to 
alanine, which cannot be phosphorylated, or aspartic acid, which mimics constitutive 
phosphorylation.  We then measured whether these mutants affect [GAR+] frequency or 
HXT3 expression.  The latter serves as a downstream readout of the Rgt2/Snf3 pathway 
and, as demonstrated above, HXT3 is turned off in [GAR+] (figure 2.2a). 
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Two mutations, S911A and S911A/T912A, increased [GAR+] frequency (figure 
2.4c).  These same two mutants also had reduced Hxt3-GFP signal (figure 2.4d).  No 
other mutant showed a significant change, either increased or decreased, although 
T912D, which showed no significant change in [GAR+] frequency or Hxt3-GFP signal 
compared to wildtype, was included as an additional control.  This demonstrates a 
connection between Pma1 and the Rgt2/Snf3 glucose signaling pathway.  Further, the 
fact that mutants in Pma1 affect the frequency of [GAR+] appearance by as much as 10 
fold supports the role of Pma1 in determining the prion state. 
 
[GAR+] is sensitive to a Pma1-dependent “species barrier” 
 To test the relation between Pma1, Std1, and [GAR+] more definitively, we 
performed a classic “species barrier” experiment.  Small differences in amino acid 
sequence cause prions that originate in one species to fail in transmission to another 
species.  Prions cannot even propagate through their originating organism if the prion-
determining gene from the host has been replaced with the prion-determining gene from 
another species.  This has been observed for mammalian prions (Prusiner, 1998) and for 
[PSI+] (Santoso et al., 2000; Bagriantsev and Liebman, 2004; Chen et al., 2007). 
We chose two species, S. bayanus and S. paradoxus, which can acquire 
spontaneous glucosamine-resistance (figure 2.5a).  The sequence differences in Pma1 
between the species are slight (figure S2.10): S. paradoxus Pma1 differs from S. 
cerevisiae Pma1 only at four amino acids, three of them in the N-terminus, and S. 
bayanus Pma1 differs from S. cerevisiae in fewer than a dozen amino acids, most in the 
N-terminus.  In a [GAR+] background, we replaced S. cerevisiae PMA1 with that from  
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 Figure 2.5: [GAR+] exhibits a Pma1-dependent species barrier 
a) The frequency of [GAR+] cells in populations of S. bayanus and S. paradoxus were 
measured at 30°C, the optimal growth temperature of S. paradoxus, and 23°C, a preferred 
growth temperature of S. bayanus.  b) Substitution of PMA1 from S. cerevisiae with 
PMA1 from S. bayanus or S. paradoxus prevents [GAR+] propagation.  Starting strain is 
haploid, [GAR+], genotype pma1::kanMX with p316-PMA1 S. cerevisiae as a covering 
plasmid.  p314-PMA1 carrying PMA1 from S. cerevisiae (S.c., top), S. bayanus (S.bay., 
middle), or S. paradoxus (S.par., bottom) was transformed in and p316-PMA1 S.c. 
selected against by replica plating to 5-FOA (S.c. 1N, S.b. 1N, or S.p. 1N).  These 
haploids were mated to a wildtype S. cerevisiae [gar-] background, restreaked two times, 
and tested for [GAR+].  Representative data from three independent experiments is 
shown. 
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the sensu stricto species S. bayanus and S. paradoxus via plasmid shuffle (see plasmids 
table, S2.4).  The S. paradoxus or S. bayanus transgenics were then mated to wildtype 
[gar-] S. cerevisiae to test the ability of the Pma1 protein from S. paradoxus or S. bayanus 
to both hold and propagate S. cerevisiae [GAR+] (figure 2.5b).  In a background where 
the entire genome otherwise remains the same, S. paradoxus PMA1 did not propagate S. 
cerevisiae [GAR+].  S. bayanus PMA1 propagated S. cerevisiae [GAR+] very weakly. 
PMA1 demonstrated a strong species barrier preventing [GAR+] propagation.  
Does [GAR+] induction also exhibit a species barrier?  The spontaneous appearance of 
glucosamine-resistant colonies is much higher in S. cerevisiae and S. bayanus than in S. 
paradoxus, despite S. paradoxus Pma1 being closer to S. cerevisiae in sequence than S. 
bayanus Pma1 is (figure S2.11).  However, the sequence of Std1, the [GAR+] induction 
factor, is much closer in S. cerevisiae and S. bayanus.  We therefore tested whether 
induction of [GAR+] by Std1 exhibits a species barrier.  STD1 from the various species 
was transiently overexpressed in cells carrying Pma1 from the different species (figure 
2.5c).  STD1 from S. cerevisiae and S. bayanus acted as general inducers: in a 
background where the entire genome otherwise remains the same, both STD1 alleles 
induced [GAR+] almost 1000 fold in strains carrying PMA1 from any of the three sibling 
species.  In contrast, STD1 from S. paradoxus did not induce [GAR+] in strains carrying 
any PMA1.  Std1 from S. cerevisiae and S. bayanus therefore acts as an inducer of 
[GAR+] but S. paradoxus Std1 does not.  Std1, like Pma1, contributes to the strong 
species barrier observed in [GAR+] induction and propagation. 
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Discussion 
 The ability of cells to sense and adapt to their nutritional circumstances is crucial 
to survival in the highly competitive and rapidly fluctuating environment.  Here we 
describe [GAR+], a prion-based heritable element involved in glucose sensing and 
signaling.  We demonstrate that [GAR+] involves the plasma membrane proton pump 
Pma1 and the glucose signaling factor Std1.  [GAR+] fulfills the genetic criteria of prions: 
it shows non-Mendelian inheritance, can by transferred via cytoplasmic exchange, is 
metastable, and is semi-dominant.  However, Pma1 and Std1 do not aggregate or form an 
SDS-resistant species (and thus amyloid) in [GAR+].  Instead, Pma1 associates with Std1 
in [GAR+] but the homolog of Std1, Mth, in [gar-], all while remaining at the plasma 
membrane.  Pma1, certainly, and possibly Pma1 and Std1 together, are involved in 
[GAR+] propagation, thus possibly making [GAR+] a prion with multiple determining 
factors.  Mutations in glucose-sensitive phosphorylation sites affect silencing of HXT3, 
demonstrating that Pma1 is involved in glucose signaling.  These same phosphorylation 
site mutants affect [GAR+] frequency, suggesting a method of regulation of [GAR+].  
Overall, the non-Mendelian mechanism that best describes [GAR+] is prion. 
 
[GAR+] is a non-Mendelian element that functions through a prion-based non-amyloid 
mechanism 
[GAR+] fulfills all the genetic characteristics of yeast prions but differs in that it 
does not involve a heritable amyloid conformation.  This likely explains why [GAR+] 
does not require Hsp104, the canonical prion chaperone, for propagation.  Prusiner’s 
original definition of “prion” was simply “proteinaceous infectious particle that lacks 
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nucleic acid” (Prusiner 1998).  This neither proposes a mechanism nor requires that a 
prion-causing protein undergoes a conformational shift.  In fungi, a self-activating 
protease, [β], can act a prion (Roberts and Wickner, 2003).  [β] fulfills all the genetic 
characteristics (Wickner, 1994) of an infectious proteinaceous element: it catalyzes its 
own activity by cleaving the inactive form, thus converting it to the active form, and the 
presence of the active form is therefore self-propagating.  However, [β] does not involve 
a conformational change in the causal protein but instead an enzymic self-catalyzing 
cleavage (?that is only self-activating in the absence of another protease) (Roberts and 
Wickner, 2003).  The use of the term “prion” in this context has been criticized because it 
to date only applies to an artificial situation, not one that occurs spontaneously or is found 
in nature. 
Another non-amyloid prion, Crippled growth (C), found in the filamentous fungus 
Podospora anserina, is thought to result from a self-activating MAP kinase cascade 
(Kicka et al., 2006) but bears some resemblance to conventional prions because one C 
causal protein contains a poly-glutamine region and several of the involved proteins show 
a change in localization between C and normal growth (Kicka and Silar, 2004).  [GAR+] 
also fulfills all the genetic criteria of an infectious proteinaceous element and does not 
form an amyloid.  However, [GAR+] is even more unusual than C because it does not 
cause a change in localization of involved proteins nor includes a glutamine- or 
asparagine-rich protein.  Overall, we propose that [GAR+] acts as a prion regardless of 
whether its infectivity involves a conformational change in Pma1.  Instead, we support 
the idea that “prions” can result from a variety of infective mechanisms, including self-
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activating enzymes and self-sustaining signaling cascades, as long as they are capable of 
acting as heritable genetic elements. 
 
Pma1 is involved in [GAR+] propagation 
 Overall, [GAR+] exhibits a strong species barrier for propagation that depends on 
Pma1 (figure 2.5b).  [GAR+] also exhibits a species barrier for induction that involves 
Std1 (figure 2.5c).  This conclusively demonstrates the importance of Pma1 in [GAR+] 
propagation.  However, these results might not be explained by sequence alone.  It is 
possible that the swap of PMA1 from different Saccharomyces species cures [GAR+] 
because it disrupts interactions between Pma1 and other proteins such as Std1.  Also, we 
have shown that a double mutations in std1 and the N-terminal 40aa of pma1 is sufficient 
to cure [GAR+] (figure 2.3c) even though neither single mutant alone is sufficient (figure 
2.2d, S2.04).  Therefore, it is possible that Std1 plays a role in the propagation of [GAR+] 
and not just the induction, perhaps by stabilizing the [GAR+]-forming Pma1 complex. 
 Are elements in addition to Pma1 and potentially Std1 involved in [GAR+] 
propagation?  Pma1 is the predominant protein at the plasma membrane; quantity alone 
suggests that it has the opportunity to interact with a wide variety of other proteins.  It is 
possible that other elements are involved in the [GAR+] heritable structure in addition to 
Std1 and Pma1.  Furthermore, these proteins are involved in signaling cascades and are 
thus likely to participate in numerous transient associations.  Our work to identify 
additional factors has not yet but successful but this is an interesting area for future 
exploration. 
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Does [GAR+] cause a new signaling complex? 
 [GAR+] exhibits some unusual and intriguing characteristics for yeast prions, 
particularly that it does not involve formation of an amyloid-like conformation.  Instead, 
[GAR+] involves an inducing factor, Std1, which stably associates with Pma1 in the 
[GAR+] form.  Pma1 and Std1 remain at the plasma membrane to cause [GAR+].  
Changes in Pma1 oligomer size correlate with altered [GAR+] frequency, and Pma1 alters 
its association with a signaling protein, from Mth1 in [gar-] to Std1 in [GAR+].  We 
therefore hypothesize that [GAR+] causes its phenotype, glucosamine resistance, by 
altering signaling through a glucose signaling pathway.  This signal does not affect the 
Snf1 pathway, otherwise greater transcriptional differences between [gar-] and [GAR+] 
would be observed in our microarray experiments.  It does, however, affect the Snf3/Rgt2 
signaling pathway as shown by the change in HXT3 expression.  We thus speculate that 
[GAR+] increases the ability of Std1 to silence HXT3, perhaps by increasing its affinity 
for that DNA binding protein Rgt1 (figure 2.6).  The increased association of Std1 and 
Pma1 could allow for this change either directly, by, for example, preventing degradation 
of Std1, or indirectly.  We have also uncovered a novel role for Pma1 in glucose sensing, 
as shown by alterations in Hxt3-GFP signal in Pma1 mutants.  Although Pma1 was 
known to respond to and be controlled by glucose (Morsomme et al, 2000), it has not 
previously been linked to glucose signaling itself. 
 
[GAR+] is semi-dominant 
 [GAR+] is also unusual for being semi-dominant in a mating rather than 
dominant, as [PSI+] are [URE3] are.  Instead, a mixed population of large (strong) and  
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Figure 2.6: Pma1 and the Rgt2/Snf3 glucose signaling pathway 
We propose that Pma1 acts as a part of the Rgt2/Snf3 signaling pathway.  a) In [gar-] 
glucose-grown cells, Pma1 associates with Mth1.  The glucose signal is propagated 
through Snf3 and Rgt2 to Yck1 and Yck2, which phosphorylate Mth1 and Std1.  This 
phosphorylation marks Mth1 and Std1 for degredation, leaving their interacting partner, 
Rgt1, free in the cytosol, where it does not repress transcription at the HXT3 locus.  b) 
Under [GAR+] conditions, HXT3 transcription is repressed, which resembles that of cells 
grown in a carbon source other than glucose.  Pma1 associates with Std1, which 
somehow facilitates the repression of HXT3, possibly by altering the affinity of Std1 for 
Rgt1.  Association with Std1 has previously been shown to facilitate the binding of Rgt1 
to DNA (Lakshmanan et al., 2003). 
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small (weak) colonies appear on glucosamine medium following mating.  Strong [GAR+] 
is very stable in meiosis and weak [GAR+] somewhat so, not because weak [GAR+] 
switches to [gar-] but because it converts to strong [GAR+].  Weak [GAR+] also converts 
to strong [GAR+] under standard mitotic conditions within approximately 25 generations.  
This could be because formation of strong [GAR+] is a multi-step process and weak 
[GAR+] represents an unstable intermediate on the pathway to strong [GAR+].  Std1 
promotes [GAR+], as transient overexpression of STD1 induced [GAR+], and Mth1 has 
an inhibitory affect, as transient overexpression of MTH1 blocked [GAR+] (table 2.1).  
Inhibition of [GAR+] formation by MTH1 is likely due in part to transcriptional 
repression of STD1, which has been observed when MTH1 is overexpressed (Kim et al., 
2006).  The association of Mth1 with Pma1 in the [gar-] state could prevent Std1 from 
associating with Pma1 and thus forming the [GAR+] state.  Another possibility is that 
[gar-] and [GAR+] are both self-propagating states involviong their associations with 
Mth1 and Std1, respectively, and weak [GAR+] is a middle state that can convert to either 
[gar-] or strong [GAR+], which are then self-perpetuating.  Regardless, the opposing 
results from STD1 and MTH1 overexpression are intriguing because MTH1 and STD1 are 
paralogs that are ~61% identical on the amino acid level (Hubbard et al., 1994).  Neither, 
however, have any known enzymatic activity or domains identifiable by BLAST 
analysis. 
 
 
Pma1 is conserved across the fungal kingdom and is even found in some plants.  
Our discovery that an extremely well-conserved transmembrane protein can act as a prion 
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raises questions whether the prion phenomenon is widespread.  Pma1 forms high 
molecular weight oligomers in plants and is regulated by nutrients (Duby and Boutry, 
2008) and might therefore have a [GAR+]-like form.  Because Pma1 is so well-conserved 
it would be extremely interest to investigate whether the [GAR+] prion is found in a 
variety of organisms.  Further, if [GAR+] is common, this lends support to the idea that 
self-propagating protein-based genetic elements might be more common as a mechanism 
of regulation than previously thought. 
 
 
 
Experimental Procedures 
Yeast strains and genetic manipulations 
Strain construction and manipulation followed standard yeast techniques.  A list of strains 
and plasmids used in this study is available in table S1.  Unless otherwise stated, data 
shown is from genetic background W303.  Five-fold dilutions were used for all spotting 
assays.  Growth rate was measured in the Bioscreen C (Growth Curves USA) at 30°C 
with intensive, intermittent shaking with the OD600 measured every 15 minutes. 
 
[GAR+] frequency assays and isolation of [GAR+] 
Cultures for [GAR+] frequency assays were grown overnight in 2% glucose, either YPD 
or SD, subcultured in the same, then grown to early exponential phase (OD600 = 0.2-0.4).  
Cultures plated straight to GGM (1% yeast extract, 2% peptone, 2% glycerol, 0.05% D-
(+)-glucosamine [Sigma G4875]) and diluted 10-4 for plating to YPD.  To isolate [GAR+] 
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for further study, colonies from GGM were restreaked once to GGM then used in 
downstream applications. 
 
Western blotting 
Protein samples were run on 4-12% SDS gels from Invitrogen and blotted to PVDF using 
standard techniques.  All samples to be tested for Pma1 were incubated in loading buffer 
(4% SDS, 50mM Tris pH 6.8, 2% β-mercaptoethanol, 10% glycerol) for 10min at 37°C.  
Monoclonal αPma1 mouse antibody was obtained from EnCor Biotechnology.  
Polyclonal αPma1 rabbit antibody was a gift from Amy Chang.  Polyclonal αSec61 
antibody was a gift from Tom Rapaport.  Immune complexes were visualized by ECL. 
 
Microarray analysis 
PolyA RNA was produced using standard methods (cite).  Samples were labeled and 
hybridized to Affymetrix S98 arrays using standard methods (cite). 
 
Hxt3-GFP analysis 
Hxt3-GFP signal was observed starting at OD600 = 0.7 in an S288C background. 
 
Immunoprecipitation 
IPs were performed using standard in IP buffer (50mM HEPES pH 7.5, 150mM NaCl, 
2.5mM EDTA, 1% V/VTriton X-100, 40mM NEM, 3mM PMSF, 1 Protease Inhibitor 
Cocktail Tablet per 5ml buffer [Roche]).  Cells were lysed either by bead beating (9 x 
30sec with 15sec on ice between) or spheroplasting (30min at 30°C in 1M D-sorbitol, 
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0.1M EDTA, 0.5mg/ml zymolase) with comparable results.  Lysates were adjusted for 
protein concentration, incubated with protein G agarose beads (Roche) for 30min at 4°C, 
centrifuged at 3300 x g for 2min, and the supernatant collected.  The supernatant was 
then incubated with 10µg mouse αHA antibody (Sigma) for 1 hour at 4°C followed by 
incubation with 50µl protein G beads (Roche) for 1 hour at 4°C.  Samples then washed 
six times in chilled IP buffer and run on a 4-12% SDS gel.  Gels were either stained with 
colloidal Coomassie (Invitrogen) or blotted for Pma1. 
 
Native gels 
Midlog cultures (150ml, OD600~0.5) were lysed by bead beating (9 x 30sec with 15sec on 
ice between) into sorbitol buffer (250mM sorbitol, 50mM Tris pH 7.5, 3mM PMSF, 1 
Protease Inhibitor Cocktail Tablet per 5ml buffer [Roche]).  Samples were equalized at a 
concentration of 15µg/µl in 650µl, a “total” sample collected, and centrifuged at 16000 x 
g for 30min at 4°C.  The supernatant was removed, a sample saved for downstream 
analysis, and the pellet washed once in sorbitol buffer.  The pellet was resuspended in 
sorbitol buffer (200µl), and an aliquot (95µl) incubated 20min on ice with digitonin to 
1% (Calbiochem).  These samples were then centrifuged at 16000 x g at 4°C for 30min 
and separated into supernatant (“digitonin soluble”) and pellet (“digitonin insoluble”) 
fractions.  15µl of the soluble fraction was incubated with Coomassie G-250 at a 
detergent to dye ratio of 8:1 for 10min on ice then loaded onto 3-12% Blue Native gel 
(Invitrogen) and run at 4°C as per the manufacturer’s instructions. 
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Trypsin digestion 
Cells were grown to mid exponential phase (OD600~0.5), washed three times in water, 
then lysed by bead beating (9 x 30sec with 15sec on ice between) into sorbitol buffer 
(250mM sorbitol, 50mM Tris pH 7.5, 3mM PMSF, 1 Protease Inhibitor Cocktail Tablet 
per 5ml buffer [Roche]).  Samples were centrifuged at 16000 x g for 30min at 4°C, the 
supernatant removed, then washed three times in sorbitol buffer with protease inhibitors 
and three times in sorbitol buffer without protease inhibitors.  For trypsin reactions, 10µg 
protein and 4µg trypsin (Worthington) were used in a total volume of 20µl.  Reactions 
were incubated at 30°C and stopped after the designated point in time by addition of 2µl 
soybean trypsin inhibitor (10mg/ml stock, from Sigma) then immediately frozen in an 
ethanol/dry ice bath.  Samples were run on gels as described above, probed with 
monoclonal αPma1, stripped, and re-probed with polyclonal αSec61. 
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Figure S2.01: Spontaneous glucosamine resistance 
 Exponential phase yeast grown in YPD (2% glucose) were plate to 2% glucose 
(left) or 2% glycerol + 0.05% glucosamine (GGM; right).  Spontaneous gluocosamine-
resistant colonies are visible on the GGM plate; these are used in [GAR+] studies. 
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Figure S2.02: Hsp70-dependent curing of [GAR+] is reversible 
a) The crosses involved in a [GAR+] propagation assay are shown.  Cells carrying 
[GAR+] were mated to [gar-] cells carrying a mutation of interest (“∆”), here ∆ssa1∆ssa2.  
Diploids were selected for, then sporulated.  These spores (“haploids”) were then crossed 
to wildtype [gar-] cells and we then selected for the resultant diploids (“diploids”).  Both 
haploids and diploids were tested for glucosamine resistance; if diploids were sensitive to 
glucosamine, then the [GAR+] heritable element cannot be propagated through the mutant 
of interest and [GAR+] is therefore “cured” to [gar-]. b) [GAR+] frequency within a 
population of wildtype [gar-] cells or cells “cured” of [GAR+] by deletion of ssa1 and 
ssa2, then crossed to [gar-].  The final cross to [gar-] demonstrates whether [GAR+] can 
propagate through ∆ssa1∆ssa2 mutants, as outlined in part a.  [GAR+] frequency is 
measured in the cells that result from this cross.  Because [GAR+] appears spontaneously 
at the same frequency as wildtype, ∆ssa1∆ssa2 mutants reversibly cure [GAR+].  Also, 
this demonstrates that [GAR+] is not “cryptic” in ∆ssa1∆ssa2 mutants, otherwise all cells 
would be [GAR+] and the measured frequency approaching 1.0. 
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Figure S2.03: Transcriptional profiling of [gar-] and [GAR+] cells 
 A SAM plot of Affymetrix microarrays comparing [gar-] and [GAR+] cells grown 
in glucose.  A single point (green) in the bottom left corner represents the only transcript 
that exhibits a significant change in abundance: YDR345C (HXT3). 
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Figure S2.04: Knockout mutants of Rgt2/Snf3 pathway members propagate [GAR+] 
 [gar-] strains in which various members of the Rgt2/Snf3 pathway were knocked 
out were crossed to [GAR+] cells, then sporulated and dissected.  These spores (“1N”) 
were tested for glucosamine resistance and then crossed to [gar-] haploids to determine 
whether [GAR+] can be propagated through these mutants (“2N”) (see S2.02 for outline 
of crosses).  ∆rgt1 1N cells are not glucosamine-resistant but 2N cells are, demonstrating 
that [GAR+] is cryptic in ∆rgt1 haploid cells.  However, RGT1 is not the causal agent of 
[GAR+] because [GAR+] can be propagated from ∆rgt1 to wildtype cells. 
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Figure S2.05: PMA1 nonsense mutations do not induce [GAR+] 
 The PMA1 ORF containing nonsense mutations at Q23 or E59 was transiently 
overexpressed.  This did not induce [GAR+] relative to vector, demonstrating that the 
increase in [GAR+] due to PMA1 overexpression (figure 2.3b) is specific to the Pma1 
protein. 
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Figure S2.06: PMA1∆40N propagates [GAR+] 
Top: tetrad spores from a [GAR+] diploid with the genotype GAL-
PMA1∆40N/PMA1.  The pma1 mutation is marked with His+.  Wildtype spores grown on 
glucosamine-containing medium but pma1 mutants cannot grown on any medium lacking 
galactose, so grown on glycerol-glucosamine cannot be measured.  Bottom: spores from 
top crossed to a [gar-] strain containing a wildtype PMA1 allele.  PMA1∆40N spores grow 
on glycerol-glucosamine medium and therefore can propagate [GAR+] to wildtype [gar-] 
yeast. 
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Figure S2.07: Pma1 from [GAR+] is more sensitive to trypsin than [gar-] Pma1 
Trypsin digestion of Pma1 (left) or Sec61 (right) from [gar-] (top) or [GAR+] 
(middle).  A total of six blots were averaged (bottom) and the amount of uncut Pma1 or 
Sec61 measured and graphed relative to t = 0.  Graph represents mean (n = 6) of 
(t=n)/(t=0) and p-value was calculated using a paired Wilcoxon test.  A red asterisks 
marks statistically significant points ( p = 0.03). 
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Figure S2.08: Pma1 and Std1 do not form SDS-resistant species 
 a) SDS-treated protein samples from [psi-] and [PSI+] (left) and [gar-] and [GAR+] 
(right) were run on Blue Native gels.  Samples were incubated 10min in 4% SDS at 37°C 
before running, transferred by standard Western techniques, then probed with αSup35 
(left) or αPma1 antibodies.  Sup35 shows protein in the well in [PSI+] but not in [psi-], 
indicated a difference in SDS-solubility.  This is expected because Sup35 forms amyloid 
in [PSI+].  Pma1, however, does not show any difference in SDS-solubility between [gar-] 
and [GAR+], indicating that Pma1 does not enter into an amyloid state.  b) Samples run 
on SDS gels and blotted for the protein of interest (top) or stained with Ponceau as a 
loading control (bottom).  [gar-] and [GAR+] samples were probed with αPma1 (far left) 
or αHA (second left; to detect Std1-6HA).  There were no differences in mobility in 
Pma1 or Std1 between [gar-] and [GAR+] samples following incubation in 4% SDS for 
10min at 37°C.  When [psi-] and [PSI+] protein samples were treated this way, however, 
(far right: 37°C for 10min), Sup35 protein from [PSI+] runs higher than that from [psi-] 
and does not resolve well.  When protein samples are boiled, however (second right), 
Sup35 shows no difference in mobility between [psi-] and [PSI+].  Sup35 therefore 
behaves like an amyloid in [PSI+] whereas neither Pma1 nor Std1 exhibit the SDS 
resistance characteristic of amyloids in [gar-] or [GAR+]. 
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Figure S2.09:  ∆lst1 and ∆sur4 both carry [GAR+] 
[gar-] strains in which either lst1 (part a) or sur4 (part b) were knocked out were crossed 
to [GAR+] cells, then sporulated and dissected.  These spores were tested for glucosamine 
resistance.  All spores grown on glycerol-glucosamine plates, demonstrating that ∆lst1 
and ∆sur4 can hold [GAR+]. 
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      1* *****     *   *               *                  50 
Scer  MTDTSSSSSS SS.ASSVSAH QPTQEKPAKT YDDAASESSD DDDIDALIEE 
Spar  MADTSSSSSS SSSASSVSAH QPTQEKPAKT YDDAASESSD DDDIDALIEE 
Sbay  ...MTDNTSS SSSASSASAH QPTQEKPAKT FDDAASESSD DDDIDALIDE 
 
      51  *   ** * **           *    *                   100 
Scer  LQSNHGVDDE DSDNDGPVAA GEARPVPEEY LQTDPSYGLT SDEVLKRRKK 
Spar  LQSNHGVDDE GSDDDGPVAA GEARPVPEEY LQTDPSYGLT SDEVLKRRKK 
Sbay  LQSNPGVDGS ESEDDGPVAA GEARLVPEEL LQTDPSYGLT SDEVLKRRKK 
 
      101    ***    **  *                                150 
Scer  YGLNQMADEK ESLVVKFVMF FVGPIQFVME AAAILAAGLS DWVDFGVICG 
Spar  YGLNQMADEK ESLVVKFVMF FVGPIQFVME AAAILAAGLS DWVDFGVICG 
Sbay  YGLNQMAENN ESLIIKFIMF FVGPIQFVME AAAILAAGLS DWVDFGVICG 
 
      151        *          *                            200 
Scer  LLMLNAGVGF VQEFQAGSIV DELKKTLANT AVVIRDGQLV EIPANEVVPG 
Spar  LLMLNAGVGF VQEFQAGSIV DELKKTLANT AVVIRDGQLV EIPANEVVPG 
Sbay  LLMLNAGVGF IQEFQAGSIV EELKKTLANT AVVIRDGQLV EIPANEVVPG 
 
      201                                              * 250 
Scer  DILQLEDGTV IPTDGRIVTE DCFLQIDQSA ITGESLAVDK HYGDQTFSSS 
Spar  DILQLEDGTI IPTDGRIVTE DCFLQIDQSA ITGESLAVDK HYGDQTFSSS 
Sbay  DILQLEDGTI IPTDGRIVTE ECFLQIDQSA ITGESLAVDK HYGDQAFSSS 
 
      251                              *                 300 
Scer  TVKRGEGFMV VTATGDNTFV GRAAALVNKA AGGQGHFTEV LNGIGIILLV 
Spar  TVKRGEGFMV VTATGDNTFV GRAAALVNKA AGGQGHFTEV LNGIGIILLV 
Sbay  TVKRGEGFMV VTATGDNTFV GRAAALVNKA SGGQGHFTEV LNGIGIILLV 
 
      301*   *                                           350 
Scer  LVIATLLLVW TACFYRTNGI VRILRYTLGI TIIGVPVGLP AVVTTTMAVG 
Spar  LVVATLLLVW TACFYRTNGI VRILRYTLGI TIIGVPVGLP AVVTTTMAVG 
Sbay  LVIITLLVVW TACFYRTNGI VRILRYTLGI TIIGVPVGLP AVVTTTMAVG 
 
      351                                                400 
Scer  AAYLAKKQAI VQKLSAIESL AGVEILCSDK TGTLTKNKLS LHEPYTVEGV 
Spar  AAYLAKKQAI VQKLSAIESL AGVEILCSDK TGTLTKNKLS LHEPYTVEGV 
Sbay  AAYLAKKQAI VQKLSAIESL AGVEILCSDK TGTLTKNKLS LHEPYTVEGV 
 
      401                               *                450 
Scer  SPDDLMLTAC LAASRKKKGL DAIDKAFLKS LKQYPKAKDA LTKYKVLEFH 
Spar  SPDDLMLTAC LAASRKKKGL DAIDKAFLKS LKQYPKAKDA LTKYKVLEFH 
Sbay  SADDLMLTAC LAASRKKKGL DAIDKAFLKS LIQYPKAKDA LTKYKVLEFH 
 
      451                                                500 
Scer  PFDPVSKKVT AVVESPEGER IVCVKGAPLF VLKTVEEDHP IPEDVHENYE 
Spar  PFDPVSKKVT AVVESPEGER IVCVKGAPLF VLKTVEEDHP IPEDVHENYE 
Sbay  PFDPVSKKVT AVVESPEGER IVCVKGAPLF VLKTVEEDHP IPEDVHENYE 
 
      501                                                550 
Scer  NKVAELASRG FRALGVARKR GEGHWEILGV MPCMDPPRDD TAQTVSEARH 
Spar  NKVAELASRG FRALGVARKR GEGHWEILGV MPCMDPPRDD TAQTVSEARH 
Sbay  NKVAELASRG FRALGVARKR GEGHWEILGV MPCMDPPRDD TAQTVSEARH 
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      551                                                600 
Scer  LGLRVKMLTG DAVGIAKETC RQLGLGTNIY NAERLGLGGG GDMPGSELAD 
Spar  LGLRVKMLTG DAVGIAKETC RQLGLGTNIY NAERLGLGGG GDMPGSELAD 
Sbay  LGLRVKMLTG DAVGIAKETC RQLGLGTNIY NAERLGLGGG GDMPGSELAD 
 
      601                                                650 
Scer  FVENADGFAE VFPQHKYRVV EILQNRGYLV AMTGDGVNDA PSLKKADTGI 
Spar  FVENADGFAE VFPQHKYRVV EILQNRGYLV AMTGDGVNDA PSLKKADTGI 
Sbay  FVENADGFAE VFPQHKYRVV EILQNRGFLV AMTGDGVNDA PSLKKADTGI 
 
      651                                                700 
Scer  AVEGATDAAR SAADIVFLAP GLSAIIDALK TSRQIFHRMY SYVVYRIALS 
Spar  AVEGATDAAR SAADIVFLAP GLSAIIDALK TSRQIFHRMY SYVVYRIALS 
Sbay  AVEGATDAAR SAADIVFLAP GLSAIIDALK TSRQIFHRMY SYVVYRIALS 
 
      701                *                               750 
Scer  LHLEIFLGLW IAILDNSLDI DLIVFIAIFA DVATLAIAYD NAPYSPKPVK 
Spar  LHLEIFLGLW IAILDNSLNI DLIVFIAIFA DVATLAIAYD NAPYSPKPVK 
Sbay  LHLEIFLGLW IAILDNSLDI DLIVFIAIFA DVATLAIAYD NAPYSPKPVK 
 
      751             *  *                               800 
Scer  WNLPRLWGMS IILGIVLAIG SWITLTTMFL PKGGIIQNFG AMNGIMFLQI 
Spar  WNLPRLWGMS IILGIILAVG SWITLTTMFL PKGGIIQNFG ALNGIMFLQI 
Sbay  WNLPRLWGMS IILGIVLAVG SWITLTTMFL PKGGIIQNFG AMNGIMFLQI 
 
      801                   *                            850 
Scer  SLTENWLIFI TRAAGPFWSS IPSWQLAGAV FAVDIIATMF TLFGWWSENW 
Spar  SLTENWLIFI TRAAGPFWSS IPSWQLAGAV FAVDIIATMF TLFGWWSENW 
Sbay  SLTENWLIFI TRAAGPFWSS VPSWQLAGAV FAVDIIATMF TLFGWWSENW 
 
      851                                   *      *     900 
Scer  TDIVTVVRVW IWSIGIFCVL GGFYYEMSTS EAFDRLMNGK PMKEKKSTRS 
Spar  TDIVTVVRVW IWSIGIFCVL GGFYYEMSTS EAFDRVMNGK PMKEKKSTRS 
Sbay  TDIVTVVRVW IWSIGIFCVL GGFYYEMSTS EAFDRMMNGK PAKEKKSTRS 
 
      901              919 
Scer  VEDFMAAMQR VSTQHEKET 
Spar  VEDFMAAMQR VSTQHEKET 
Sbay  VEDFLAAMQR VSTQHEKEA 
 
 
Figure S2.10: Pma1 alignment 
Alignment of Pma1 from Saccharomyces cerevisiae, S. paradoxus, and S. bayanus.  
Identical amino acids are marked in blue and different amino acids in red.  Red dots mark 
gaps. 
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Scer  MFVSPPPATA RNQVLGKRKS KRHDENPKNV QPNADTEMTN SVPSIGFNSN 
Sbay  MFVSPPPATA RNQVLGKRKS KRRGSNSKNV QPISNSPDVD KSVSFVPNNH 
Spar  .......... .......... .......... .......... .......... 
 
      51******** ********** ********** ********** ******100 
Scer  LPHNNQEINT PNHYNLSSNS GNVRSNNNFV TTPPEYADRA RIEIIKRLLP 
Sbay  PSYSEQEANT PNHYSLNASP GNSRSN..FV STPPEYADRA RIEIRKRLLP 
Spar  .......... .......... .......... .......... .......... 
 
      101******* ********** ********** ********** *******150 
Scer  TAGTKPMEVN SNTAENANIQ HINTPDSQSF VSDHSSSYES SIFSQPSTAL 
Sbay  TGGNKPISVN SVFLDNANIH QVTSPDSQSF VSDQASSYES SIFSHPSTVL 
Spar  .......... .......... .......... .......... .......... 
 
      151******* ********** ********** ***  *            200 
Scer  TDITTGSSLI DTKTPKFVTE VTLEDALPKT FYDMYSPEVL MSDPANILYN 
Sbay  TRVTTDSSLI DLKTPKFVTE ITLEDALPKT FYDMYTPEVL MSDPANILYN 
Spar  .......... .......... .......... ...MYSPEVL MSDPANILYN 
 
      201                        *        *  *           250 
Scer  GRPKFTKREL LDWDLNDIRS LLIVEQLRPE WGSQLPTVVT SGINLPQFRL 
Sbay  GRPKFTKREL LDWDLNDIRS LLIVERLRPE WGSRLPSVIT SGINLPQFRL 
Spar  GRPKFTKREL LDWDLNDIRS LLIVEQLRPE WGSQLPTVVT SGINLPQFRL 
 
      251  *                  *                          300 
Scer  QLLPLSSSDE FIIATLVNSD LYIEANLDRN FKLTSAKYTV ASARKRHEEM 
Sbay  QLLPLCSSDE FIIATLVNSD LYIEANLDRD FKLTSAKYTV ASARKRHEEI 
Spar  QLLPLRSSDE FIIATLVNSD LYMEANLDRN FKLTSAKYTV ASARKRHEEM 
 
      301* *                                          *  350 
Scer  TGSKEPIMRL SKPEWRNIIE NYLLNVAVEA QCRYDFKQKR SEYKRWKLLN 
Sbay  VGYNETIMRL SKPEWRNIIE NYLLNVAVEA QCRYDFKQKR SEYKKWKQLN 
Spar  TGSNEPIMRL SKPEWRNIIE NYLLNVAVEA QCRYDFKQKR SEYKRWKLLN 
 
      351             ** **   ***          *            *400 
Scer  SNLKRPDMPP PSLIPHGFKI HDCTNSGSLL KKALMKNLQL KNYKNDAKTL 
Sbay  SNLKRPDMPP PSLIPPDFHT HEHISSGSLL KKALMKNLQL KNYKNDTKTL 
Spar  SNLKRPDMPP PSLIPHGFLA HDCANSGSLL KKALIKNLQL KNYKNDAKAL 
 
      401             *     *  *               *   444 
Scer  GAGTQKNVVN KVSLTSEERA AIWFQCQTQV YQRLGLDWKP DGMS 
Sbay  GAGTQKNVVN KVSLTKEERA GIWLQCQTQV YQRLGLDWTP DGMS 
Spar  GAGTQKNVVN KVSLTSEERA AIWFQCQTQV YQRLGLDWKP DKMS 
 
 
Figure S2.11: Std1 alignment 
Alignment of Std1 from Saccharomyces cerevisiae, S. paradoxus, and S. bayanus.  
Identical amino acids are marked in blue and different amino acids in red.  Red dots mark 
gaps.  Note that the N-terminal region of Std1 from S. paradoxus is missing. 
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ORF number 
gene 
name ORF number 
gene 
name 
YAL056W GPB2 YIL148W RPL40A 
YBL079W NUP170 YJL003W COX16 
YCL036W GFD2 YJL179W PFD1 
YCR044C PER1 YJR039W   
YCR050C   YJR055W HIT1 
YCR085W   YJR058C APS2 
YDL006W PTC1 YJR118C ILM1 
YDL160C DHH1 YKL073W LHS1 
YDL194W SNF3 YKR024C DBP7 
YDL232W OST4 YKR055W RHO4 
YDR074W TPS2 YLR402W   
YDR129C SAC6 YML048W GSF2 
YDR521W   YML063W RPS1B 
YER115C SPR6 YML094W GIM5 
YER131W RPS26B YML115C VAN1 
YGL015C   YML129C COX14 
YGL084C GUP1 YMR074C   
YGL127C SOH1 YMR307W GAS1 
YGL197W MDS3 YNL133C FYV6 
YGR036C CAX4 YNL238W KEX2 
YGR071C   YNR052C POP2 
YGR159C NSR1 YOL081W IRA2 
YGR180C RNR4 YOR175C   
YGR229C SMI1 YOR253W NAT5 
YHL019C APM2 YPL090C RPS6A 
YHL033C RPL8A YPL178W CBC2 
YHR075C PPE1 YPL179W PPQ1 
YHR087W   YPR129W SCD6 
YIL040W APQ12 YPR170C   
significant GO categories: signal transduction (p = 
0.013)       
 
Table S2.1: ORFs that exhibit glucosamine-resistance when knocked out 
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ORF 
number 
gene 
name   significant GO terms p-value genes 
YAL013W DEP1  
organelle organization and 
biogenesis 0.002 DEP1 
YBL061C SKT5     MIS1 
YBR084W MIS1     RPP1A 
YBR120C CBP6     RTF1 
YDL081C RPP1A     SUR4 
YDR017C KCS1     RPL13B
YGL244W RTF1     DMA2 
YJL165C HAL5     CSE2 
YKL038W RGT1  protein modification process 0.034 DEP1 
YLR372W SUR4     MIS1 
YMR142C RPL13B     RTF1 
YNL040W       DMA2 
YNL116W DMA2  translation 0.001 MIS1 
YNR010W CSE2     CBP6 
YOL023W IFM1     RPP1A 
YOR333C       RPL13B
YDR277C MTH1     IFM1 
YOR047C STD1  ligase activity 0.039 MIS1 
      DMA2 
   transcription regulator activity 0.005 DEP1 
      RTF1 
      RGT1 
       CSE2 
 
Table S2.2: ORFs that show low [GAR+] levels when knocked out 
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ORF 
number 
gene 
name   significant GO terms p-value genes 
YGL028C SCW11  
carbohydrate metabolic 
processing 0.049 INM1 
YGL041C        KRE6 
YGL138C    cytokinesis 0.02 SCW11 
YGR027C RPS25A      BUD2 
YHR046C INM1  hydrolase activity 0.032 INM1 
YJL198W PHO90      KRE6 
YKL092C BUD2      SCW11 
YLR032W RAD5      RAD5 
YNL168C FMP41     
YOL092W       
YOR108W LEU9     
YOR275C RIM20     
YPR159W KRE6     
YHR046C       
 
Table S2.3: ORFs that show high [GAR+] levels when knocked out 
 
plasmid name backbone contains source 
pPMA1 ura+ pRS316 -1700 to +2950 PMA1 this study 
pPMA1 trp+ pRS314 -1700 to +2950 PMA1 this study 
pPMA1 S. bay. pRS314 
5' UTR of S. cerevisiae PMA1 (to -1700) fused to S. bayanus PMA1 
ORF this study  
pPMA1 S. par. pRS314 
5' UTR of S. cerevisiae PMA1 (to -1700) fused to S. paradoxus 
PMA1 ORF this study 
pPMA1 S899A pRS314 pPMA1 mutated at S899 this study 
pPMA1 S899D pRS314 pPMA1 mutated at S899 this study 
pPMA1 S911A pRS314 pPMA1 mutated at S911 this study 
pPMA1 S911D pRS314 pPMA1 mutated at S911 this study 
pPMA1 T912A pRS314 pPMA1 mutated at T912 this study 
pPMA1 T912D pRS314 pPMA1 mutated at T912 this study 
pPMA1 911A912A pRS314 pPMA1 mutated at S911 and T912 this study 
pPMA1 911D912D pRS314 pPMA1 mutated at S911 and T912 this study 
pRGT2 p413GPD RGT2 ORF under control of a GPD promoter (high expression) this study 
pSNF3 p413GPD SNF3 ORF under control of a GPD promoter this study 
pYCK1 p413GPD YCK1 ORF under control of a GPD promoter this study 
pYCK2 p413GPD YCK2 ORF under control of a GPD promoter this study 
pSTD1 p413GPD STD1 ORF under control of a GPD promoter this study 
pMTH1 p413GPD MTH1 ORF under control of a GPD promoter this study 
pRGT1 p413GPD RGT1 ORF under control of a GPD promoter this study 
pHXT3 p413GPD HXT3 ORF under control of a GPD promoter this study 
pPMA1-OX p414GPD PMA1 ORF under control of a GPD promoter this study 
pPMA1∆40N-OX p414GPD PMA1∆40N ORF under control of a GPD promoter this study 
pPMA1∆104N-OX p414GPD PMA1∆104N ORF under control of a GPD promoter this study 
pPMA1∆40C-OX p414GPD PMA1∆40C ORF under control of a GPD promoter this study 
pPMA1Q23stop p414GPD pPMA1-OX with nonsense mutation at Q23 this study 
pPMA1E59stop p414GPD pPMA1-OX with nonsense mutation at E59 this study 
 
    Table S24: Plasmids used in Chapter 2. 
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strain name purpose source 
W303 [gar-]   R. Rothstein 
W303 [GAR+]   this study 
W303 ∆pma1 pPMA1 
genomic copy of pma1 replaced with KanMX, covered by 
plasmid pPMA1 ura+ this study 
W303 ∆rgt2 [GAR+] propagation studies this study 
W303 ∆snf3 [GAR+] propagation studies this study 
W303 ∆yck1 [GAR+] propagation studies this study 
W303 ∆yck2 [GAR+] propagation studies this study 
W303 ∆std1     [GAR+] propagation studies this study
W303 ∆mth1 [GAR+] propagation studies this study 
W303 ∆rgt1 [GAR+] propagation studies this study 
W303 ∆hxt3 [GAR+] propagation studies this study 
W303 ∆sur4 Pma1 oligomerization studies this study 
W303 ∆lst1 Pma1 oligomerization studies this study 
W303 ∆lcb3 Pma1 oligomerization studies this study 
W303 ∆lcb4 Pma1 oligomerization studies this study 
W303 ∆dpl1 Pma1 oligomerization studies this study 
W303 ∆atg19 Pma1 oligomerization studies this study 
W303 ∆erg5 Pma1 oligomerization studies this study 
W303 GAL-∆40N [GAR+] propagation studies Liu et al., 2006 
W303 GAL-∆40N ∆std1 [GAR+] propagation studies this study 
S288c HXT3-GFP monitoring Hxt3 protein levels in [gar-] and [GAR+] Huh et al., 2003 
S288c/W303 HXT3-GFP 
∆pma1 pPMA1 monitoring Hxt3 protein levels in [gar-] and [GAR+] this study 
 
 
Table S2.5: Yeast strains used in Chapter 2. 
 
 
 
 
 
 
Figure S2.12: Overexpression of STD1 rescues ∆sur4’s inability to form [GAR+] 
a) Constitutive overexpression of STD1 rescues the inability of ∆sur4 to become [GAR+].  
Note that the y-axis is a logarithmic scale. b) Native gel of digitonin-soluble protein 
extracts from wildtype (wt) or ∆sur4 backgrounds carrying an empty vector or a vector 
overexpressing STD1 and probed with α-Pma1.  Note that HMW oligomers of Pma1 are 
not rescued when STD1 is overexpressed.  c) Total protein stained with Ponceau S 
(bottom) and Western of fractions using an α-Pma1 antibody.  Note that the amount of 
Pma1 in the fractions in the ∆sur4 STD1 sample only increased slightly, despite the 
increase in [GAR+] frequency.  Low levels of Pma1 protein therefore do not affect 
[GAR+] formation. 
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Chapter Three: 
 
Natural Variation, the Environment and the [GAR+] Prion 
 
Introduction 
 Microbes live in dynamic environments with widespread competition and limited 
resources.  Among other things, they are subject to changing temperatures, toxins, 
nutrient starvation, and osmotic changes.  The number and variety of competing 
organisms is increased in “easy” niches, so decreased environmental stress begets 
increased competition.  The ability to survive diverse stress and to outgrow competitors is 
therefore crucial to fitness. 
 In order for organisms to survive in fluctuating environments, they must be 
responsive to changes in them.  This is particularly important for plants and fungi, which 
are immobile or relatively immobile and therefore have no choice but to adapt to 
circumstances (Winkelmann, 2007). Two major mechanisms for adaptation are 
phenotypic variation and pleiotropy.  Prions are an unusual source of pleiotropy and 
phenotypic variation that may contribute to environmental adaptation (Eaglestone et al., 
1999; True and Lindquist, 2000; Masel and Bergman, 2003). 
 Fungal prions are protein-based elements of genetic inheritance.  They involve 
proteins with an unusual ability to acquire an altered conformation that is associated with 
an altered function.  Most particularly, these changes in conformation and function are 
propagated to newly synthesized proteins of the same type in an extremely stable manner. 
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Mother cells pass the prion proteins to their daughters perpetuating the change in 
function, and its associated phenotypes, from generation to generation.  Proteins can enter 
the prion state spontaneously at a low rate.  And occasionally the prion state is not passed 
on to daughter cells (Uptain and Lindquist, 2002; Chien et al., 2004; Wickner et al., 2004; 
Shorter and Lindquist, 2005; Tuite and Cox, 2006).  These means that colonies arising 
from cells without the prion, will generally contain some cells that have it, and colonies 
arising from cells with the prion will generally contain some cells that have lost it.  This 
creates a diversity of phenotypes within a colony even though the genome of each cell is 
identical.  By increasing the number of phenotypes associated with that genome, we have 
suggested that prions might increase the chance that that a particular genome will survive 
in a changing environment (Eaglestone et al., 1999; True and Lindquist, 2000; Masel and 
Bergman, 2003; True et al., 2004).  
The work of several groups has shown that the prion known as [PSI+] confers a 
growth advantage compared to [psi-] under a variety of different environmental 
conditions (Eaglestone et al., 1999; True and Lindquist, 2000).  Of about 100 conditions 
tested, 50 showed no difference, [psi-] had a growth advantage in 25%, and [PSI+] had a 
growth advantage in 25% (True and Lindquist, 2000).  The spontaneous appearance of 
PSI therefore provides a temporary survival advantage under some conditions.  The 
[PSI+]-dependent survival advantage can become fixed by genetic change, so that [PSI+] 
can subsequently be lost but the [PSI+]-dependent phenotype maintained (True et al., 
2004). 
[PSI+] is both induced and lost at an increased rate under stressful conditions, 
such as when cells are exposed to changes in osmotic conditions and diverse chemicals 
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((Eaglestone et al., 1999; Tyedmers et al., unpublished).  This is almost certainly due to 
the increase in protein misfolding and the induction of chaperone protein, under these 
conditions (Eaglestone et al., 1999). Thus, the prion-forming ability of Sup35, the causal 
agent of [PSI+], allows it to act as a “contingency locus”.  Under stressful conditions, 
when cells are inherently not well adapted to their environment, the rate at which cells 
switch between prions states increases from one in 106 to one in 104 or 105 cells. This 
increases the likelihood that that might sample and advantageous phenotype, but most 
cells in the culture retain their initial prion state (Tyedmers et al., unpublished).  If [PSI+] 
is advantageous in that environment, then the proportion of [PSI+] in the population can 
increase allowing survival of that genotype.  If it is disadvantageous, only a small number 
of cells will perish. 
 The idea that a prion could be advantageous is, however, fairly controversial.  
Neither [PSI+] nor [URE3] have been found in environmental sampling experiments (n = 
70), although the selfish 2µ plasmid was found in 54% of yeast tested.  The argument 
was that [PSI+] and [URE3] are therefore more detrimental than the mildly detrimental 
2µ plasmid (Nakayashiki et al., 2005).  However, [PSI+] is envisioned as being only 
temporarily advantageous and only in some conditions (True and Lindquist, 2000; True 
et al., 2004).  Thus one could not expect to find [PSI+] or [URE3] in environmental 
isolates.  [PSI+]-dependent phenotypes can also be fixed quite easily (True et al., 2004). 
In this case the loss of [PSI+] would not be disadvantageous, even if the original [PSI+]-
dependent trait is advantageous.  Furthermore, [RNQ+] was found in 16% of these 
isolates (Nakayashiki et al., 2005).  As the only known phenotype of [RNQ+] is to allow 
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the induction of [PSI+], this suggests that a subpopulation of the yeast isolates tested 
maintain the ability to induce [PSI+] even if they do not currently carry [PSI+]. 
Arguing in favor of a beneficial role for this prion, the ability of Sup35 to form 
[PSI+] has been conserved over a billion years of fungal evolution (Nakayashiki et al., 
2001; Tanaka et al., 2005; Harrison et al., 2007).  The precise sequence of the prion-
determining region (PrD) is not conserved but the highly unusual amino acid composition 
of the prion-determining region, which allows it to switch into the prion state has been 
conserved across the basidiomyces (Harrison et al., 2007). Sup35 alleles from K. lactis, 
C. albicans, and other fungi are demonstrably capable of forming [PSI+] in S. cerevisiae.  
K. lactis, S. bayanus, and S. paradoxus Sup35 also form [PSI+] in their species of origin 
(Nakayashiki et al., 2001; Tanaka et al., 2005).  Of course, it might be argued that Sup35 
PrD has been conserved to provide some other function.  However, the nature of its 
conservation, which allows it to assume an amyloid, prion conformation, rather than to 
assume a more normal, globular fold, argues against it.  
 Saccharomyces cerevisiae is used in the production of bread, alcoholic beverages, 
and industrial alcohol.  It has been selected over millennia for such purposes, resulting in 
a variety of strains with vastly different properties.  Indeed, these optimizations have 
resulted in such specialized strains that many breweries and wineries regard them as 
industrial secrets (Landry et al., 2006).  S. cerevisiae can also be isolated from the 
environment; samples have been found in soil and on plant bark, leaves, and fruits.  
Occasionally S. cerevisiae infects immunocompromised patients, although S. cerevisiae 
infection is considerably less common than infection by other fungal species such as 
Candida albicans or Aspergillus fumigatus.  Overall, S. cerevisiae is capable of adapting 
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to a wide variety of ecological niches and their accompanying stressors.  These include 
nutrient starvation, low pH, fluctuating environments, high ethanol (fermentation) 
(Querol et al., 2003), heat stress, and hypoxia (animal infection) (Brown et al., 2007).  
Unsurprisingly, S. cerevisiae isolates from these different environments exhibit a wide 
variety of phenotypes and considerable genetic variation (Fay and Benavides, 2005; 
Landry et al., 2006). 
The phenotype resulting from the presence of the [GAR+] prion, resistance to 
glucosamine, involves changes in the fundamental process of carbon metabolism.  We 
wondered if [GAR+] might play a role in the adaptation of S. cerevisiae to distinct 
biological niches.  We asked whether [GAR+] is found in wild yeast isolates, whether 
[GAR+] can be induced in wild yeasts, and what environmental and genetic factors affect 
the appearance of [GAR+].  We found great variation in [GAR+] frequency between 
isolates with particular enrichment for higher [GAR+] frequency in fruit isolates.  We also 
identified two potential genetic mechanisms that might explain variation in [GAR+] 
frequency: natural variation in PMA1 sequence and genome-wide genetic differences.  
We sequenced PMA1 and upstream regions from 45 different S. cerevisiae isolates.  We 
also performed quantitative trait locus (QTL) analysis on the 103 genotyped progeny 
from a cross between a vineyard isolate and a lab strain, using [GAR+] frequency as a 
quantitative trait (Brem et al., 2002).  From this we hypothesized that we would both 
identify PMA1-independent and PMA1-linked regulators of [GAR+]. 
 Our findings suggest that [GAR+] plays an important role in the S. cerevisiae 
lifestyle.  The frequency of the [GAR+] prion varies with ecological niche.  We tested 
diploid samples of S. cerevisiae used to brew beer (“brewery”) or isolated from fruit, soil, 
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or human patients (“clinical”).  The phenotype of glucosamine-resistance is common in 
one niche, soil, but we have yet to determine whether this is the result of [GAR+].  
Polymorphisms within the PMA1 sequence did not correlate with the [GAR+] frequency 
but we did note a surprisingly high degree of heterozygosity at the PMA1 locus (~45% of 
samples) in diploid isolates of S. cerevisiae. 
Using [GAR+] frequency as a quantitative trait, we identified two genomic 
regions that are correlated with high rate of appearance of [GAR+] by QTL analysis.  A 
difference in copy number of two genes that confer 2-deoxyglucose resistance when 
overexpressed (Randez-Gil et al., 1995), DOG1 and DOG2, are the most likely source of 
increased [GAR+] frequency in one of these regions.  Finally, [GAR+] cells have a 
competitive advantage over [gar-] cells in rich medium.  However, [GAR+] is more 
sensitive to glucose starvation than [gar-] in defined medium.  Overall, these data suggest 
that [GAR+] is beneficial in certain ecological niches and environmental conditions and 
[GAR+] serves as a source of phenotypic flexibility. 
 
Results 
[GAR+] frequency varies with ecological niche 
 Saccharomyces cerevisiae can survive a wide variety of ecological niches and has 
been isolated from a number of different environments.  As utilization of carbon sources 
is fundamental to survival, we hypothesized that [GAR+] could be important for survival 
in particular environments.  We therefore tested a number of S. cerevisiae isolates from a 
variety of environments for resistance to glucosamine.  If isolates were glucosamine-
sensitive, we measured the frequency of appearance of [GAR+]. 
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Table 3.1: Yeast strains and their source 
 
strain name category source sample origin 
Abbey Ale beer brewing White Labs 
Belgian Ale beer brewing White Labs 
English Ale beer brewing White Labs 
Forbidden Fruit 
Ale beer brewing Wyeast 
Irish Ale beer brewing White Labs 
Northwest Ale beer brewing Wyeast 
Trappist Ale beer brewing White Labs 
Urquell Pilsner beer brewing Wyeast 
Y-7327 beer Tibetan beer starter 
Agricultural Research Service 
Collection 
        
YJM521 clinical patient John McCusker 
YJM522 clinical patient John McCusker 
YJM273 clinical patient John McCusker 
YJM310 clinical patient John McCusker 
YJM311 clinical patient John McCusker 
YJM436 clinical patient John McCusker 
YJM440 clinical patient John McCusker 
YJM454 clinical patient John McCusker 
YJM210 clinical patient John McCusker 
YJM455 clinical patient John McCusker 
Y-27806 clinical patient 
Agricultural Research Service 
Collection 
Y-27788 clinical patient 
Agricultural Research Service 
Collection 
Y-502 clinical patient 
Agricultural Research Service 
Collection 
Y-492 clinical patient 
Agricultural Research Service 
Collection 
Y-10988 clinical patient 
Agricultural Research Service 
Collection 
YJM128 clinical patient John McCusker 
YJM309 clinical patient John McCusker 
        
YB-4081 fruit guava 
Agricultural Research Service 
Collection 
Y-5511 fruit coconut 
Agricultural Research Service 
Collection 
YB-399 fruit cherries 
Agricultural Research Service 
Collection 
 145
        
strain name category source sample origin 
Y-382 fruit grain 
Agricultural Research Service 
Collection 
Y-1537 fruit grapes 
Agricultural Research Service 
Collection 
Y-7568 fruit papaya 
Agricultural Research Service 
Collection 
YB-210 fruit banana 
Agricultural Research Service 
Collection 
YB-3121 fruit mimosa 
Agricultural Research Service 
Collection 
YB-4082 fruit papaya 
Agricultural Research Service 
Collection 
YB-432 fruit pineapple 
Agricultural Research Service 
Collection 
Y-35 fruit Ilex aquifolium 
Agricultural Research Service 
Collection 
Y-139 fruit grape 
Agricultural Research Service 
Collection 
Y-12657 fruit olive 
Agricultural Research Service 
Collection 
        
OP1 soil Occoneechee Park, VA Dietzmann, Dietrich 
OP2 soil Occoneechee Park, VA Dietzmann, Dietrich 
OP3 soil Occoneechee Park, VA Dietzmann, Dietrich 
OP4 soil Occoneechee Park, VA Dietzmann, Dietrich 
OP6 soil Occoneechee Park, VA Dietzmann, Dietrich 
OP7 soil Occoneechee Park, VA Dietzmann, Dietrich 
OP8 soil Occoneechee Park, VA Dietzmann, Dietrich 
OP9 soil Occoneechee Park, VA Dietzmann, Dietrich 
SM1 soil Stone Mountain, GA Dietzmann, Dietrich 
SM2 soil Stone Mountain, GA Dietzmann, Dietrich 
SM12 soil Stone Mountain, GA Dietzmann, Dietrich 
SM17 soil Stone Mountain, GA Dietzmann, Dietrich 
SM66 soil Stone Mountain, GA Dietzmann, Dietrich 
SM69 soil Stone Mountain, GA Dietzmann, Dietrich 
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Figure 3.1: [GAR+] frequency varies with ecological niche. 
 [GAR+] frequency was measured for each yeast strain listed in table 3.1.  Three 
independent cultures were grown at the temperature specified and each culture was plated 
in duplicate.  Small points represent an individual strain within a category (dark blue: 
clinical, 30°C; light blue: clinical, 37°C; green: fruit, 30°C; purple: beer, 30°C; gray: 
beer, 20°C).  Larger shapes represent the average for the category (peach: clinical, 30°C; 
orange: clinical, 37°C; pink: fruit, 30°C; yellow: beer, 30°C; purple: beer, 20°C).  Error 
bars represent the standard deviation of the [GAR+] frequency for the category as a 
whole.  The average [GAR+] frequency for the set of strains isolate from fruits is 
approximately 20 fold higher than the average for the clinical strains at either 30°C or 
37°C.  The large data point in each series that is the same color as the rest of the series is 
the median point. 
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 site variation S288c sequence amino acid heterozygosity 
-1557 G insertion   N/A yes 
-1038 A, G G N/A yes 
-704 C, T T N/A yes 
-611 C, T T N/A yes 
-314 A, G A N/A yes 
-287 C, G, T G N/A yes 
-272 C, T T N/A no 
-257 C, T C N/A yes 
-116 T insertion T N/A yes 
-111 C, T C N/A no 
-13 A, G A N/A yes 
156 C, T T synonymous no 
221 C, T C P-->L yes 
246 C, T T synonymous yes 
348 C, T C synonymous no 
349 C, G G V-->L yes 
426 C, T C synonymous no 
454 A, C A M-->L yes 
625 A, G G V-->I yes 
891 A, G A synonymous yes 
904 A, G A I-->V yes 
1380 C, G, T C synonymous yes 
1563 A, G A synonymous yes 
2055 C, T T synonymous no 
2152 A, G G D-->N yes 
2241 A, C C synonymous yes 
2283 C, T T synonymous yes 
2286 A, G G synonymous yes 
2289 C, T C synonymous yes 
2292 A, T A synonymous yes 
2293 A, G G V-->I yes 
2298 A, G A synonymous yes 
2301 C, T T synonymous yes 
2302 A, G A I-->V yes 
2304 A, C A  yes 
2310 A, T T synonymous yes 
2460 C, T C synonymous yes 
2466 A, C C synonymous yes 
2475 A, G G synonymous yes 
2506 G, T G A-->S yes 
 
Table II: Polymorphisms in PMA1 from -1700 to +2950 
Common polymorphisms found within the PMA1 sequence.  Polymorphism had to be 
found in at least five of 45 total samples to be included in this table.  “Heterozygosity” 
indicates that any single strain was heterozygous at the site in question. 
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We measured [GAR+] frequency from 45 different yeast isolates (table 3.1).  We found 
that the rate of appearance of [GAR+] varied with ecological niche of the host (figure 
3.1).  S. cerevisiae lab strains, brewery strains, and clinical isolates all showed 
approximately the same average [GAR+] frequencies, around 3 in 103 cells.  Samples 
from each niche exhibited high variance in [GAR+] frequency and therefore different 
medians.  The median [GAR+] frequencies of clinical isolates was around 1 in 104 cells, 
whereas the median [GAR+] frequency of beer isolates was around 4 in 105.  Temperature 
did not affect [GAR+] frequency in clinical isolates but it decreased with increasing 
temperatures in brewery isolates.  Yeast samples from fruits showed a much higher 
appearance of [GAR+], on average 20 fold higher than the average [GAR+] frequency and 
five fold higher than the median [GAR+] frequency in clinical isolates.  Fruit yeasts also 
show a greater variance in [GAR+] frequency than clinical and brewery isolates. 
 One possible origin of this variation in [GAR+] frequency is changes in the 
sequence of PMA1 or its surrounding region.  We therefore sequenced the PMA1 locus, 
1700bp 5’ of the gene, and 250bp 3’ of the gene to determine whether any 
polymorphisms correlate with [GAR+] frequency.  Initial data from direct sequencing 
suggested that some samples were heterozygous, so we switched to subcloning our region 
of interest and sequencing four separate samples from each yeast strain.  We did not find 
any single change that is necessary for high [GAR+] frequency (polymorphisms are listed 
in table 3.2) or any clear haplotypes. 
 Sequencing PMA1 from a variety of S. cerevisiae isolates showed that PMA1 
exhibits a surprising degree of heterozygosity.  Because S. cerevisiae is homothallic, it is  
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Figure 3.2: Does [GAR+] exist in wild yeast? 
a) Spot tests of [gar-], [GAR+], and four soil isolates; the remaining ten showed the same 
growth patterns.  Each serial dilution factor is five-fold.  Cultures were diluted and 
spotted to 2% glucose, 2% glycerol, and glycerol-glucosamine medium (GGM). 
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known that diploid S. cerevisiae samples are mostly homozygous, since haploids could 
switch mating types then mate with the neighboring, genetically identical cell.  
Population analysis of the closely related S. paradoxus, which is also homothallic, 
predicts a 99% inbreeding rate in the wild (Johnson et al., 2004).  However, PMA1 was 
heterozygous in 20 of our 45 samples, usually at multiple sites in each heterozygous 
strain.  Some of these changes are nonsynonymous, including an alanine to serine change 
at amino acid 835 that is found in nine samples and is heterozygous in three more. 
 
Soil isolates are resistant to glucosamine and an environmental isolate induces [GAR+] 
 We tested 14 S. cerevisiae samples isolated from the soil at two different locations 
in the Southeastern United States.  All of these showed glucosamine-resistance (figure 
3.2).  Whether this is the result of [GAR+] or caused by a genetic mutation we cannot yet 
say because isolates are homothallic and therefore not genetically tractable.  Experiments 
are underway to analyze the segregation patterns of this phenotype. 
 
Various Staphylococcus species induce [GAR+] 
 We serendipitously discovered that a bacterial species is capable of inducing 
glucosamine-resistance in S. cerevisiae when it appeared as a contaminant on an agar 
plate.  [gar-] cells grown on a plate next to the bacterial cells acquired resistance to 
glucosamine over time (figure 3.3a).  When the initially [gar-] samples are removed from 
this plate and grown on glycerol/glucosamine without the bacteria present, they remain 
glucosamine-resistant.  This induced resistance is semi-dominant in a mating test, 
suggesting that its resistance to glucosamine is caused by [GAR+] and not a genetic  
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 Figure 3.3: Staphylococcus species induce the conversion of [gar-] to [GAR+] 
a) Induction of glucosamine resistance by Staphylococcus hominis.  Cultures were grown 
in YPD, diluted in five-fold serial dilutions, then spotted to 2% glucose (YPD), 2% 
glycerol, and GGM.  GGM plates were incubated five days before being photographed.  
Note that the [gar-] sample adjacent to the unknown bacteria grew on GGM proportional 
to the plating cell density.  b) Mating of the induced glucosamine-resistant strains in part 
a to [gar-] to test for dominance.  Induced glucosamine-resistance yeast show semi-
dominant glucosamine-resistance, suggesting that the induced strain is [GAR+] rather 
than a genetic change.  c) [gar-] samples grown adjacent to additional Staphylococcus 
species isolates.  Five of nine Staphylococcus species induced the conversion of [gar-] to 
[GAR+].  S. gallinarium induced [GAR+] at high efficiency (top), S. capitis induced 
[GAR+] with medium efficiency (middle), and S. chromogenes did not induce [GAR+] 
(bottom). 
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alteration (figure 3.3b).  The [GAR+]-inducing bacterium was identified as 
Staphylococcus hominis by 16S rDNA sequencing (figure S3.1). 
Staphylococcus is a ubiquitous genus of gram positive bacteria capable of 
growing in a wide variety of ecological niches, particularly on animals.  Staphylococcus 
is even occasionally in the soil (Madigan and Martinko, 2006).  We also tested eight 
other Staphylococcus species (out of a total of 31 species) and found that six of these 
induced [GAR+] when cultured with S. cerevisiae, albeit with varying efficiency (figure 
3.3c). 
 
Genetic factors influence [GAR+] frequency 
 The rate of appearance of [GAR+] varied widely between yeast strains and their 
ecological niche.  As the frequency of appearance of [GAR+] is a quantitative trait, we 
sought to identify factors that influence [GAR+] frequency by quantitative trait locus 
(QTL) mapping.  We used a set of genotyped segregants from a cross between a vineyard 
isolate, RM11, and the lab strain BY4617, which is virtually identical to S288c (Brem et 
al., 2002).  The BY4617 parent showed a higher frequency of [GAR+] appearance than 
the RM11 strain.  Parents and segregants were grown in 2% glucose then plated to 
medium containing glycerol and glucosamine.  Growth on glucosamine medium was 
tracked over the course of twelve days and density of growth was taken as a measure of 
[GAR+] frequency (figure 3.4a). 
As a control to ensure we were working with [GAR+] and not Mendelian genetic 
mutations, glucosamine-resistant samples were mated to a [gar-] strain and diploids 
selected.  [GAR+] is semi-dominant in a mating (see chapter two) but Mendelian 
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mutations would most likely be recessive.  All glucosamine-resistant segregants for 
which we could select diploids showed semi-dominant glucosamine-resistance following 
mating (figure 3.4b).  This demonstrates that the glucosamine-resistance we measured is 
likely the result of [GAR+] and not a Mendelian mutation. 
We identified two regions correlated with high appearance of [GAR+] (figure 
3.4c).  One of these regions associated with a high rate of appearance of [GAR+] is on 
chromosome XIV, bp 412,000 to 450,000 (figure 3.4c, top).  The causal polymorphisms 
are less blatant; there are a number of polymorphisms in a leucine tRNA upstream of 
PHO23 and a number within the 350 bp region 5’ of PHO23.  For these reasons and 
because this region is only slightly above the significance cutoff for LOD scores (figure 
3.4c), we focused on the second significant region. 
The second region is located to bp 180,000 to 220,000 on chromosome VIII (top).  
The region that confers higher [GAR+] frequency corresponded with that from the 
BY4617 parent (bottom).  This region contains genes DOG1 and DOG2, which were 
originally identified from a screen for mutations that confer resistance to the non-
hydrolyzable glucose analog 2-deoxyglucose (Sanz et al., 1994).  The RM11 parents 
lacks DOG2 whereas the BY4617 carries both DOG1 and DOG2 (figure S3.2).  Since 
DOG1 and DOG2 confer 2-deoxyglucose resistance when overexpressed  (Randez-Gil et 
al., 1995), the copy number difference could well account for the difference in frequency 
of [GAR+]. 
Additionally, we screened ~5000 S. cerevisiae ORFs to identify candidates that 
induce [GAR+] following transient overexpression.  Three genes were found to induce  
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Figure 3.4: QTL analysis of [GAR+] frequency 
a) Growth of segregants on GGM after five days.  Samples that grew on GGM were 
mated to a [gar-] strain with appropriate auxotrophies to select for diploids.  Segregants 
marked with a red ‘X’ are completely prototrophic and so were not mated to [gar-]; those 
with a green asterisks contained auxotrophies that allowed for selection of diploids.  
Parental strains were also not mated.  b) Segregants from part a were pinned to GGM 
following mating and selection of diploids.  However, prototrophic segregants were not 
included.  Diploids grew on GGM, demonstrating that the glucosamine-resistant 
phenotype displayed is semi-dominant and therefore is likely caused by [GAR+] rather 
than a genetic mutation.  c) Chromosome map (x-axis, top) with associated LOD scores 
(y-axis, top) from QTL analysis.  A significant peak is visible on chromosome VIII and 
chromosome XIV (top).  The bottom area of the graph shows the extent of association 
with either parent (BY is negative, RM11 is positive) and the trait of interest.  Note that 
the QTL on chromosome VIII is enriched for BY and the QTL on chromosome XIV is 
enriched for RM11. 
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glucosamine-resistance: STD1, DOG2, and SPO23 (figure S3.3).  STD1 was the first 
factor identified to induce [GAR+] (see chapter two).  DOG2 was also identified by QTL 
analysis, suggesting that its affects on [GAR+] are real and important in the natural 
biology of the organism. 
 
[GAR+] cells have a competitive advantage in rich medium but not in minimal medium 
 To determine whether [GAR+] might have a growth advantage over [gar-], we 
measured growth rate (change in OD600) in varying carbon sources (figure 3.5a).  The 
growth rates of [gar-] and [GAR+] were almost identical in 2% glucose and 2% galactose.  
In the mixture of glucose and galactose, [GAR+] reached a high maximum growth rate 
and did not show as much of a decrease in growth rate as [gar-] did when transitioning 
between carbon sources during the diauxic shift.  This suggests that [GAR+] might 
exhibit a competitive advantage under particular environmental conditions.  To test this, 
we co-cultured [gar-] and [GAR+] in both rich and defined media containing 2% glucose; 
a mixture of 0.1% glucose and 1.9% galactose, 2% galactose, and 0.2% glucose.  Co-
culture conditions allow for direct competition, as both [gar-] cells and [GAR+] cells have 
access to the same nutrients.  Throughout the experiments, cells are plated to rich 
medium to determine density (colony-forming units, or cfu) then replica plated to 
glycerol-glucosamine medium to score the number of [GAR+] cfu. 
[GAR+] cells outcompeted [gar-] cells in all conditions involving a rich media 
base (1% yeast extract, 2% peptone).  [GAR+] cells compromise between 60% culture (in 
glucose medium) and 90% (in a mixture of glucose and galactose) of all cfu in the culture  
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Figure 3.5: Do [GAR+] cells have a competitive advantage over [gar-] cells in some 
conditions? 
a) [GAR+] grows faster than [gar-] in a glucose/galactose mixture.  Growth rate, as 
represented by change in OD600, is shown on the y-axis.  [GAR+] and [gar-] cells show 
virtually identical growth rates in 2% glucose and 2% galactose but [GAR+] does not 
decrease growth rate at six hours as [gar-] does.  Data shown are the mean of four 
difference samples  b,c) Pictures (b) and quantification (c) of [GAR+] frequency and 
strain (“large”) following growth in different carbon sources.  “Large” colonies are 
indicative of strong [GAR+] strains.  Large colonies are defined as those having a 
diameter of 1mm or more.  Graph represents the mean +/- the standard deviation.  d) 
Competition between [gar-] and [GAR+] cells in rich (top) or minimal (bottom) media.  
The Y-axis represents the ratio of [GAR+] cfu to [gar-] cfu and the x-axis represents the 
number of generations.  Three separate samples were competed, each was plated in 
duplicate, and all six plates were average for each data point. 
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at the end of the experiment but started at ~35% of cfu (figure 3.5b, top).  [GAR+] did 
less well in 2% glucose than the other conditions; 2% glucose was the only condition in 
which [GAR+] never increased to more than 71% of the total population of yeast in the 
culture from a starting point of approximately 35%. 
 [GAR+] was at best neutral compared to [gar-] in defined medium (yeast nitrogen 
base + amino acids) (figure 3.5b, bottom).  Cultures grown in 2% glucose maintained the 
starting point of approximately 40% [GAR+] cfu for 100 generations.  [GAR+] showed a 
slight advantage in 2% galactose.  It attained about 50% of the S. cerevisiae population 
by 50 generations and maintained that until 100 generations.  However, [GAR+] fared 
poorly in the glucose/galactose mixture; it was less than 5% of total yeast by 100 
generations.  [GAR+] also did not survive limiting glucose conditions well, and 
constituted only 10% of that yeast population after 100 generations.  Data points from 
competition experiments represent the average of three independent cultures.  
Experiments were repeated three times. 
 
The rate of [GAR+] appearance varies with environmental conditions 
 Pma1 conformation and ATPase activity are regulated by environmental 
conditions, particularly carbon source (Morsomme et al., 2000).  Therefore, because 
Pma1 is a causal agent of [GAR+], we hypothesize that the GAR prion would also be 
sensitive to environmental conditions.  To test this, we grew [gar-] yeast in rich media 
with a variety of different carbon sources.  The [GAR+] frequency (figure 3.45) and strain 
(“strong” vs. “weak”) (figure 3.5d) varied with carbon source.  This suggests that GAR, 
like Pma1, responds to the host environment. 
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[GAR+] alters the cell wall architecture and affects susceptibility to anti-fungal drugs 
 The S. cerevisiae cell wall is largely composed of glucose polymers and changes 
in environmental conditions alter the total amount of various components of the wall 
(Klis et al., 2006).  Because [GAR+] alters glucose utilization and is environmentally 
responsive, we hypothezied that [GAR+] might affect the cell wall.  First we stained by β-
glucans using aniline blue, which binds to glucan but not chitin or mannoprotein.  (Paul 
and Johnson, 1977).  As β-glucan is completely masked in a normal cell wall (Klis et al., 
2006) and, as expected, [gar-] cells did not shown aniline glue staining.  Surprisingly, we 
found that [GAR+] cells showed some aniline blue staining, implying exposure of β-
glucan.  [gar-] cells did not show aniline blue staining (figure 3.6a). 
We further investigated differences in the cell walls of [GAR+] cells compared to 
[gar-] cells by measuring responses to cell wall-inhibiting drugs.  The antifungal drug 
caspofungin targets yeasts by inhibit β-glucan synthase (Denning, 2003), and [GAR+] 
was more sensitive to caspofungin than [gar-].  [GAR+] is also more sensitive to 
fluconozole  (figure 3.6b), which permealizes the fungal plasma membrane by inhibiting 
ergosterol synthesis (Odds et al., 2003). 
 
Discussion 
[GAR+] might play a role in yeast ecology 
 We observed a 20-fold higher average rate of appearance of [GAR+] and a 
five-fold higher median rate of appearance in fruit isolates than in clinical or brewery 
isolates, regardless of temperature.  This suggests that [GAR+] might be advantageous in 
conditions resembling those of fruit isolates, such as low pH.  As Pma1, a component of  
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 Figure 3.6: The cell wall architecture differs between [gar-] and [GAR+] cells 
a) Aniline blue staining of β-glucans (left).  [GAR+] cells (bottom) exhibit more staining 
than [gar-] cells (top), suggesting that the β-glucan is more exposed in [GAR+] cells.  b) 
[GAR+] cells are more sensitive to antifugal drugs than [gar-] cells.  Cells were grown to 
midlog in YPD, serially diluted 5-fold, then spotted to the drug plates shown.  [GAR+] 
cells are more sensitive to caspofungin than [gar-] cells.  As caspofungin targets β-glucan 
synthase, this supports the data from part a.  [GAR+] cells are also more sensitive to 
fluconazole, implying that [GAR+] cells are extra-sensitive to membrane stress. 
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[GAR+], is a proton pump and is the major controller of cytoplasmic pH (Morsomme), it 
would not be surprising if [GAR+] were sensitive to pH.  We also demonstrated that the 
[GAR+] prion is sensitive to the host environment, as [GAR+] frequency and strain varies 
with carbon source.  The [GAR+] prion phenotype that is environmentally responsive. 
 
PMA1 exhibits high levels of heterozygosity 
Sequencing of PMA1 from these wild yeast isolates did not yield any single 
polymorphism associated with [GAR+] frequency.  However, a large number of our yeast 
samples were heterozygous for PMA1, which was surprising.  S. cerevisiae is 
predominantly homothallic (capable of switching mating type) and is thought to 
frequently inbreed due to intratetrad matings.  Heterozygosity should thus be rare, as 
inbreeding leads to homozygosity (Kirby, 1984).  The probability of obtaining 
homozygosity at a particular locus increases if that locus is centromeric (Zakharov, 
2005).  This is the case with PMA1, which is only 4cM away from the centromere of 
chromosome VII (Capieaux et al., 1991). 
However, we found that 20 of our 45 samples (44%) were heterozygous at the 
PMA1 locus.  In contrast, one group who sequenced 27 samples at four loci found that 2 
(7%) contained heterozygosity (Aa et al., 2006).  Heterozygous samples were observed in 
isolates from all ecological niches, although only one fruit isolate showed heterozygosity.  
Heterozygosity complicated analysis of the PMA1 sequence, however, as heterozygous 
samples were not included in Wilcoxon calculations of the association between 
polymorphisms and rate of appearance of [GAR+]. 
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[GAR+] is influenced by other organisms 
 We demonstrated that Staphylococcus species are capable of switching [gar-] S. 
cerevisiae cells to [GAR+].  This suggests that [GAR+] could well be found in wild yeast, 
as Staphylococcus species are commonly found in a wide variety of ecological niches, 
including in close association with humans (Madigan and Martinko, 2006).  As S. 
cerevisiae is used in a variety of industrial processes, it is certainly possible that yeast 
would encounter Staphylococcus frequently. 
 
[GAR+] has a competitive advantage over [gar-] under some conditions 
 Initial data suggest that [GAR+] has an advantage in rich medium independent of 
carbon source but that [GAR+] is neutral or disadvantageous in defined medium.  
Similarly, the [PSI+] prion is advantageous in some conditions and disadvantageous in 
others (Eaglestone et al., 1999; True and Lindquist, 2000).  Because [GAR+] appears 
quite frequently in yeast strains isolated from fruit and because we have yet to identify an 
S. cerevisiae strain that cannot become [GAR+], it seems likely that [GAR+] occasionally 
serves some advantage. 
 
 Efficient carbon source utilization and energy production are among the most 
important processes for a cell.  [GAR+] alters carbon source utilization by conferring on 
its host the ability to use alternative carbon sources when glucose is present.  Because 
processing of carbon sources is so important for a cell, we suggest that [GAR+] is an 
excellent example prion for addressing the question of whether fungal prions play any 
role in microbe biology.  The observation that an unknown bacterium seems to induce 
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[GAR+] further supports the idea that [GAR+] is environmentally responsive and might 
even be a plasticity factor. 
Overall, our data suggest that [GAR+] could have a competitive advantage under 
certain environmental conditions and that the GAR phenotype is sensitive to its 
environment.  [GAR+] exhibits a faster growth rate compared to [gar-] under certain 
environmental conditions.  Also, since [GAR+] appears at a frequency of up to 1 in 20 
cells in some yeast strains isolated from fruit, [GAR+] could well confer some sort of 
advantage in this niche.  Further experiments will attempt to address these questions. 
 
Experimental procedures 
[GAR+] frequency assays 
[gar-] cells were grown to midlog in YPD (2% glucose unless otherwise stated).  
Samples were diluted appropriately and plated to YPD and medium containing 2% 
glycerol and 0.05% glucosamine (GGM).  Colony forming units (CFU) were counted 
after 2 days on YPD and after 6 days on GGM.  Colony size was measured by using 
Scion Image. 
 
Yeast strains and genetic manipulations 
 Strain construction and manipulation followed standard yeast techniques.  Growth 
rate was measured in the Bioscreen C (Growth Curves USA) at 30°C with intensive, 
intermittent shaking with the OD600 measured every 15 minutes. 
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Sequencing of PMA1 
 PCR products of -1700 to +2950 were amplified using a high fidelity LA taq 
polymerase (Takara).  Samples were subcloned using TA cloning methods into pCR2.1 
(Invitrogen), transformed into DH5α E. coli, and selected for the presence of the insert 
using X-gal as per the manufacturer’s instructions.  A minimum of four plamids from two 
independent transformations were sequenced by the Northwoods DNA facility.  
Sequencing reactions were analyzed in Sequencher 4.7.  Strains were considered 
heterozygous if one of the two conditions were met: two samples showed one nucleotide 
and two another or a single sample consistently differed from the other three at a rate 
higher than the observed error rate.  In the latter case, more samples were usually 
sequenced unless the outlier sample showed heterozygosity only at sites of previously 
observed heterozygous polymorphisms. 
 
QTL analysis 
 Segregants were grown in YPD in 96 well plates to midlog, then spotted to GGM.  
Growth density of spots was determined using Scion Image.  Data were analyzed using 
WinQTLCartographer and JMP 5.0. 
 
Cell wall staining 
 Cells were stained for chitin by growing in YPD or CSM until midlog, washing 
once in water, then incubating 5 minutes in a solution of 1% aniline blue (Sigma).  
Samples were washed twice in water then imaged on a Zeiss axioplan microscope. 
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Staph. hominis  gatgaacgctggcggcgtgcctaatacatgcaagtcgagcgaacagacgaggagcttgct 
Unknown          gatg::acgctggcggcgtgcctaatacatgcaagtcgagcgaacagacgaggagcttgct 
 
Staph. hominis cctttgacgttagcggcggacgggtgagtaacacgtgggtaacctacctataagactggg  
Unknown         cctttgacgttagcggcggacgggtgagtaacacgtgggtaacctacctataagactggg 
 
Staph. hominis ataacttcgggaaaccggagctaataccggataatatttcgaaccgcatggttcgatagt  
Unknown         ataacttcgggaaaccggagctaataccggataatatttcgaaccgcatggttcgatagt 
 
Staph. hominis gaaagatggctctgctatcacttatagatggacctgcgccgtattagctagttggtaagg  
Unknown         gaaagatggctctgctatcacttatagatggacctgcgccgtattagctagttggtaagg 
 
Staph. hominis taacggcttaccaaggcaacgatacgtagccgacctgagagggtgatcggccacactgga  
Unknown         taacggcttaccaaggcaacgatacgtagccgacctgagagggtgatcggccacactgga 
 
Staph. hominis actgagacacggtccagactcctacgggaggcagcagtagggaatcttccgcaatgggcg  
Unknown         actgagacacggtccagactcctacgggaggcagcagtagggaatcttccgcaatgggcg 
 
Staph. hominis aaagcctgacggagcaacgccgcgtgagtgatgaaggtcttcggatcgtaaaactctgtt  
Unknown         aaagcctgacggagcaacgccgcgtgagtgatgaaggtcttcggatcgtaaaactctgtt 
 
Staph. hominis attagggaagaacaaacgtgtaagtaactgtgcacgtcttgacggtacctaatcagaaag  
Unknown         attagggaagaacaaacgtgtaagtaactgtgcacgtcttgacggtacctaatcagaaag 
 
Staph. hominis ccacggctaactacgtgccagcagccgcggtaatacgtaggtggcaagcgttatccggaa  
Unknown         ccacggctaactacgtgccagcagccgcggtaatacgtaggtggcaagcgttatccggaa 
 
Staph. hominis ttattgggcgtaaagcgcgcgtaggcggttttttaagtctgatgtgaaagcccacggctc  
Unknown         ttattgggcgtaaagcgcgcgtaggcggttttttaagtctgatgtgaaagcccacggctc 
 
Staph. hominis aaccgtggagggtcattggaaactggaaaacttgagtgcagaagaggaaagtggaattcc  
Unknown         aaccgtggagggtcattggaaactggaaaacttgagtgcagaagaggaaagtggaattcc 
 
Staph. hominis atgtgtagcggtgaaatgcgcagagatatggaggaacaccagtggcgaaggcgactttct  
Unknown         atgtgtagcggtgaaatgcgcagagatatggaggaacaccagtggcgaaggcgactttct 
 
Staph. hominis ggtctgtaactgacgctgatgtgcgaaagcgtggggatcaaacaggattagataccctgg  
Unknown         ggtctgtaactgacgctgatgtgcgaaagcgtggggatcaaacaggattagataccctgg 
 
Staph. hominis tagtccacgccgtaaacgatgagtgctaagtgttagggggtttccgccccttagtgctgc  
Unknown         tagtccacgccgtaaacgatgagtgctaagtgttagggggtttccgccccttagtgctgc 
 
Staph. hominis agctaacgcattaagcactccgcctggggagtacgaccgcaaggttgaaactcaaaggaa  
Unknown         agctaacgcattaagcactccgcctggggagtacgaccgcaaggttgaaactcaaaggaa 
 
 
 170
Staph. hominis ttgacggggacccgcacaagcggtggagcatgtggtttaattcgaagcaacgcgaagaac  
Unknown         ttgacggggacccgcacaagcggtggagcatgtggtttaattcgaagcaacgcgaagaac 
 
Staph. hominis cttaccaaatcttgacatcctttgacccttctagagatagaagtttccccttcgggggac  
Unknown         cttaccaaatcttgacatcctttgacccttctagagatagaagtttccccttcgggggac 
 
Staph. hominis aaagtgacaggtggtgcatggttgtcgtcagctcgtgtcgtgagatgttgggttaagtcc  
Unknown         aaagtgacaggtggtgcatggttgtcgtcagctcgtgtcgtgagatgttgggttaagtcc 
 
Staph. hominis cgcaacgagcgcaacccttaagcttagttgccatcattaagttgggcactctaagttgac  
Unknown         cgcaacgagcgcaacccttaagcttagttgccatcattaagttgggcactctaagttgac 
 
Staph. hominis tgccggtgacaaaccggaggaaggtggggatgacgtcaaatcatcatgccccttatgatt  
Unknown         tgccggtgacaaaccggaggaaggtggggatgacgtcaaatcatcatgccccttatgatt 
 
Staph. hominis tgggctacacacgtgctacaatggacaatacaaagggcagcgaaaccgcgaggtcaagca  
Unknown         tgggctacacacgtgctacaatggacaatacaaagggcagcgaaaccgcgaggtcaagca 
 
Staph. hominis aatcccataaagttgttctcagttcggattgtagtctgcaactcgactacatgaagctgg  
Unknown         aatcccataaagttgttctcagttcggattgtagtctgcaactcgactacatgaagctgg 
 
Staph. hominis aatcgctagtaatcgtagatcagcatgctacggtgaatacgttcccgggtcttgtacaca  
Unknown         aatcgctagtaatcgtagatcagcatgctacggtgaatacgttcccgggtcttgtacaca 
 
Staph. hominis ccgcccgtcacaccacgagagtttgtaacacccgaagccggtggagtaaccatttggagc  
Unknown         ccgcccgtcacaccacgagagtttgtaacacccgaagccggtggagtaaccatttggagc 
 
Staph. hominis tagccgtcgaaggtgggacaaatgattg  
Unknown         tagccgtcgaaggtgggacaaatgattg 
 
Figure S3.1: 16S rDNA alignment of unknown and Staphylococcus hominis 
16S rDNA was PCR amplified from the contaminating microorganisms that induced 
[gar-] to switch to [GAR+] cells.  The PCR product was sequenced as described and 
BLAST analysis performed against the GenBank database.  The unknown sample was 
99% identical to Staphylococcus hominis (1467 out of 1468 bases, the one difference 
being a gap). 
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S288c ttttattttcatttttaatgatcgcgattattctgttggaaataacg  
RM11 ttttattttcatttttaatgatcgcgattattctgttggaaataacg 
 
S288c ttctgatggagattgttggttacgttgccactcacgtaagaagttc 
RM11 ttctgatggagattgttggttacgttgccactcacgtaagaagttc  
 
S288c aaaggataatggcagaattttcagctgatctatgtctttttgacct 
RM11 aaaggataatggcagaattttcagctgatctatgtctttttgacct 
DOG1               atggcagaattttcagctgatctatgtctttttgacct 
 
S288c agatggtaccatagtgagtacaacagtggccgcagagaaagcatg  
RM11 agatggtaccatagtgagtacaacagtggccgcagagaaagcatg 
DOG1 agatggtaccatagtgagtacaacagtggccgcagagaaagcatg 
 
S288c gaccaagttgtgttacgaatacggtgttgatccttccgagttattt 
RM11 gaccaagttgtgttacgaatacggtgttgatccttccgagttattt 
DOG1 gaccaagttgtgttacgaatacggtgttgatccttccgagttattt 
 
S288c aagcattctcatggtgcaagaacacaagaggttttgagaaggtttt  
RM11 aagcattctcatggtgcaagatcacaagaaatgatgaagaaatttt 
DOG1 aagcattctcatggtgcaagaacacaagaggttttgagaaggtttt 
 
S288c tccctaaattggatgatacagacaataaaggtgttcttgctctaga 
RM11 ttccaaaattggacaataccgataataaaggtgttcttgcgttaga  
DOG1 tccctaaattggatgatacagacaataaaggtgttcttgctctaga 
 
S288c aaaagatat tgcccatagttacttggacacagtaagccttattcct  
RM11 aaaggatatggcagataattatttggacacagtaagccttatccct  
DOG1 aaaagatattgcccatagttacttggacacagtaagccttattcct 
 
S288c  ggtgcagagaacttactgttatcgttagatgtagatactgagactc  
RM11  ggtgcagagaatttattgttatcgttagatgtaaatactgagactc  
DOG1 ggtgcagagaacttactgttatcgttagatgtagatactgagactc 
 
S288c aaaaaaagttacctgaaaggaaatgggctatcgttacctctggttc  
RM11 aaaaaaagttacctgaaaggaaatgggctatcgttacctctggttc  
DOG1 aaaaaaagttacctgaaaggaaatgggctatcgttacctctggttc 
 
 
S288c tccatatttggcattttcatggttcgagacaatattgaaaaatgttg 
RM11 tccctatttggcattttcatggttcgagacaatattgaaaaatgttg  
DOG1 tccatatttggcattttcatggttcgagacaatattgaaaaatgttg  
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S288c gaaagcccaaagttttcattactgggtttgacgtgaagaacggtaa  
RM11 gaaagcccaaagttttcattactgggtttgacgtgaagaacggtaa 
DOG1 gaaagcccaaagttttcattactgggtttgacgtgaagaacggtaa 
 
S288c gcctgatcccgagggttattcaagagctcgtgatttattgcgtcaa  
RM11 gcctgatcccgagggttattcaagagctcgtgatttattgcgtcaa 
DOG1 gcctgatcccgagggttattcaagagctcgtgatttattgcgtcaa 
 
S288c gatttgcaattaactggtaaacaggatctgaagtatgttgtcttcg  
RM11 gatttgcaattaactggtaaacaggatctgaagtatgttgtctttg 
DOG1 gatttgcaattaactggtaaacaggatctgaagtatgttgtcttcg 
 
S288c aagatgcacccgtgggcataaaggccggcaaagcaatgggcgcca  
RM11 aagatgcacccgtgggcataaaggccggtaaagcaatgggcgcaa 
DOG1 aagatgcacccgtgggcataaaggccggcaaagcaatgggcgcca 
 
S288c ttactgtgggtataacatcctcgtatgacaagagcgttttatttgac 
RM11 ttactgtgggtataacatcctcgtatgataagagcgttttatttgac 
DOG1 ttactgtgggtataacatcctcgtatgacaagagcgttttatttgac 
 
S288c gcaggagcagattatgtagtctgtgatttgacacaggtttccgtgg  
RM11 gcaggtgcagattatgtagtctgtgatttgacacaggtttccgtgg 
DOG1 gcaggagcagattatgtagtctgtgatttgacacaggtttccgtgg 
 
S288c ttaagaacaatgaaaacggtattgtcatccaggtaaacaacccttt 
RM11 ttaagaacaatgagaacggtatcgttatccaggtaaacaacccttt 
DOG1 ttaagaacaatgaaaacggtattgtcatccaggtaaacaacccttt 
 
 
S288c gacaagggcctgagtaaacaaaaatgtgacaaaagaacgaatata 
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG1 gacaagggcctga 
 
S288c tatagatgtaaaacatatggacaagcaaaaagtcgaattatgtatg  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::  
 
S288c tcattttaggtactgaagaggtaagattttttttgagtttttcttcg  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
 
S288c aagatggttgtgtggttatatgttaatcttccttagcgcaaaacact 
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
  
S288c tccatcaactgtatttcgttggaatgctttgtattcagttttgtatca 
RM11 ::::::::::::::::::::::::: ::::::::::::::::::::::::::::::::::::::: 
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S288c ttatctttaatcacaattgcgtcaggatgtaagaactacgtaatgat  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::  
 
S288c cttattatttctcgtagagaatagttccgtagattgaatacgctccg 
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
 
S288c tcattatttttaaatgtggggaaggggtaattctcgaggatttttca  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
 
S288c aaaacttaaaatgcgctggcaacatcttctttggtgaaaacaaatg  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
 
S288c ctaaaaggagactaagagtactttttgttattcactatagtattagc  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
 
S288c caacacgttatcgatacatttactgctatatacataaaaaatttacg  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
 
S288c tcaaaaaaataaaaaaaaaaaatgccacaattttcagtagatcttt  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2                                    atgccacaattttcagtagatcttt 
 
S288c gtctttttgacctagatgggactattgtcagcacaacaactgcagcg  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 gtctttttgacctagatgggactattgtcagcacaacaactgcagcg 
 
S288c gaaagtgcctggaaaaaattatgccgtcagcatggggttgatcctg  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 gaaagtgcctggaaaaaattatgccgtcagcatggggttgatcctg 
 
S288c ttgagttattcaagcattcccatggtgcaagatcacaagaaatgatg  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 ttgagttattcaagcattcccatggtgcaagatcacaagaaatgatg 
 
S288c aagaaattttttccaaaattggacaataccgataataaaggtgttct  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 aagaaattttttccaaaattggacaataccgataataaaggtgttct 
 
S288c tgcgttagaaaaggatatggcagataattatttggacacagtaagcc  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 tgcgttagaaaaggatatggcagataattatttggacacagtaagcc 
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S288c ttatccctggtgcagagaatttattgttatcgttagatgtagatactg  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 ttatccctggtgcagagaatttattgttatcgttagatgtagatactg 
 
S288c agactcaaaaaaagttacctgaaaggaaatgggctatcgttacctct  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 agactcaaaaaaagttacctgaaaggaaatgggctatcgttacctct 
 
S288c ggttctccatatttggcattttcatggttcgagacaatattgaaaaat  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 ggttctccatatttggcattttcatggttcgagacaatattgaaaaat 
 
S288c gttggaaagcccaaagttttcattactggatttgacgtgaagaacgg  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 gttggaaagcccaaagttttcattactggatttgacgtgaagaacgg 
 
S288c taagcctgatcccgagggttactcaagagctcgtgatttattgcgtc  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 taagcctgatcccgagggttactcaagagctcgtgatttattgcgtc 
 
S288c aagatttgcaattaactggtaaacaggatctgaagtatgttgtcttt  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 aagatttgcaattaactggtaaacaggatctgaagtatgttgtcttt 
 
S288c gaagatgcacccgtgggcataaaggccggcaaagcaatgggcgcaa  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 gaagatgcacccgtgggcataaaggccggcaaagcaatgggcgcaa 
 
S288c ttactgtgggtataacatcctcgtatgataagagcgttttatttgacg  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 ttactgtgggtataacatcctcgtatgataagagcgttttatttgacg 
 
S288c caggtgcagattatgtggtctgtgatttgacacaggtttccgtggtt  
RM11 ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 caggtgcagattatgtggtctgtgatttgacacaggtttccgtggtt 
 
S288c aagaacaatgagaacggtatcgttatccaggtaaacaaccctttgac  
RM11 :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
DOG2 aagaacaatgagaacggtatcgttatccaggtaaacaaccctttgac 
 
S288c gagagattaaataaataaggacatcgcagaagcacgaatatata 
RM11 ::::::::: gacgagagattaaataaataaggacatcgcagaagcacga  
DOG2 gagagattaa 
 
S288c agataaaattgtatgtaaaagcaaaagttga::::::::::actgcgtatga 
RM11 agataaaattgtatgtaaaagcaaaagttgattgaactgcgtatga  
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S288c tttcttatagtgagtatgaaatttttttttttttt:::::ggttatctaact  
RM11 tttcttatagtgagtatgaaattttttttttttttttggttatctaact  
 
S288c tatttttctt 
RM11 tatttttctt 
 
 
Figure S3.2: Alignment of S288c and RM11 in the region surrounding DOG1 and DOG2 
Region on chromosome VIII that corresponds with altered [GAR+] frequency by QTL 
mapping (figure 3.4).  The RM11 parent has lost DOG2 and its upstream region, whereas 
BY4716 contains both DOG1 and DOG2.  As the DOG genes confer resistance to 2-
deoxyglucose, this region could be responsible for the difference in [GAR+] frequency 
observed between BY and RM11. 
 
 176
  
 
 
 
 
 
 
 
 
 
 177
  
Figure S3.3: Screen for inducers of [GAR+] 
A library of ~5000 ORFs was overexpressed as previously described using the inducible 
GAL1 promoter combined with the estradiol system (Louvion et al., 1993; Quintero et al., 
2007).  Following 48 hours growth in inducing medium, cells were plated to glycerol-
glucosamine medium to select for [GAR+] cells.  a) A typical glycerol-glucosamine plate 
from this screen.  Control cells are in the upper left corner in the red box.  STD1 under 
control of the GPD promoter (top left) and the GAL-estradiol system (top right) grew on 
glycerol-glucosamine medium, as expected.  Cells containing empty vectors (bottom left) 
did not grow.  No ORF tested on this plate induced [GAR+].  b) Controls (red box) are the 
same as in part a.  On this plate three ORFs induced [GAR+] following overexpression 
(green circles): STD1 (left), DOG2 (middle), and SPO23 (right).  c) Quantification of the 
increase in [GAR+] frequency following overexpression of STD1, DOG2, or SPO23.  The 
increase in [GAR+] cells is seven fold, 23 fold, or 28 fold relative to vector, respectively.  
Error bars are +/- standard deviation. 
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Chapter Four: 
 
Conclusions and Further Experiments 
 
When we began this work, fungal prions were limited in number, involved an 
amyloid-based structure only, and tended to be rich in glutamines and asparagines.  
[PSI+], [URE3], and [Het-s] were long-standing, previously unexplained phenotypes that 
had been identified as prions based on genetic characteristics.  All three proteins 
aggregated in their [PRION+] form and entered into insoluble, SDS-resistant heritable 
aggregates.  Chaperone activity, particularly that of Hsp104, fragmented aggregates to 
create heritable prion seeds (Shorter and Lindquist, 2005).  To the best of anyone’s 
knowledge, fulfillment of the genetic attributes of prions required an aggregation- and 
amyloid-based mechanism of inheritance. 
Most of the early attempts to identify additional fungal prions were based on 
sequence, particularly looking for N- and Q-rich proteins.  These identified [RNQ+] 
(Sondheimer and Lindquist, 2000) and [NU+] (Michelitsch and Weissman, 2000; 
Osherovich et al., 2004) but pre-disposed the results to amyloid-based prions. 
Prions in general were originally defined only as a protein-based infectious 
element and fungal prions were defined by their genetic characteristics, albeit with the 
suggestion that they could be caused by a conformational change (Wickner, 1994; 
Prusiner, 1998; Shorter and Lindquist, 2005).  However, because the initial set of fungal 
prions aggregated in the [PRION+] form, the first decade or so of work on fungal prions 
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focused on how aggregation was linked to heritability.  Recent work in the fungal prion 
field has considered whether genetic elements that do not involve amyloids might act as 
prions (Wickner et al., 2007).  The first of these was a self-activating protease, [β], which 
under artificial conditions is self-propagating.  However, because [β] is only self-
propagating in a ∆pep4 background, it serves more as a proof-of-principle than a 
physiologically important non-amyloid based fungal prion (Roberts and Wickner, 2003).  
Another putative non-amyloid prion, Crippled growth (C), seems to be caused by a self-
sustaining MAP kinase cascade.  However, data on the mechanism of C propagation or 
even which proteins are involved are limited (Kicka and Silar, 2004; Kicka et al., 2006). 
Our work on [GAR+] advances the prion field by demonstrating the existence of a 
non-amyloid, composite prion consisting of a transmembrane protein and a signaling 
protein that likely alter a signaling cascade in the [PRION+] form.  [GAR+] fulfills all the 
genetic characteristics of a prion: it exhibits semi-dominant, non-Mendelian, infectious 
inheritance, appears spontaneously at a very high frequency, and is susceptible to 
chaperones.  However, [GAR+] is otherwise quite different from the other fungal prions. 
The signaling protein STD1 strongly induces a stable [GAR+] state following 
transient overexpression but is not essential for [GAR+] propagation.  [PSI+] and [URE3] 
are both induced by transient overexpression of their prion-determining proteins but these 
proteins are then necessary for prion propagation (Wickner et al., 1995).  The closest 
situation to that of [GAR+] and STD1 is that [RNQ+] is necessary for [PSI+] induction but 
not propagation (Derkatch et al., 2000; Derkatch et al., 2001). 
[GAR+] is also novel among fungal prions because Pma1, one protein involved in 
[GAR+], is a transmembrane protein.  PrP, the mammalian prion protein, is GPI-
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anchored, but it changes location in the disease-associated form and enters into 
extracellular aggregates (Prusiner, 1998).  [GAR+] therefore expands the category of 
potential prions to include transmembrane proteins and proteins that do not change 
localization or solubility between [prion-] and [PRION+]. 
Finally, [GAR+] appears to be involved in a signaling cascade.  Std1 is part of the 
Rgt2/Snf3 signaling pathway in [gar-] cells (Schmidt et al., 1999) and seems to still be 
associated with that pathway in [GAR+] cells.  When S. cerevisiae is grown in glucose, a 
signal is propagated through the Snf3/Rgt2 pathway that prevents transcriptional 
repression of HXT3.  However, in HXT3 is prematurely silenced in [GAR+].  Mutations in 
Pma1 that alter the rate of appearance of [GAR+] also show increased silencing at HXT3.  
This silencing is greater than can be accounted for by the increased [GAR+] frequency 
alone.  Therefore, we hypothesize that Pma1 is involved in the Rgt2/Snf3 signaling 
pathway and that [GAR+] represents an altered signaling cascade through the Rgt2/Snf3 
pathway.  This is quite different from [PSI+], [URE3], [Het-s], and [RNQ+]. 
There are four outstanding questions about [GAR+] that we find particularly 
interesting: do Pma1 and Std1 act together to create [GAR+]; how is [GAR+] passed from 
mother to daughter cells; is the transition between [gar-] and [GAR+] regulated and if so, 
how; and is [GAR+] found in other species or outside fungi.  These are related to the 
larger question of what sort of proteins can be heritable and how and whether prions are 
common or found in a variety of species. 
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How are Pma1 and Std1 involved in [GAR+] propagation and induction? 
PMA1 is sufficient for a species barrier in [GAR+] and replacing PMA1 from S. 
cerevisiae with PMA1 from other Saccharomyces species is sufficient to block [GAR+] 
propagation.  These data demonstrate the importance of Pma1 in [GAR+] propagation.  
Swapping PMA1 between species, however, could also disrupt protein interactions 
involving Pma1.  The species barrier experiment there implicates Pma1 but does not 
eliminate the involvement of other proteins.  Further, mutations in both Pma1 and Std1 
are required for preventing [GAR+] propagation and neither mutation alone is sufficient 
to cure [GAR+].  Is Std1 also involved in [GAR+] propagation? 
Random mutagenesis of Std1 and Pma1 could help determine how the two 
interact and what makes [GAR+] heritable.  If one could isolate a form of Std1 that 
increases the frequency of [GAR+] appearance, whether the mutant Std1 acted by 
increasing association with Pma1 or by some other mechanism would be informative.  
Mutational analysis should be extended to the N-terminal region of Pma1 to determine 
whether association with Std1 or oligomerization of Pma1 is more important for the 
formation of [GAR+].  The N-terminus of Pma1 is thought to be involved in but is not 
sufficient for Pma1 homooligomerization (Kuhlbrandt et al., 2002; Liu et al., 2006).  
Transient overexpression of a PMA1 mutant lacking the N-terminal 40 amino acids does 
not increase [GAR+] frequency, whereas overexpression of wildtype PMA1 increases 
[GAR+] appearance.  Does the N-terminal truncation change Pma1 oligomers or its 
association with Std1?  Blue Native gel analysis could be performed on the N-terminus 
mutant to determine whether it is still capable of associating with Std1 and whether Pma1 
still forms high molecular weight oligomers.  If both oligomers and Std1 association are 
 182
disrupted, one could create smaller mutations within the N-terminal region of the 
endogenous copy of Pma1 in an attempt to identify mutants that no longer stably 
associate with Std1.  These could then be used to determine whether Std1 is necessary for 
[GAR+] propagation, propagating the signal through the Rgt2/Snf3 pathway, or whether 
the two are irretrievably linked. 
[GAR+] exhibits a strong species barrier, since Pma1 from S. paradoxus cannot 
propagate [gar-] of S. cerevisiae Pma1 origin (see chapter two).  The sequence of Pma1 
differs little between the species but Std1 differs considerably.  Is this “species barrier” 
between S. paradoxus and S. cerevisiae [GAR+] the result of differences in Std1?  This 
could be shown by substituting STD1 from S. paradoxus for the S. cerevisiae version.  
Also, one could test whether S. bayanus Pma1, which weakly propagates S. cerevisiae 
[GAR+] can associate with S. cerevisiae Std1 and vice versa. 
Another way of probing the Std1/Pma1 relationship would be to determine 
whether the association in [GAR+] between individual Std1 and Pma1 molecules is long- 
or short-lived.  Our data suggest that the association overall is stable, but if the turnover is 
high that it suggests a model such Std1 being protected from degradation but still 
interacting with Rgt1, rather than a long-term association between Std1 and Pma1 
creating a new signal or altering the membrane organization through shifting protein 
complexes.  Fluorescent recovery after photobleaching (FRAP) could be used to monitor 
the association between Std1 and Pma1 and such methods have been used to monitor 
membrane protein turnover in the past.  First tagged Std1 could be bleached and 
monitored to determine dynamics and whether its association with Pma1 is long- or 
short-lived.  Tagged Pma1 could then be monitored to determine whether Pma1 in 
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[GAR+] shows different dynamics than Pma1 in [gar-] cells.  This could also show 
whether membrane fluidity is similar in [gar-] cells and [GAR+] cells. 
Std1 is involved in propagating the glucose signal (Schmidt et al., 1999; Kaniak et 
al., 2004) and our data suggest that Pma1 is also involved in signaling through the 
Rgt2/Snf3 pathway.  What role does Mth1, the homolog of Std1 (Hubbard et al., 1994), 
play in [GAR+] propagation?  Mth1 blocks [GAR+] appearance when transiently 
overexpressed, possibly due to transcriptional repression of STD1 (Kaniak et al., 2004), 
and we see Mth1 associating with Pma1 oligomers in the [gar-] form.  Does the 
association of Mth1 physically block the association of Std1, thus preventing the 
formation of [GAR+]?  Or does Mth1 set up a [gar-] state that, like [GAR+], is also self-
supporting?  One could perform mutation analysis of Mth1 and Std1 by domain swapping 
to determine which regions are important for the association with Pma1.  Mth1 and Std1 
have been shown to be degraded when glucose is present but Std1 is then newly 
transcribed, whereas MTH1 transcription is repressed (Flick et al., 2003).  Is this turnover 
of the cellular Std1 somehow important for [GAR+]?  Which regions in Std1 and Mth1 
are involved in their different associations with Pma1?  The N-terminal half is most 
probably, as that is the divergent region; the C-terminal portions are fairly similar to each 
other (supplemental).  Chimeric proteins could be overexpressed to determine which 
promote and which block [GAR+] appearance. 
Finally, the role of the N- and C-termini of Pma1 in formation of the [GAR+] 
heritable element is not completely understood.  Engineering chimeric proteins 
containing either the N- or the C-terminus fused to a stable protein containing a single 
membrane-spanning domain would help address this question.  The constructs could be 
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overexpressed, presumably without the toxicity that results from PMA1 overexpression, 
to definitively establish whether the N- or C-terminus can induce [GAR+].  Random 
mutagenesis of the Pma1 N- and C-terminal regions of these constructs could be used to 
identify contacts important for [GAR+] formation and propagation.  That information 
could then be used to investigate the importance of the Pma2 oligomer for [GAR+] and 
further strengthen the argument that Pma1 is responsible for [GAR+]. 
 
How is [GAR+] heritable? 
Previously described yeast prions form amyloid aggregates in the [PRION+] form; 
transmission of these aggregates from mother cells to daughter cells renders the 
[PRION+] protein conformation heritable (Cox et al., 2003).  However, [GAR+] does not 
form aggregates, so how is it propagated from mother cell to daughter cell?  This 
question would be relatively easy to answer for amyloid-based prions, but no one has 
observed a heritable phenotype dependent on a membrane protein before.  Is [GAR+] 
heritable due to Pma1/Std1 prion “seeds” or is it heritable because it creates a self-
propagating signaling cascade (figure 4.1)? 
The ideal way to answer the mechanism of heritability would be by protein 
transformation.  The transformation of S. cerevisiae cells from [psi-] to [PSI+] by 
transformation of Sup35 protein fibers provided definitive proof of protein-only 
inheritance and thus the prion hypothesis (Tanaka et al., 2004).  Since these experiments, 
researchers have been able to induce [URE3] (Brachmann et al., 2005), [RNQ+] (Patel 
and Liebman, 2007), [Het-s] (Ritter et al., 2005), and [Cin] (Collin et al., 2004) by 
protein transformation.  Protein transformation of [GAR+] by Pma1 would 
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Figure 4.1: How is [GAR+] heritable? 
a) The [GAR+] element could be heritable because it establishes a self-perpetuating 
signaling pathway.  For instance, transcriptional repression caused by Std1 and Rgt1 
could repress genes in addition to HXT3 that, for example, might degrade Std1 protein or 
repress the STD1 gene or a gene involved in the glucosamine-resistant phenotype.  This 
could setup a feedback loop, in which Pma1 and Std1 alter glucose signaling in such a 
way that the new signal strengthens the association between Pma1 and Std1, thus 
sustaining the original signal.  b) A second model for [GAR+] proposes that Pma1 enters 
into a self-propagating protein conformation, possibly due to its association with Std1.  
This conformation could alter signaling through the Rgt2/Snf3 signaling pathway, which 
accounts for the transcriptional repression of HXT3 in glucose-grown [GAR+] cells. 
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incontroversially establish Pma1 as a causal agent of [GAR+] but show whether the 
heritable form is modified, enzymatically active, etc.  These would help determine 
whether [GAR+] is heritable solely because of conformation or because of activity such 
as a self-propagating cascade.  Unfortunately, protein transformation with Pma1 presents 
a number of difficulties.  A large protein with 10 transmembrane domains would be hard 
to purify from E. coli.  One could purify just the N-terminal region, which when deleted 
prevents induction of [GAR+] by transient overexpression of PMA1.  However, one lacks 
a method of inducing this peptide to enter into the [GAR+] conformation, assuming the 
[GAR+] form results from protein conformation and not posttranslational modification.  
If a protein transformation protocol could be established for [GAR+], it could be 
used to determine what is necessary and sufficient for [GAR+].  Is Std1 necessary for 
transformation of Pma1 or does Std1 just make the conversion more efficient?  Do 
posttranslational modifications facilitate the switch between [gar-] cells and [GAR+] 
cells?  The creation of [GAR+] in vitro might also provide enough material for structural 
studies. 
If a protein transformation protocol cannot be established, one could attempt to 
address the question of conformation or signaling cascade using some of the mutational 
analysis described in the previous section.  The question of how posttranslational 
modification affects Pma1 and [GAR+] could be addressed with alanine- and/or glutamic 
acid-scanning mutagenesis of the N-terminal region of Pma1. 
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What causes the switch between [gar-] and [GAR+] and is it regulated? 
It is not known whether or how the switch from [prion-] cells to [PRION+] cells is 
regulated.  Chaperones are necessary for the maintenance and inheritance of prion 
phenotypes and conditions that alter chaperone levels affect the appearance and 
propagation of prions (Jones and Tuite, 2005).  For example, a number of chemical stress 
conditions increase the frequency of [PSI+] appearance (Tyedmers et al., unpublished).  
As all prions are sensitive to chaperones, are all prions similarly sensitive to 
environmental conditions?  If so, this would strengthen the argument that prions can 
occasionally be beneficial, as it would suggest that prions represent an environmentally 
responsive mechanism of phenotypic sampling. 
[GAR+] suggests an additional mechanism of prion regulation: phosphorylation.  
Pma1 enzyme activity is regulated by phosphorylation and serine to alanine mutations in 
phosphorylation sites increase [GAR+] frequency.  Can phosphorylation or 
dephosphorylation induce Pma1 to switch between different prion states?  A number of 
kinases have been shown to phosphorylate Pma1; the expression level of some of these 
could be altered to determine whether they alter [GAR+] frequency.  Several of kinases 
that regulate Pma1 are members of Npr/Hal5 family, which regulate nutrient transporters 
(Goossens et al., 2000).  [GAR+] might therefore have a level of regulation beyond what 
other prions have, and be sensitive both to nutrient-sensitive phosphorylation and changes 
in chaperone levels. 
As Pma1 is already known to be phosphorylated, why would it be subject to the 
additional level of regulation that is this stable, heritable propagation of the [GAR+] prion 
phenotype?  Phosphorylation acts rapidly and responds quickly to environmental 
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conditions, which renders [GAR+] seemingly redundant.  However, a possible advantage 
of [GAR+] is that the entire population of cells, or even all of the protein in a single cell, 
does not enter into the [GAR+] form.  Instead, a subset switches to [GAR+] but the 
population as a whole does not suffer from the negative consequences of [GAR+].  This 
would be more difficult to obtain through kinase activity, which tends to have high 
penetrance. 
 
Does the [GAR+] heritable element confer a benefit to its host? 
Whether prions are found in wild yeast and whether they confer any benefit to 
their hosts are points of ongoing debate (True and Lindquist, 2000; True et al., 2004; 
Wickner et al., 2007).  The [GAR+] element provides a particularly interesting subject for 
these questions because glucose metabolism is central to cell survival.  [GAR+] appears 
spontaneously at extremely high frequency, up to one in 100 cells in some strains.  Yeast 
isolated from a particular ecological niche, fruit, showed enrichment for high [GAR+] 
frequency, suggesting that [GAR+] might occasionally be advantageous.  Experiments 
directly competing [gar-] cells and [GAR+] cells suggest the same conclusion.  [GAR+] 
can be induced by a number of Staphylococcus species, making it probable that yeast 
cells carrying the [GAR+] element could be found in the wild. 
However, we do not currently know whether [GAR+] is found in other fungi or 
plants.  If [GAR+] is conserved, it is more likely to be beneficial.  The plant equivalent of 
Pma1 exists in many isoforms, including 11 in Arabidopsis and seven in tomato.  The 
enzyme activity and sometimes expression levels of many of these are sensitive to 
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environmental conditions, including glucose, the hormone auxin, and light (Portillo, 
2000). 
 
How widespread is [GAR+] and, by extension, prions in general? 
Pma1 is a highly conserved protein that is found in both fungi and plants.  
Whether Pma1’s prion-forming ability is also conserved is potentially very interesting, 
particularly since prions have not yet been identified in plants.  Pma1 in other fungi also 
show interesting properties.  For instance, Pma1 from C. albicans species is responsive to 
the clinically important dimorphic switch (Monk et al., 1993). 
One difficulty in assaying for [GAR+] outside of S. cerevisiae is that they 
phenotype of [GAR+] requires glucose repression.  While many fungi exhibit some sort 
of carbon catabolite repression, it is very efficientt in S. cerevisiae and S. pombe.  These 
other fungi do, however, carry PMA1 (Portillo, 2000).  In many cases, the predicted 
Pma1 protein has a long, unstructured, cytoplasmic N-terminal region that resembles the 
S. cerevisiae one necessary for overexpression-induced increase in [GAR+] frequency.  
One therefore should not limit searching for [GAR+] in organisms that have glucose 
repression or STD1 but instead look at a variety of organisms, particularly those in which 
Pma1 has unstructured cytoplasmic regions.  Regulation of enzyme activity of Pma1 
relatives by environmental conditions is found in other fungi and in plants; this could be 
an important property in whether something can for [GAR+]. 
To determine whether PMA1 from other organisms can form a prion, tests can 
first be perform in S. cerevisiae, then developed in the native organism.  This has been 
used before to identify prions; SUP35 from a variety of fungi has been shown to act as a 
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prion in S. cerevisiae.  A gene from the sea slug Aplysia californica was successfully 
tested for prion-like properties in S. cerevisiae (Si et al., 2003).  Our work suggests that 
PMA1 from Saccharomyces paradoxus and Saccharomyces bayanus can maintain 
[GAR+] in S. cerevisiae even though they cannot propagate [GAR+] to S. cerevisiae 
PMA1.  It therefore seems reasonable to test PMA1 alleles from other organisms, even 
those that lack STD1 or MTH1, in S. cerevisiae for prion-like properties. 
If PMA1 from other organisms can act as a prion in S. cerevisiae, it would be 
interesting to test whether PMA1 can form a prion in its organism of origin.  This is more 
difficult because the [PRION+] phenotype is unknown.  Fortunately Pma1 is a well-
studied protein, so one could use known phenotypes of mutants as a starting point to 
identify a possible [GAR+] phenotype.  For example, S. cerevisiae [GAR+] is more 
sensitive to caspofungin in [GAR+] than [gar-]; perhaps C. albicans or C. neoformans 
[GAR+] equivalent would exhibit a similar phenotype. 
[GAR+] is an interesting new prion partly because its causal agent, Pma1, is well 
conserved and could be the basis for identifying prions in plants.  However, because 
Pma1 is a transmembrane protein it also could serve as a starting point for identifying 
transmembrane proteins that can form prions.  Recent work showed that the 
transmembrane protein syntaxin forms large homooligomers via its extracellular regions 
(Sieber et al., 2007).  Pma1 similarly forms large homooligomers through a domain not 
embedded in the membrane.  This leads us to speculate that either the prion phenotype of 
Pma1 is a byproduct of the oligomerization or the oligomerization leads to its prion-
forming ability.  Can proteins that form large oligomers in the membrane form prions?  
One could start by testing transporters in S. cerevisiae that show unstructured 
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cytoplasmic regions for prion-like properties and then perhaps extend the study to other 
organisms. 
 
We described here a new prion, [GAR+], which involves the transmembrane 
protein Pma1 and the glucose signaling molecule Std1.  These two elements associate in 
the [GAR+] but do not aggregate, change localization, or form an amyloid.  [GAR+] 
therefore represents a novel type of prion that functions by an unknown mechanism that 
might involve a signaling cascade.  This expands the pool of potential prions to include 
transmembrane proteins and demonstrates that prions need not aggregate or form 
amyloid.  As Pma1 is a well-conserved protein found in a variety of species it is an 
excellent candidate for testing the commonality of the prion phenomenon.  We also 
suggest that [GAR+] might be beneficial to its host under some conditions and is induced 
by co-culturing S. cerevisiae with a variety of Staphylococcus species.  These data 
suggest that the [GAR+] heritable element could well be found in the wild. 
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